Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 3.4.24.23 - matrilysin

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Abortion, Spontaneous
Functional single nucleotide polymorphisms of matrix metalloproteinase 7 and 12 genes in idiopathic recurrent spontaneous abortion.
Acquired Immunodeficiency Syndrome
Application of MMP-7 and MMP-10 in assisting the diagnosis of malignant pleural effusion.
Acute Coronary Syndrome
Role of matrix metalloproteinases in coronary artery disease.
[Changes in proinflammatory cytokine and destructive metalloproteinase levels during formation of unstable atherosclerotic plaque]
[Inflammatory-destructive biomarkers of atherosclerotic plaques instability. Study of arterial wall and blood].
Acute Kidney Injury
Matrix metalloproteinase-7 protects against acute kidney injury by priming renal tubules for survival and regeneration.
Measurement of urinary matrix metalloproteinase-7 for early diagnosis of acute kidney injury based on an ultrasensitive immunomagnetic microparticle-based time-resolved fluoroimmunoassay.
The Many Faces of Matrix Metalloproteinase-7 in Kidney Diseases.
Acute Lung Injury
Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury.
Adenocarcinoma
A Panel of Tumor-associated Autoantibodies for the Detection of Early-stage Breast Cancer.
Analyses of matrix metalloproteinases and their inhibitors in cyst fluid of serous ovarian tumors.
Association between expression of MMP-7 and MMP-9 and pelvic lymph node and para-aortic lymph node metastasis in early cervical cancer.
Association of matrilysin expression with progression and poor prognosis in human pancreatic adenocarcinoma.
Association of matrilysin mRNA expression with K-ras mutations and progression in pancreatic ductal adenocarcinomas.
Beta-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: relationships with carcinogenesis and metastasis.
Citrus auraptene targets translation of MMP-7 (matrilysin) via ERK1/2-dependent and mTOR-independent mechanism.
Clarification of the active gelatinolytic sites in human ovarian neoplasms using in situ zymography.
Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer.
Correlation between the immunohistochemical expressions of MMP-1, MMP-7 and VEGF and prognostic factors in colorectal adenocarcinoma.
Differential expression of matrix metalloprotease-7 in each component of uterine carcinosarcoma.
EGF induces the expression of matrilysin in the human prostate adenocarcinoma cell line, LNCaP.
Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis.
Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study.
Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer Relation to clinicopathological factors, beta-catenin and prognosis.
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.
Expression of metalloproteinase genes in human prostate cancer.
Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.
Expression of mRNA MMP-7 and mRNA TIMP-1 in non-small cell lung cancer.
Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric adenocarcinoma.
Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas.
Expressions of Matrix Metalloproteinases 2, 7, and 9 in Carcinogenesis of Pancreatic Ductal Adenocarcinoma.
Immunohistochemical study of fibrosis and adenocarcinoma in dominant-negative p53 transgenic mice exposed to chrysotile asbestos and benzo(a)pyrene.
Immunohistochemical study of vascular endothelial growth factor (VEGF) and matrilysin (MMP-7) in T1 adenocarcinoma of the colon and rectum to predict lymph node metastases or distant metastases.
Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition.
Intraductal papillary mucinous neoplasms of the pancreas: an analysis of protein expression and clinical features.
Matrilysin-1 (MMP-7) and MMP-19 are expressed by Paget's cells in extramammary Paget's disease.
Matrix metalloproteinase (MMP)-7 in Barrett's esophagus and esophageal adenocarcinoma: expression, metabolism, and functional significance.
Matrix metalloproteinase 7 is required for tumor formation, but dispensable for invasion and fibrosis in SMAD4-deficient intestinal adenocarcinomas.
Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers.
Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas.
Metalloproteinase-1, metalloproteinase-7, and p53 immunoexpression and their correlation with clinicopathological prognostic factors in colorectal adenocarcinoma.
MT1-MMP and MMP-7 in invasion and metastasis of human cancers.
Multiplex Soluble Biomarker Analysis from Pleural Effusion.
Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer.
Predictive value of MMP-7 expression for response to chemotherapy and survival in patients with non-small cell lung cancer.
Serum CA19-9, cathepsin D, and matrix metalloproteinase-7 as a diagnostic panel for pancreatic ductal adenocarcinoma.
Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.
The expression of mmp-7 messenger-RNA in primary and metastatic human colorectal adenocarcinoma.
The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma.
Tumorigenesis and phenotypic characteristics of mucin-producing bile duct tumors: an immunohistochemical approach.
Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett's oesophageal adenocarcinoma.
Urachal Carcinoma of the Bladder: Impact of Clinical and Immunohistochemical Parameters on Patient Prognosis.
[The significance of beta-catenin and matrix metalloproteinase-7 expression in colorectal adenoma and carcinoma]
Adenocarcinoma of Lung
Antisense oligonucleotide targeting matrix metalloproteinase-7 (MMP-7) changes the ultrastructure of human A549 lung adenocarcinoma cells.
Chronic exposure to exogenous matrilysin induces chemoresistance and enhances Bcl-2 expression in A549 lung adenocarcinoma cells.
Matrilysin inhibits proliferation and modulates sensitivity of lung cancer cells to FasL-mediated apoptosis.
MiR-22-3p Expression is down-regulated in lung adenocarcinoma.
MMP-7 is upregulated by COX-2 and promotes proliferation and invasion of lung adenocarcinoma cells.
Pericellular activation of proMMP-7 (promatrilysin-1) through interaction with CD151.
Rapid detection of matrix metalloproteinase-7 and carcinoembryonic antigen mRNA expression in intraoperative pleural lavage samples using the reverse transcriptase loop-mediated isothermal amplification method.
Adenocarcinoma, Mucinous
Distinct clinicopathologic characteristics of lung mucinous adenocarcinoma with KRAS mutation.
Intraductal papillary mucinous neoplasms of the pancreas: an analysis of protein expression and clinical features.
Tumorigenesis and phenotypic characteristics of mucin-producing bile duct tumors: an immunohistochemical approach.
Adenoma
Analyses of matrix metalloproteinases and their inhibitors in cyst fluid of serous ovarian tumors.
Detection of colorectal adenomas using a bioactivatable probe specific for matrix metalloproteinase activity.
Differential gene expression between flat adenoma and normal mucosa in the colon in a microarray analysis.
E1A-F is overexpressed early in human colorectal neoplasia and associated with cyclooxygenase-2 and matrix metalloproteinase-7.
Enhanced secretion and activation of matrilysin during malignant conversion of human colorectal epithelium and its relationship with invasive potential of colon cancer cells.
Examining the role of Paneth cells in the small intestine by lineage ablation in transgenic mice.
Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis.
Expression of matrilysin mRNA in colorectal adenomas and its induction by truncated fibronectin.
Expression of matrix metalloproteinase matrilysin (MMP-7) was induced by activated Ki-ras via AP-1 activation in SW1417 colon cancer cells.
Expression of matrix metalloproteinases and related tissue inhibitors in the cyst fluids of ovarian mucinous neoplasms.
Expression of matrix metalloproteinases in benign and malignant follicular thyroid lesions.
Expression of putative anticancer targets in familial adenomatous polyposis and its association with the APC mutation status.
Immunohistochemical expression of matrix metalloproteinase-7 in human colorectal adenomas using specified automated cellular image analysis system: a clinicopathological study.
Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin.
Intraductal papillary mucinous neoplasms of the pancreas: an analysis of protein expression and clinical features.
Matrilysin gene expression in sporadic and familial colorectal adenomas.
Matrilysin is associated with progression of colorectal tumor.
Matrix metalloproteases expression in different histological types of colorectal polyps.
Matrix metalloproteinase-9 contributes to intestinal tumourigenesis in the adenomatous polyposis coli multiple intestinal neoplasia mouse.
Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways.
Overexpression of poly(ADP-ribose) polymerase-1 (PARP-1) in the early stage of colorectal carcinogenesis.
Prognostic and predictive potential molecular biomarkers in colon cancer.
Relationship between matrix metalloproteinase-7 and pit pattern in early stage colorectal cancer.
Role of matrix metalloproteinase-7 in colorectal adenomas.
Role of matrix metalloproteinases in colorectal carcinogenesis.
Sulindac treatment alters collagen and matrilysin expression in adenomas of ApcMin/+ mice.
The behavior of MMP-2, MMP-7, MMP-9 and their inhibitors TIMP-1, TIMP-2 in adenoma-colorectal cancer sequence.
The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors.
The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors.
Truncated mouse adenomatous polyposis coli reduces connexin32 content and increases matrilysin secretion from Paneth cells.
[The significance of beta-catenin and matrix metalloproteinase-7 expression in colorectal adenoma and carcinoma]
Adenoma, Liver Cell
Distinction of hepatocellular adenoma from hepatocellular carcinoma with and without cirrhosis using E-cadherin and matrix metalloproteinase immunohistochemistry.
Adenoma, Villous
Role of matrix metalloproteinase-7 in colorectal adenomas.
Adenomatous Polyposis Coli
Correlation between beta-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors.
Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms.
Matrilysin gene expression in sporadic and familial colorectal adenomas.
Matrix metalloproteinase-9 contributes to intestinal tumourigenesis in the adenomatous polyposis coli multiple intestinal neoplasia mouse.
Nestin positively regulates the Wnt/?-catenin pathway and the proliferation, survival and invasiveness of breast cancer stem cells.
Truncated mouse adenomatous polyposis coli reduces connexin32 content and increases matrilysin secretion from Paneth cells.
Adenomatous Polyps
Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?
Adenomyosis
Polymorphisms in the promoter regions of the matrix metalloproteinases-7, -9 and the risk of endometriosis and adenomyosis in China.
[Expression of the small molecular weight matrix metalloproteinase in adenomyosis of the mouse uterus]
Adrenal Cortex Neoplasms
MicroRNA signature in massive macronodular adrenocortical disease and implications for adrenocortical tumorigenesis.
Aggressive Periodontitis
Matrix metalloproteinase -7, -8, -9 and -13 in gingival tissue of patients with type 1 diabetes and periodontitis.
The in vivo expression of the collagenolytic matrix metalloproteinases (MMP-2, -8, -13, and -14) and matrilysin (MMP-7) in adult and localized juvenile periodontitis.
AIDS Dementia Complex
Matrix metalloproteinase activity stimulates N-cadherin shedding and the soluble N-cadherin ectodomain promotes classical microglial activation.
Albuminuria
Canonical Wnt/?-catenin signaling mediates transforming growth factor-?1-driven podocyte injury and proteinuria.
Alzheimer Disease
Analysis of Matrix Metallo-Proteases and the Plasminogen System in Mild Cognitive Impairment and Alzheimer's Disease Cerebrospinal Fluid.
MMP-7 cleaves amyloid ? fragment peptides and copper ion inhibits the degradation.
Ameloblastoma
Immunohistochemical expression of matrilysins (MMP-7 and MMP-26) in ameloblastomas and adenomatoid odontogenic tumors.
MMP-7, -8, -9, E-cadherin, and beta-catenin expression in 34 ameloblastoma cases.
Amyotrophic Lateral Sclerosis
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy.
Genetic analysis of matrin 3 gene in French amyotrophic lateral sclerosis patients and frontotemporal lobar degeneration with amyotrophic lateral sclerosis patients.
Heterogeneity of Matrin 3 in the developing and aging murine central nervous system.
Knockdown of genes involved in axonal transport enhances the toxicity of human neuromuscular disease-linked MATR3 mutations in Drosophila.
Matrin 3 Is a Component of Neuronal Cytoplasmic Inclusions of Motor Neurons in Sporadic Amyotrophic Lateral Sclerosis.
Mutant MATR3 mouse model to explain multisystem proteinopathy.
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis.
Subcellular Localization of Matrin 3 Containing Mutations Associated with ALS and Distal Myopathy.
Aneurysm
Aneurysm Severity is Increased by Combined Mmp-7 Deletion and N-cadherin Mimetic (EC4-Fc) Over-Expression.
The expression of MMP-7 in serum and aneurysm tissues of patients with abdominal aortic aneurysm associated with hypertension and the clinical efficacy of endovascular exclusion.
Angina, Stable
Role of matrix metalloproteinases in coronary artery disease.
Aortic Aneurysm, Abdominal
The expression of MMP-7 in serum and aneurysm tissues of patients with abdominal aortic aneurysm associated with hypertension and the clinical efficacy of endovascular exclusion.
Arthritis
Metalloproteinase-7 contributes to joint destruction in Staphylococcus aureus induced arthritis.
Arthritis, Infectious
Metalloproteinase-7 contributes to joint destruction in Staphylococcus aureus induced arthritis.
Arthritis, Rheumatoid
Expression of ADAM15 in rheumatoid synovium: up-regulation by vascular endothelial growth factor and possible implications for angiogenesis.
Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis.
Asbestosis
Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: a case-control study.
Asthma
Divergent functions for airway epithelial matrix metalloproteinase 7 and retinoic acid in experimental asthma.
IL-13 and TH2 cytokine exposure triggers matrix metalloproteinase 7-mediated Fas ligand cleavage from bronchial epithelial cells.
Astrocytoma
Association between the functional polymorphism in the matrix metalloproteinase-7 promoter and susceptibility to adult astrocytoma.
Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
Matrix metalloproteinase-9 interplays with the IGFBP2-IGFII complex to promote cell growth and motility in astrocytomas.
[Correlations of polymorphisms in matrix metalloproteinase-3 and -7 promoters to susceptibility to brain astrocytoma]
Atherosclerosis
Apolipoprotein A-IV is a novel substrate for matrix metalloproteinases.
Associations of D-dimer with CT Lung Abnormalities, Serum Biomarkers of Lung Injury, and Forced Vital Capacity: MESA Lung Study.
Cholesterol, lipoproteins and subclinical interstitial lung disease: the MESA study.
Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes.
Serum Matrix Metalloproteinase-7, Respiratory Symptoms, and Mortality in Community-dwelling Adults: The Multi-Ethnic Study of Atherosclerosis.
Atrial Fibrillation
Effect of matrix metalloproteinase and their inhibitors on atrial myocardial structural remodeling.
Bacterial Infections
Matrilysin (MMP-7) catalytic activity regulates ?-catenin localization and signaling activation in lung epithelial cells.
Stimulation of MMP-7 (matrilysin) by Helicobacter pylori in human gastric epithelial cells: role in epithelial cell migration.
Barrett Esophagus
Matrix metalloproteinase (MMP)-7 in Barrett's esophagus and esophageal adenocarcinoma: expression, metabolism, and functional significance.
Biliary Atresia
Current Concepts of Biliary Atresia and Matrix Metalloproteinase-7: A Review of Literature.
Diagnostic Accuracy of Serum Matrix Metalloproteinase-7 for Biliary Atresia.
Increased MMP-7 expression in biliary epithelium and serum underpins native liver fibrosis after successful portoenterostomy in biliary atresia.
Large-scale proteomics identifies MMP-7 as a sentinel of epithelial injury and of biliary atresia.
Matrilysin (MMP-7) is a major matrix metalloproteinase upregulated in biliary atresia-associated liver fibrosis.
Predicting native liver injury and survival in biliary atresia.
Serum MMP-7 in the Diagnosis of Biliary Atresia.
Biliary Tract Diseases
Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy.
Prospective study of MMP7 serum levels in the diagnosis of cholangiocarcinoma.
Bone Diseases
A loss of host-derived MMP-7 promotes myeloma growth and osteolytic bone disease in vivo.
Matrilysin/MMP-7 Cleavage of Perlecan/HSPG2 Complexed with Semaphorin 3A Supports FAK-Mediated Stromal Invasion by Prostate Cancer Cells.
Bowen's Disease
Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma.
Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas.
Brain Injuries, Traumatic
Blood-brain barrier dysfunction significantly correlates with serum matrix metalloproteinase-7 (MMP-7) following traumatic brain injury.
Brain Neoplasms
MMP-7 (matrilysin) expression in human brain tumors.
Production of recombinant human matrix metalloproteinase 7 (Matrilysin) with potential role in tumor invasion by refolding from Escherichia coli inclusion bodies and development of sandwich ELISA of MMP-7.
Breast Neoplasms
ADAM28 is overexpressed in human breast carcinomas: implications for carcinoma cell proliferation through cleavage of insulin-like growth factor binding protein-3.
Alcohol Stimulates Activation of Snail, Epidermal Growth Factor Receptor Signaling, and Biomarkers of Epithelial-Mesenchymal Transition in Colon and Breast Cancer Cells.
beta-Catenin and p53 analyses of a breast carcinoma tissue microarray.
Breast Heterogeneity: Obstacles to Developing Universal Biomarkers of Breast Cancer Initiation and Progression.
CCR10 activation stimulates the invasion and migration of breast cancer cells through the ERK1/2/MMP-7 signaling pathway.
Coagulation factor VIIa-mediated protease-activated receptor 2 activation leads to ?-catenin accumulation via the AKT/GSK3? pathway and contributes to breast cancer progression.
Common MMP-7 polymorphisms and breast cancer susceptibility: a multistage study of association and functionality.
Delphinidin suppresses breast carcinogenesis through the HOTAIR/microRNA-34a axis.
Estrogen-deficient osteoporosis enhances the recruitment and activity of osteoclasts by breast cancer cells.
Expression of gelatinases A and B, stromelysin-3 and matrilysin genes in breast carcinomas: clinico-pathological correlations.
Expression of metalloproteases and their inhibitors in different histological types of breast cancer.
Expression of tissue levels of matrix metalloproteinases and their inhibitors in breast cancer.
Genetic polymorphisms in the MMP-7 gene and breast cancer survival.
Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy.
IL-18 immunoadjuvanted xenogeneic canine MMP-7 DNA vaccine overcomes immune tolerance and supresses the growth of murine mammary tumor.
Inhibitors of polyamine biosynthesis decrease the expression of the metalloproteases meprin alpha and MMP-7 in hormone-independent human breast cancer cells.
Investigating the regulation mechanism of baicalin on triple negative breast cancer's biological network by a systematic biological strategy.
LEF-1 regulates proliferation and MMP-7 transcription in breast cancer cells.
Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation.
Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression.
MMP-7 A-181G Polymorphism in Breast Cancer Patients from Western Iran.
MT1-MMP and MMP-7 in invasion and metastasis of human cancers.
Plasma Concentrations of Matrilysins MMP-7 and MMP-26 as Diagnostic Biomarkers in Breast Cancer.
Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion.
Silencing of KIF3B Suppresses Breast Cancer Progression by Regulating EMT and Wnt/?-Catenin Signaling.
Study of the topographic distribution of ets-1 protein expression in invasive breast carcinomas in relation to tumor phenotype.
Targeting matrilysin and its impact on tumor growth in vivo: the potential implications in breast cancer therapy.
The Contribution of Matrix Metalloproteinase-7 Promoter Genotypes in Breast Cancer in Taiwan.
The multifunctional role of the immunohistochemical expression of MMP-7 in invasive breast cancer.
Tumor suppressive function of Matrin 3 in the basal-like breast cancer.
[Expressions of FOXC1 and MMP-7 in molecular subtypes of breast cancer and their association with clinicopathological characteristics].
Bronchiectasis
Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis.
Matrix Metalloproteinases Vary with Airway Microbiota Composition and Lung Function in Non-Cystic Fibrosis Bronchiectasis.
Carcinogenesis
A study on angiogenesis-related matrix metalloproteinase networks in primary hepatocellular carcinoma.
Achaete-scute complex homolog-1 promotes DNA repair in the lung carcinogenesis through matrix metalloproteinase-7 and O(6)-methylguanine-DNA methyltransferase.
Association of Ets-related transcriptional factor E1AF expression with overexpression of matrix metalloproteinases, COX-2 and iNOS in the early stage of colorectal carcinogenesis.
Beta-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: relationships with carcinogenesis and metastasis.
Charge-Triggered Membrane Insertion of Matrix Metalloproteinase-7, Supporter of Innate Immunity and Tumors.
Colorectal carcinoma: from tumorigenesis to treatment.
Correlation of polymorphism of IL-8 and MMP-7 with occurrence and lymph node metastasis of early stage cervical cancer.
Development of in situ zymography to localize active matrix metalloproteinase-7 (matrilysin-1).
Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms.
E1A-F is overexpressed early in human colorectal neoplasia and associated with cyclooxygenase-2 and matrix metalloproteinase-7.
Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?
Epidermal growth factor upregulates matrix metalloproteinase-7 expression through activation of PEA3 transcription factors.
ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells.
Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis.
Expression of matrilysin mRNA in colorectal adenomas and its induction by truncated fibronectin.
Expression of matrix metalloproteinase-7 involving in growth, invasion, metastasis and angiogenesis of gastric cancer.
Helicobacter pylori potentiates epithelial:mesenchymal transition in gastric cancer: links to soluble HB-EGF, gastrin and matrix metalloproteinase-7.
Helicobacter pylori upregulates matrilysin (MMP-7) in epithelial cells in vivo and in vitro in a Cag dependent manner.
High gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancer.
Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin.
Matrilysin (matrix metalloproteinase-7) expression in ulcerative colitis-related tumorigenesis.
Matrilysin gene expression in sporadic and familial colorectal adenomas.
Matrilysin in early stage intestinal tumorigenesis.
Matrix metalloproteinase 7 mediates mammary epithelial cell tumorigenesis through the ErbB4 receptor.
Matrix metalloproteinase-7 and premalignant host responses in Helicobacter pylori-infected mice.
MMP-7 is upregulated by COX-2 and promotes proliferation and invasion of lung adenocarcinoma cells.
MMP7 as a potential biomarker of colon cancer and its prognostic value by bioinformatics analysis.
New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression.
Overexpression of poly(ADP-ribose) polymerase-1 (PARP-1) in the early stage of colorectal carcinogenesis.
Overexpression of SOX18 correlates with accelerated cell growth and poor prognosis in human pancreatic ductal adenocarcinoma.
p120 and Kaiso regulate Helicobacter pylori-induced expression of matrix metalloproteinase-7.
Physiological activities of carbon monoxide-releasing molecules: Ca ira.
Polyamine-dependent expression of the matrix metalloproteinase matrilysin in a human colon cancer-derived cell line.
Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis.
Role of matrix metalloproteinases in colorectal carcinogenesis.
Role of PTEN and MMP-7 expression in growth, invasion, metastasis and angiogenesis of gastric carcinoma.
Roles of matrix metalloproteinase-7 (MMP-7) in cancer.
Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas.
The Contribution of MMP-7 Genotypes to Colorectal Cancer Susceptibility in Taiwan.
The detection of Helicobacter pylori cag pathogenicity islands (PAIs) and expression of matrix metalloproteinase-7 (MMP-7) in gastric epithelial dysplasia and intramucosal cancer.
The influence of matrix metalloproteinase-7 on early mammary tumorigenesis in the multiple intestinal neoplasia mouse.
The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis.
The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors.
The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors.
Up-regulation of TRPM-2, MMP-7 and ID-1 during sex hormone-induced prostate carcinogenesis in the Noble rat.
Carcinoid Tumor
Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study.
Increased gastric expression of MMP-7 in hypergastrinemia and significance for epithelial-mesenchymal signaling.
Carcinoma
A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 7 (matrilysin) using monoclonal antibodies.
A Panel of Tumor-associated Autoantibodies for the Detection of Early-stage Breast Cancer.
A subset of high-grade pulmonary neuroendocrine carcinomas shows up-regulation of matrix metalloproteinase-7 associated with nuclear beta-catenin immunoreactivity, independent of EGFR and HER-2 gene amplification or expression.
Achaete-scute complex homolog-1 promotes DNA repair in the lung carcinogenesis through matrix metalloproteinase-7 and O(6)-methylguanine-DNA methyltransferase.
Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin.
Active matrix metalloproteinase-7 is associated with invasion in buccal squamous cell carcinoma.
Activin A enhances MMP-7 activity via the transcription factor AP-1 in an esophageal squamous cell carcinoma cell line.
ADAM28 is overexpressed in human non-small cell lung carcinomas and correlates with cell proliferation and lymph node metastasis.
Adhesion molecules, extracellular matrix, and proteases in prostate carcinoma.
An integrated clinical-genomics approach identifies a candidate multi-analyte blood test for serous ovarian carcinoma.
Association of matrilysin expression with progression and poor prognosis in human pancreatic adenocarcinoma.
Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma.
Association of matrilysin mRNA expression with K-ras mutations and progression in pancreatic ductal adenocarcinomas.
Association of matrix metalloproteinase-7 (-181A>G) polymorphism with risk of esophageal squamous cell carcinoma in Kashmir Valley.
Associations of Promoter Methylations and mRNA Expressions of MMP-2, MMP-7 and MMP-9 with Primary Fallopian Tube Carcinoma.
Autoantibodies against MMP-7 as a novel diagnostic biomarker in esophageal squamous cell carcinoma.
Bacterial exposure induces and activates matrilysin in mucosal epithelial cells.
Beta-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: relationships with carcinogenesis and metastasis.
Binding of alpha5 monoclonal antibody to cell surface alpha5beta1 integrin modulates MMP-2 and MMP-7 activity in B16F10 melanoma cells.
Binding of matrilysin-1 to human epithelial cells promotes its activity.
Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions.
Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
Cleavage of beta 4 integrin by matrilysin.
Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma.
Clinical significance of mucin phenotype, beta-catenin and matrix metalloproteinase 7 in early undifferentiated gastric carcinoma.
Clinical significance of serum MMP-2 and MMP-7 in patients with ovarian cancer.
Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers.
Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer.
Clinicopathological significance of MMP-7, laminin ?2 and EGFR expression at the invasive front of gastric carcinoma.
Coexpression of matrix metalloproteinase-7 (MMP-7) and epidermal growth factor (EGF) receptor in colorectal cancer: an EGF receptor tyrosine kinase inhibitor is effective against MMP-7-expressing cancer cells.
Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma.
Correlation among 16 biological factors [p53, p21(waf1), MIB-1 (Ki-67), p16(INK4A), cyclin D1, E-cadherin, Bcl-2, TNF-?, NF-?B, TGF-?, MMP-7, COX-2, EGFR, HER2/neu, ER, and HIF-1?] and clinical outcomes following curative chemoradiation therapy in 10 patients with esophageal squamous cell carcinoma.
COX-2, MMP-7 expression in oral lichen planus and oral squamous cell carcinoma.
CYR61 downregulation correlates with tumor progression by promoting MMP-7 expression in human gastric carcinoma.
Cysteine-rich protein 61 suppresses cell invasion via down-regulation of matrix metalloproteinase-7 expression in the human gastric carcinoma cell line MKN-45.
Detection of Matrilysin Activity Using Polypeptide Functionalized Reduced Graphene Oxide Field-Effect Transistor Sensor.
Development of in situ zymography to localize active matrix metalloproteinase-7 (matrilysin-1).
Difference in responsiveness of human esophageal squamous cell carcinoma lines to epidermal growth factor for MMP-7 expression.
Differential expression of c-jun and c-fos mRNAs in squamous cell carcinoma of the head and neck: associations with uPA, gelatinase B, and matrilysin mRNAs.
Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma.
Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas.
E1A-F is overexpressed early in human colorectal neoplasia and associated with cyclooxygenase-2 and matrix metalloproteinase-7.
Effusion cytodiagnosis of carcinosarcoma derived from the female genital tract: immunohistochemical features of MMP-7 and Ki-67 and immunofluorescence double staining analyses of eight cases.
EGF induces the expression of matrilysin in the human prostate adenocarcinoma cell line, LNCaP.
Elevated matrix metalloproteinase 7 expression promotes the proliferation, motility and metastasis of tongue squamous cell carcinoma.
Elevated matrix metalloproteinase-7 expression promotes metastasis in human lung carcinoma.
Enhanced production and activation of matrix metalloproteinase-7 (matrilysin) in human endometrial carcinomas.
Epidermal growth factor induces FoxO1 nuclear exclusion to activate MMP7-mediated metastasis of larynx carcinoma.
Evaluation of matrix metalloproteinase 7 in plasma and pancreatic juice as a biomarker for pancreatic cancer.
Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas.
Expression and significance of IGF-2, PCNA, MMP-7, and ?-actin in gastric carcinoma with Lauren classification.
Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinomas. Implications for vessel invasion and metastasis.
Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study.
Expression of heparanase gene, CD44v6, MMP-7 and nm23 protein and their relationship with the invasion and metastasis of gastric carcinomas.
Expression of matrilysin in vascular endothelial cells adjacent to matrilysin-producing tumors.
Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-1 in human prostate.
Expression of matrix metalloproteinase-7 correlates with the invasion of T1 colorectal carcinoma.
Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis.
Expression of matrix metalloproteinases 3, 10 and 11 (stromelysins 1, 2 and 3) and matrix metalloproteinase 7 (matrilysin) by cancer cells in non-small cell lung neoplasms. Clinicopathologic studies.
Expression of matrix metalloproteinases 7 and 2 in human renal cell carcinoma.
Expression of matrix metalloproteinases and related tissue inhibitors in the cyst fluids of ovarian mucinous neoplasms.
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.
Expression of matrix metalloproteinases in benign and malignant follicular thyroid lesions.
Expression of matrix metalloproteinases in human transitional cell carcinoma of the urinary bladder.
Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases.
Expression of metalloproteases and their inhibitors in different histological types of breast cancer.
Expression of metalloproteinase genes in human prostate cancer.
Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis.
Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.
Expression of mRNA MMP-7 and mRNA TIMP-1 in non-small cell lung cancer.
Expression of the matrix metalloproteinase promatrilysin in coculture of prostate carcinoma cell lines.
Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice.
Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas.
Expressions of Matrix Metalloproteinase-7 and -9 and their Prognostic Significances in Rectal Cancer.
Gene Expression Profiling of the Leading Edge of Cutaneous Squamous Cell Carcinoma: IL-24-Driven MMP-7.
Heregulin-beta promotes matrix metalloproteinase-7 expression via HER2-mediated AP-1 activation in MCF-7 cells.
High gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancer.
In silico trials to design potent inhibitors against matrilysin (MMP-7).
In vitro method for diagnosing and monitoring renal cell carcinoma using matrix metalloprotease-7 as humoral biomarker.
Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas.
Integrin- and cadherin-mediated induction of the matrix metalloprotease matrilysin in cocultures of malignant oral squamous cell carcinoma cells and dermal fibroblasts.
Interleukin-1beta secreted from monocytic cells induces the expression of matrilysin in the prostatic cell line LNCaP.
Interrelation between expression of matrix metalloproteinase 7 and beta-catenin in esophageal cancer.
Inverse relationship between matrilysin expression and proliferative activity of cells in advanced gastric carcinoma.
Matrilsin expression is a useful marker of submucosal invasion and lymph node metastasis in early stage signet ring cell carcinoma of the stomach.
Matrilysin (matrix metalloproteinase-7) expression in ulcerative colitis-related tumorigenesis.
Matrilysin (MMP-7) catalytic activity regulates ?-catenin localization and signaling activation in lung epithelial cells.
Matrilysin (MMP-7) induces homotypic adhesion of human colon cancer cells and enhances their metastatic potential in nude mouse model.
Matrilysin (MMP-7) is a novel broadly expressed tumor antigen recognized by antigen-specific T cells.
Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase.
Matrilysin (PUMP) correlates with dermal invasion during appendageal development and cutaneous neoplasia.
Matrilysin 1 influences colon carcinoma cell migration by cleavage of the laminin-5 beta3 chain.
Matrilysin expression in human prostate carcinoma.
Matrilysin-1 (MMP-7) and MMP-19 are expressed by Paget's cells in extramammary Paget's disease.
Matrilysin-specific antisense oligonucleotide inhibits liver metastasis of human colon cancer cells in a nude mouse model.
Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties.
Matrix metalloproteinase 7 and perlecan in oral epithelial dysplasia and carcinoma in situ: an aid for histopathologic recognition of their cell proliferation centers.
Matrix metalloproteinase 7 expression in ampullary carcinoma.
Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers.
Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma.
Matrix metalloproteinase-7 and matrix metalloproteinase-25 in oral tongue squamous cell carcinoma.
Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer.
Matrix metalloproteinase-7 expression in gastric carcinoma.
Matrix metalloproteinase-7 mRNA and protein expression in gastric carcinoma: a meta-analysis.
Matrix metalloproteinase-7, -8, -9, -15, and -25 in minor salivary gland adenoid cystic carcinoma.
Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment.
Matrix metalloproteinases (MMPs) and inhibitor of metalloproteinases (TIMP) mRNA and protein expression in laryngeal squamous cell carcinoma.
Matrix Metalloproteinases and Their Tissue Inhibitors in Blood Serum of Patients with Endometrial Cancer: Clinical and Morphological Correlations.
Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.
MiRNA-34a inhibits EGFR-signaling-dependent MMP7 activation in gastric cancer.
MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues.
MMP-7 expression may influence the rate of distant recurrences and disease-specific survival in HPV-positive oropharyngeal squamous cell carcinoma.
MMP-7 is a highly specific negative marker for benign and malignant mesothelial cells in serous effusions.
MMP-7, MMP-8, and MMP-9 in oral and cutaneous squamous cell carcinomas.
Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo.
Modulation of matrix metalloproteinase-7 (matrilysin) secretion in coculture of human colon carcinoma cells with fibroblasts from orthotopic and ectopic organs.
Monensin induces cell death by autophagy and inhibits matrix metalloproteinase 7 (MMP7) in UOK146 renal cell carcinoma cell line.
MT1-MMP and MMP-7 in invasion and metastasis of human cancers.
Multistep carcinogenesis of perihilar cholangiocarcinoma arising in the intrahepatic large bile ducts.
Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer.
Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas.
Paracrine factor and cell-cell contact-mediated induction of protease and c-ets gene expression in malignant keratinocyte/dermal fibroblast cocultures.
Pericellular activation of proMMP-7 (promatrilysin-1) through interaction with CD151.
Plasma matrix metalloproteinase-7 as a metastatic marker and survival predictor in patients with renal cell carcinomas.
Polymorphisms of matrix metalloproteinase-7 and -9 are associated with oral tongue squamous cell carcinoma.
Predictive value of MMP-7 expression for response to chemotherapy and survival in patients with non-small cell lung cancer.
Preoperative estimation of neural invasion in rectal carcinoma.
Preoperative levels of matrix metalloproteinase-7 and -9 and tissue inhibitor of matrix metalloproteinase-1 relation to pathologic parameters in bladder carcinoma patients.
Prognostic significance of matrix metalloproteinase-7 (MMP-7) expression at the invasive front in gastric carcinoma.
Prognostic value of matrix metalloproteinases in oral squamous cell carcinoma.
Purification and characterization of extracellular matrix-degrading metalloproteinase, matrin (pump-1), secreted from human rectal carcinoma cell line.
Quantitative immunohistochemical analysis of matrilysin 1 (MMP-7) in various renal cell carcinoma subtypes.
Regulation of matrilysin expression in cells of squamous cell carcinoma by E-cadherin-mediated cell-cell contact.
Relationship between E-cadherin, matrix metalloproteinase-7 gene expression and clinicopathological features in gastric carcinoma.
Role of matrix metalloproteinases in colorectal carcinogenesis.
Role of PTEN and MMP-7 expression in growth, invasion, metastasis and angiogenesis of gastric carcinoma.
SLC12A5 interacts and enhances SOX18 activity to promote bladder urothelial carcinoma progression via upregulating MMP7.
The Contribution of MMP-7 Promoter Polymorphisms in Renal Cell Carcinoma.
The expression and clinical significance of matrix metalloproteinase 7 and tissue inhibitor of matrix metalloproteinases 2 in clear cell renal cell carcinoma.
The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma.
The matrix metalloprotease pump-1 (MMP-7, Matrilysin): A candidate marker/target for ovarian cancer detection and treatment.
Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer.
Urachal Carcinoma of the Bladder: Impact of Clinical and Immunohistochemical Parameters on Patient Prognosis.
Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
[beta-Catenin induces invasive growth by activating matrix metalloproteinases in colorectal carcinoma]
[Correlation between expression of MMP-7 in gastric submucosal invasive carcinoma and lymph node micrometastasis]
[Expression and clinical significance of Ang-2 and MMP-7 in laryngeal carcinoma]
[Expression of ETV5 and MMP-7 in Early Stage Cervical Squamous Cell Carcinoma and Its Role in Lymphatic Metastasis.]
[Matrix metalloproteinases and their tissue inhibitors in malignancies of the female genital tract]
[Prognostic significance of the molecular markers in human gastrointestinal cancer]
[Relationship of matrilysin with invasion, metastasis, and prognosis in laryngeal cancer]
[The expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in transplanted tumor of salivary adenoid cystic carcinoma cell lines]
[The significance of beta-catenin and matrix metalloproteinase-7 expression in colorectal adenoma and carcinoma]
Carcinoma in Situ
Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions.
Matrix metalloproteinase 7 and perlecan in oral epithelial dysplasia and carcinoma in situ: an aid for histopathologic recognition of their cell proliferation centers.
Carcinoma, Adenoid Cystic
Matrix metalloproteinase-7, -8, -9, -15, and -25 in minor salivary gland adenoid cystic carcinoma.
[The expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in transplanted tumor of salivary adenoid cystic carcinoma cell lines]
Carcinoma, Adenosquamous
Association between expression of MMP-7 and MMP-9 and pelvic lymph node and para-aortic lymph node metastasis in early cervical cancer.
Carcinoma, Basal Cell
Matrilysin (PUMP) correlates with dermal invasion during appendageal development and cutaneous neoplasia.
Carcinoma, Ductal
MMP-7 A-181G Polymorphism in Breast Cancer Patients from Western Iran.
Carcinoma, Hepatocellular
Assessing matrix metalloproteinase expression and activity in hepatocellular carcinomas.
Association of E-cadherin, matrix metalloproteinases, and tissue inhibitors of metalloproteinases with the progression and metastasis of hepatocellular carcinoma.
c-Myc transactivates GP73 and promotes metastasis of hepatocellular carcinoma cells through GP73-mediated MMP-7 trafficking in a mildly hypoxic microenvironment.
Distinction of hepatocellular adenoma from hepatocellular carcinoma with and without cirrhosis using E-cadherin and matrix metalloproteinase immunohistochemistry.
Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
Expression of matrix metalloproteinases (MMPs) in cultured hepatocellular carcinoma (HCC) cells and surgically resected HCC tissues.
Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Involvement of the Ets-1 gene in overexpression of matrilysin in human hepatocellular carcinoma.
Isofraxidin, a coumarin component from Acanthopanax senticosus, inhibits matrix metalloproteinase-7 expression and cell invasion of human hepatoma cells.
Messenger RNA expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human hepatocellular carcinoma.
microRNA-489 Plays an Anti-Metastatic Role in Human Hepatocellular Carcinoma by Targeting Matrix Metalloproteinase-7.
No association of MMP-7, MMP-8, and MMP-21 polymorphisms with the risk of hepatocellular carcinoma in a Chinese population.
Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma.
[Expressions of MDM2 and MMP-7 in normal liver, cirrhosis, hepatocellular carcinoma tissues]
Carcinoma, Intraductal, Noninfiltrating
Study of matrix metalloproteinases and their tissue inhibitors in ductal in situ carcinomas of the breast.
Carcinoma, Lewis Lung
Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment.
Carcinoma, Lobular
MMP-7 A-181G Polymorphism in Breast Cancer Patients from Western Iran.
Carcinoma, Mucoepidermoid
Matrix metalloproteinase (MMP)-7 in salivary gland cancer.
Carcinoma, Neuroendocrine
A subset of high-grade pulmonary neuroendocrine carcinomas shows up-regulation of matrix metalloproteinase-7 associated with nuclear beta-catenin immunoreactivity, independent of EGFR and HER-2 gene amplification or expression.
Carcinoma, Non-Small-Cell Lung
Beyond Conventional: The New Horizon of Anti-Angiogenic microRNAs in Non-Small Cell Lung Cancer Therapy.
Clinical significance of immunohistochemical expression of insulin-like growth factor-1 receptor and matrix metalloproteinase-7 in resected non-small cell lung cancer.
Correlation Between MMP-7 and bFGF Expressions in Non-small Cell Lung Cancer Tissue and Clinicopathologic Features.
Effect of Osimertinib on the expression of serum mmp-7 and mmp-9 in patients with non-small cell lung cancer.
Expression of matrix metalloproteinases 3, 10 and 11 (stromelysins 1, 2 and 3) and matrix metalloproteinase 7 (matrilysin) by cancer cells in non-small cell lung neoplasms. Clinicopathologic studies.
Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer Relation to clinicopathological factors, beta-catenin and prognosis.
Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.
Expression of mRNA MMP-7 and mRNA TIMP-1 in non-small cell lung cancer.
Fibulin-3 promoter methylation alters the invasive behavior of non-small cell lung cancer cell lines via MMP-7 and MMP-2 regulation.
Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer.
Predictive value of MMP-7 expression for response to chemotherapy and survival in patients with non-small cell lung cancer.
Prognostic value of matrix metalloproteinase-7 expression in patients with non-small cell lung cancer.
Roles of osteopontin and matrix metalloproteinase-7 in occurrence, progression, and prognosis of nonsmall cell lung cancer.
The Contribution of MMP-7 Promoter Polymorphisms to Taiwan Lung Cancer Susceptibility.
The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma.
Carcinoma, Ovarian Epithelial
Clinical utility of circulating matrix metalloproteinase-7 (MMP-7), CC chemokine ligand 18 (CCL18) and CC chemokine ligand 11 (CCL11) as markers for diagnosis of epithelial ovarian cancer.
Expression of MMP-2, -7, -9, MT1-MMP and TIMP-1 and -2 has no prognostic relevance in patients with advanced epithelial ovarian cancer.
Inhibition of matrilysin expression by antisense or RNA interference decreases lysophosphatidic acid-induced epithelial ovarian cancer invasion.
Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase.
Plasma levels of MMP-7 and TIMP-1 in laboratory diagnostics and differentiation of selected histological types of epithelial ovarian cancers.
Prognostic significance of matrix metalloproteinase-7 in epithelial ovarian cancer and its relation to beta-catenin expression.
Carcinoma, Papillary
MT1-MMP and MMP-7 in invasion and metastasis of human cancers.
Carcinoma, Renal Cell
Bio-informatics analysis of renal carcinoma gene matrix metalloproteinase-7.
Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis.
Expression of matrix metalloproteinases 7 and 2 in human renal cell carcinoma.
In vitro method for diagnosing and monitoring renal cell carcinoma using matrix metalloprotease-7 as humoral biomarker.
Matrilysin (MMP-7) is a novel broadly expressed tumor antigen recognized by antigen-specific T cells.
Monensin induces cell death by autophagy and inhibits matrix metalloproteinase 7 (MMP7) in UOK146 renal cell carcinoma cell line.
Plasma matrix metalloproteinase-7 as a metastatic marker and survival predictor in patients with renal cell carcinomas.
Prognostic Role of Matrix Metalloproteinases 2, 7, 8, 9 and Their Type 1 Tissue Inhibitor in Blood Serum of Patients with Kidney Cancer.
Quantitative immunohistochemical analysis of matrilysin 1 (MMP-7) in various renal cell carcinoma subtypes.
The Contribution of MMP-7 Promoter Polymorphisms in Renal Cell Carcinoma.
The expression and clinical significance of matrix metalloproteinase 7 and tissue inhibitor of matrix metalloproteinases 2 in clear cell renal cell carcinoma.
Validation of the diagnostic and prognostic relevance of serum MMP-7 levels in renal cell cancer by using a novel automated fluorescent immunoassay method.
Carcinoma, Small Cell
Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study.
Carcinoma, Squamous Cell
Active matrix metalloproteinase-7 is associated with invasion in buccal squamous cell carcinoma.
Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma.
Differential expression of c-jun and c-fos mRNAs in squamous cell carcinoma of the head and neck: associations with uPA, gelatinase B, and matrilysin mRNAs.
Elevated matrix metalloproteinase 7 expression promotes the proliferation, motility and metastasis of tongue squamous cell carcinoma.
Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study.
Expression of matrix metalloproteinases 3, 10 and 11 (stromelysins 1, 2 and 3) and matrix metalloproteinase 7 (matrilysin) by cancer cells in non-small cell lung neoplasms. Clinicopathologic studies.
Gene Expression Profiling of the Leading Edge of Cutaneous Squamous Cell Carcinoma: IL-24-Driven MMP-7.
Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas.
Integrin- and cadherin-mediated induction of the matrix metalloprotease matrilysin in cocultures of malignant oral squamous cell carcinoma cells and dermal fibroblasts.
Interrelation between expression of matrix metalloproteinase 7 and beta-catenin in esophageal cancer.
Matrilysin (PUMP) correlates with dermal invasion during appendageal development and cutaneous neoplasia.
Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers.
Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma.
Matrix metalloproteinase-7 and matrix metalloproteinase-25 in oral tongue squamous cell carcinoma.
MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues.
MMP-7, MMP-8, and MMP-9 in oral and cutaneous squamous cell carcinomas.
Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer.
Paracrine factor and cell-cell contact-mediated induction of protease and c-ets gene expression in malignant keratinocyte/dermal fibroblast cocultures.
Polymorphisms of matrix metalloproteinase-7 and -9 are associated with oral tongue squamous cell carcinoma.
Predictive value of MMP-7 expression for response to chemotherapy and survival in patients with non-small cell lung cancer.
Regulation of matrilysin expression in cells of squamous cell carcinoma by E-cadherin-mediated cell-cell contact.
Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer.
[Expression of ETV5 and MMP-7 in Early Stage Cervical Squamous Cell Carcinoma and Its Role in Lymphatic Metastasis.]
[The expression of tumor related macrophages and matrix solution element in laryngeal squamous carcinoma tissue and the relationship with tumor microvascular density].
Carcinoma, Transitional Cell
Expression of matrix metalloproteinases in human transitional cell carcinoma of the urinary bladder.
Carcinosarcoma
Differential expression of matrix metalloprotease-7 in each component of uterine carcinosarcoma.
Effusion cytodiagnosis of carcinosarcoma derived from the female genital tract: immunohistochemical features of MMP-7 and Ki-67 and immunofluorescence double staining analyses of eight cases.
Cardiomegaly
Matrix metalloproteinase-7 and ADAM-12 (a disintegrin and metalloproteinase-12) define a signaling axis in agonist-induced hypertension and cardiac hypertrophy.
MMP-2 mediates angiotensin II-induced hypertension under the transcriptional control of MMP-7 and TACE.
Cardiovascular Diseases
Cholesterol, lipoproteins and subclinical interstitial lung disease: the MESA study.
Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes.
MMP-7 and cardiovascular disease: not so surprising!
Serum tissue-degrading proteinases and incident cardiovascular disease events.
Carotid Artery Diseases
Matrix metalloproteinase 7 is associated with symptomatic lesions and adverse events in patients with carotid atherosclerosis.
Carotid Stenosis
Elevated circulating metalloproteinase 7 predicts recurrent cardiovascular events in patients with carotid stenosis: a prospective cohort study.
Cataract
Higher aqueous levels of matrix metalloproteinases indicated visual impairment in patients with retina vein occlusion after anti-VEGF therapy.
Cholangiocarcinoma
CX-4945 Induces Methuosis in Cholangiocarcinoma Cell Lines by a CK2-Independent Mechanism.
Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy.
Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts.
Expression of Matrix Metalloproteinase-7 is an Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma.
Expression pattern of matrix metalloproteinases in human liver.
Matrix metalloproteinase-7 expression and biologic aggressiveness of cholangiocellular carcinoma.
Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a preliminary case-control study.
Plasma hydroxyproline, MMP-7 and collagen I as novel predictive risk markers of hepatobiliary disease-associated cholangiocarcinoma.
Prospective study of MMP7 serum levels in the diagnosis of cholangiocarcinoma.
Cholangitis, Sclerosing
Serum Matrix Metalloproteinase 7 Is a Diagnostic Biomarker of Biliary Injury and Fibrosis in Pediatric Autoimmune Liver Disease.
Cholestasis
Diagnostic Accuracy of Serum Matrix Metalloproteinase-7 for Biliary Atresia.
Increased MMP-7 expression in biliary epithelium and serum underpins native liver fibrosis after successful portoenterostomy in biliary atresia.
Large-scale proteomics identifies MMP-7 as a sentinel of epithelial injury and of biliary atresia.
Predicting native liver injury and survival in biliary atresia.
Quantification of Serum Matrix Metallopeptide 7 Levels May Assist in the Diagnosis and Predict the Outcome for Patients with Biliary Atresia.
Cholesteatoma
Evaluation of significant gene expression changes in congenital and acquired cholesteatoma.
Chondrosarcoma
By activating matrix metalloproteinase-7, shear stress promotes chondrosarcoma cell motility, invasion and lung colonization.
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas.
Choroidal Neovascularization
Role of matrix metalloproteinase-7 in angiogenesis associated with age-related macular degeneration.
Chronic Periodontitis
Study of the participation of MMP-7, EMMPRIN and cyclophilin A in the pathogenesis of periodontal disease.
Colitis
Cellular sources of MMP-7, MMP-13 and MMP-28 in ulcerative colitis.
Expression profiles of matrix metalloproteinases and their inhibitors in colonic inflammation related to pediatric inflammatory bowel disease.
Colitis, Ulcerative
Cellular sources of MMP-7, MMP-13 and MMP-28 in ulcerative colitis.
Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers.
Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?
Enhanced secretion and activation of matrilysin during malignant conversion of human colorectal epithelium and its relationship with invasive potential of colon cancer cells.
Expression of matrilysin mRNA in colorectal adenomas and its induction by truncated fibronectin.
Expressions of Matrix Metalloproteinases (MMP-2, MMP-7, and MMP-9) and Their Inhibitors (TIMP-1, TIMP-2) in Inflammatory Bowel Diseases.
Matrilysin (matrix metalloproteinase-7) expression in ulcerative colitis-related tumorigenesis.
Matrix metalloproteinases cleave membrane-bound PD-L1 on CD90+ (myo-)fibroblasts in Crohn's disease and regulate Th1/Th17 cell responses.
The expression of matrix metalloproteinase matrilysin indicates the degree of inflammation in ulcerative colitis.
Colonic Neoplasms
Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer.
Binding of active matrilysin to cell surface cholesterol sulfate is essential for its membrane-associated proteolytic action and induction of homotypic cell adhesion.
Cancer chemopreventive effects of lycopene: suppression of MMP-7 expression and cell invasion in human colon cancer cells.
Cancer invasion regulates vascular complexity in a three-dimensional biomimetic model.
Construction of a novel DNA decoy that inhibits the oncogenic beta-catenin/T-cell factor pathway.
Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers.
Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor.
Decreased synthesis of matrix metalloproteinase-7 and adhesion to the extracellular matrix proteins of human colon cancer cells treated with troglitazone.
Detection of regional lymph node metastases in colon cancer by using RT-PCR for matrix metalloproteinase 7, matrilysin.
Dimerumic Acid Inhibits SW620 Cell Invasion by Attenuating H(2)O(2)-Mediated MMP-7 Expression via JNK/C-Jun and ERK/C-Fos Activation in an AP-1-Dependent Manner.
Distinct expression pattern of the full set of secreted phospholipases A2 in human colorectal adenocarcinomas: sPLA2-III as a biomarker candidate.
Effect of preoperative radiotherapy on matrilysin gene expression in rectal cancer.
Effect of sulindac sulfide on metallohydrolases in the human colon cancer cell line HT-29.
Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer.
Enhanced secretion and activation of matrilysin during malignant conversion of human colorectal epithelium and its relationship with invasive potential of colon cancer cells.
Epidermal growth factor upregulates matrix metalloproteinase-7 expression through activation of PEA3 transcription factors.
Expression of matrix metalloproteinase matrilysin (MMP-7) was induced by activated Ki-ras via AP-1 activation in SW1417 colon cancer cells.
Expressions of TIMP-1, COX-2 and MMP-7 in Colon Polyp and Colon Cancer.
Farnesoid X receptor represses matrix metalloproteinase 7 expression, revealing this regulatory axis as a promising therapeutic target in colon cancer.
FGF-1/-3/FGFR4 signaling in cancer-associated fibroblasts promotes tumor progression in colon cancer through Erk and MMP-7.
Global gene expression analysis of rat colon cancers induced by a food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Identification of amino acid residues of matrix metalloproteinase-7 essential for binding to cholesterol sulfate.
Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells.
Inhibitory effect of matrilysin antisense oligonucleotides on human colon cancer cell invasion in vitro.
Integrin- and cadherin-mediated induction of the matrix metalloprotease matrilysin in cocultures of malignant oral squamous cell carcinoma cells and dermal fibroblasts.
Interleukin-1? promotes extracellular shedding of syndecan-2 via induction of matrix metalloproteinase-7 expression.
Knockdown of MMP-7 inhibits cell proliferation and enhances sensitivity to 5-fluorouracil and X-ray irradiation in colon cancer cells.
Matrilysin (matrix metalloprotease-7) cleaves membrane-bound annexin II and enhances binding of tissue-type plasminogen activator to cancer cell surfaces.
Matrilysin (MMP-7) induces homotypic adhesion of human colon cancer cells and enhances their metastatic potential in nude mouse model.
Matrilysin as a target for chemotherapy for colon cancer: use of antisense oligonucleotides as antimetastatic agents.
Matrilysin stimulates DNA synthesis of cultured vascular endothelial cells and induces angiogenesis in vivo.
Matrilysin-specific antisense oligonucleotide inhibits liver metastasis of human colon cancer cells in a nude mouse model.
Matrix metalloproteinase-7 induces homotypic tumor cell aggregation via proteolytic cleavage of the membrane-bound Kunitz-type inhibitor HAI-1.
Matrix metalloproteinase-7-catalyzed release of HB-EGF mediates deoxycholyltaurine-induced proliferation of a human colon cancer cell line.
Matrix-degrading metalloproteinases in tumor progression.
MMP7 as a potential biomarker of colon cancer and its prognostic value by bioinformatics analysis.
Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo.
NOX1 to NOX2 switch deactivates AMPK and induces invasive phenotype in colon cancer cells through overexpression of MMP-7.
Oncogenic beta-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer.
Overexpression of Reg4, alone or combined with MMP-7 overexpression, is predictive of poor prognosis in colorectal cancer.
Peroxisome proliferator-activated receptor gamma agonists inhibit the proliferation and invasion of human colon cancer cells.
Polyamine-dependent expression of the matrix metalloproteinase matrilysin in a human colon cancer-derived cell line.
Polymorphisms in MMP-1, MMP-2, MMP-7, MMP-13 and MT2A do not contribute to breast, lung and colon cancer risk in polish population.
Processing of syndecan-2 by matrix metalloproteinase-14 and effect of its cleavage on VEGF-induced tube formation of HUVECs.
Prognostic significance of the TNM system criteria, levels of serum insulin-like growth factors and their transport proteins, VEGF and MMP-7 in colorectal cancer.
Proliferative effects of apical, but not basal, matrix metalloproteinase-7 activity in polarized MDCK cells.
Radixin enhances colon cancer cell invasion by increasing MMP-7 production via Rac1-ERK pathway.
Retinoic acids reduce matrilysin (matrix metalloproteinase 7) and inhibit tumor cell invasion in human colon cancer.
Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas.
Suppression of matrilysin inhibits colon cancer cell invasion in vitro.
Syndecan-2 cytoplasmic domain upregulates Matrix Metalloproteinase-7 expression via Protein KinaseC? mediated FAK/ERK signaling pathway in colon cancer.
Syndecan-2 enhances E-cadherin shedding and fibroblast-like morphological changes by inducing MMP-7 expression in colon cancer cells.
Syndecan-2 functions as a docking receptor for pro-matrix metalloproteinase-7 in human colon cancer cells.
Synergistic cooperation between the AP-1 and LEF-1 transcription factors in activation of the matrilysin promoter by the src oncogene: implications in cellular invasion.
The matrix metalloproteinase-7 regulates the extracellular shedding of syndecan-2 from colon cancer cells.
Tissue factor/activated factor VIIa induces matrix metalloproteinase-7 expression through activation of c-Fos via ERK1/2 and p38 MAPK signaling pathways in human colon cancer cell.
Tungsten Oxide Nanoplates; the Novelty in Targeting Metalloproteinase-7 Gene in Both Cervix and Colon Cancer Cells.
Tyrosine 51 residue of the syndecan-2 extracellular domain is involved in the interaction with and activation of pro-matrix metalloproteinase-7.
Wnt/?-catenin signaling mediates the antitumor activity of magnolol in colorectal cancer cells.
[Expression and clinical significance of survivin and matrix metalloproteinase-7 in colon cancer.]
Colorectal Neoplasms
(-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells.
A/G Polymorphism of the MMP-7 Gene Promoter Region in Colorectal Cancer.
Aluminum exposure promotes the metastatic proclivity of human colorectal cancer cells through matrix metalloproteinases and the TGF-?/Smad signaling pathway.
Andrographolide could inhibit human colorectal carcinoma Lovo cells migration and invasion via down-regulation of MMP-7 expression.
Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
ASSOCIATION OF MMP-7 -181A>G POLYMORPHISM WITH COLORECTAL CANCER AND GASTRIC CANCER SUSCEPTIBILITY: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer.
beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer.
Cancer chemopreventive effects of lycopene: suppression of MMP-7 expression and cell invasion in human colon cancer cells.
Clinical impact of matrix metalloproteinase-7 mRNA expression in the invasive front and inner surface of tumor tissues in patients with colorectal cancer.
Clinical Significance of MMP-7 and PTEN Expression in Colorectal Cancer.
Clinical utility of grading criteria for submucosal invasion in the prognosis of T1 colorectal carcinomas.
Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers.
Clinicopathological assessment and quantitative estimation of the matrix metalloproteinases MMP-2 and MMP-7 and the inhibitors TIMP-1 and TIMP-2 in colorectal carcinoma tissue samples.
Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
Co-expression of matrix metalloproteinase-7 (MMP-7) and phosphorylated insulin growth factor receptor I (pIGF-1R) correlates with poor prognosis in patients with wild-type KRAS treated with cetuximab or panitumumab: a GEMCAD study.
Coexpression of matrilysin and laminin-5 gamma2 chain may contribute to tumor cell migration in colorectal carcinomas.
Coexpression of matrix metalloproteinase-7 (MMP-7) and epidermal growth factor (EGF) receptor in colorectal cancer: an EGF receptor tyrosine kinase inhibitor is effective against MMP-7-expressing cancer cells.
Coexpression of p-IGF-1R and MMP-7 Modulates Panitumumab and Cetuximab Efficacy in RAS Wild-Type Metastatic Colorectal Cancer Patients.
Colorectal carcinoma susceptibility and metastases are associated with matrix metalloproteinase-7 promoter polymorphisms.
Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers.
Diagnostic values of MMP-7, MMP-9, MMP-11, TIMP-1, TIMP-2, CEA, and CA19-9 in patients with colorectal cancer.
Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms.
E-cadherin and metalloproteinase-1 and -7 polymorphisms in colorectal cancer.
E-cadherin, beta-catenin adhesion complex and relation to matrilysin expression in pT3 rectosigmoid cancers.
Effect of preoperative radiotherapy on matrilysin gene expression in rectal cancer.
Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?
Enhanced secretion and activation of matrilysin during malignant conversion of human colorectal epithelium and its relationship with invasive potential of colon cancer cells.
Evaluation of alpha 1-antitrypsin and the levels of mRNA expression of matrix metalloproteinase 7, urokinase type plasminogen activator receptor and COX-2 for the diagnosis of colorectal cancer.
Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and ?-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
Expression and activity levels of matrix metalloproteinase-7 and in situ localization of caseinolytic activity in colorectal cancer.
Expression and prognostic value of matrix metalloproteinase-7 in colorectal cancer.
Expression of matrilysin in vascular endothelial cells adjacent to matrilysin-producing tumors.
Expression of matrix metalloproteinase 7, laminin and type IV collagen-associated liver metastasis in human colorectal cancer: immunohistochemical approach.
Expression of matrix metalloproteinase matrilysin (MMP-7) was induced by activated Ki-ras via AP-1 activation in SW1417 colon cancer cells.
Expression of matrix metalloproteinase-7 correlates with the invasion of T1 colorectal carcinoma.
Expression of matrix metalloproteinases 2, 7 and 9 in patients with colorectal cancer.
Expression of MMP-7(PUMP-1) mRNA in human colorectal cancers.
Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases.
Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening.
High expression of matrix metalloproteinases: MMP-2 and MMP-9 predicts poor survival outcome in colorectal carcinoma.
Immunohistochemical expression of MMP-7 protein and its serum level in colorectal cancer.
Immunohistochemical molecular markers as predictors of curability of endoscopically resected submucosal colorectal cancer.
Implications of Isoprostanes and Matrix Metalloproteinase-7 Having Potential Role in the Development of Colorectal Cancer in Males.
Inhibitory effect of matrilysin antisense oligonucleotides on human colon cancer cell invasion in vitro.
Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin.
Knockdown of MMP-7 inhibits cell proliferation and enhances sensitivity to 5-fluorouracil and X-ray irradiation in colon cancer cells.
Malignant Potential of Gastrointestinal Cancers Assessed by Structural Equation Modeling.
Matrilysin (matrix metalloproteinase-7) expression in ulcerative colitis-related tumorigenesis.
Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas.
Matrilysin (MMP-7) degrades VE-cadherin and accelerates accumulation of beta-catenin in the nucleus of human umbilical vein endothelial cells.
Matrilysin is associated with progression of colorectal tumor.
Matrix metalloproteinase 7 is a useful marker for 5-fluorouracil-based adjuvant chemotherapy in stage II and stage III colorectal cancer patients.
Matrix metalloproteinase 7 is required for tumor formation, but dispensable for invasion and fibrosis in SMAD4-deficient intestinal adenocarcinomas.
Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases.
Matrix metalloproteinase-7 increases resistance to Fas-mediated apoptosis and is a poor prognostic factor of patients with colorectal carcinoma.
Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers.
Matrix metalloproteinases 7 and 9 and their types 1 and 4 tissue inhibitors in tumors and plasma of patients with colorectal cancer.
Matrix metalloproteinases may contribute compensationally to tumor invasion in T1 colorectal carcinomas.
Metalloproteinase-1, metalloproteinase-7, and p53 immunoexpression and their correlation with clinicopathological prognostic factors in colorectal adenocarcinoma.
MMP-7 (matrilysin) accelerated growth of human umbilical vein endothelial cells.
MMP-7 and SGCE as distinctive molecular factors in sporadic colorectal cancers from the mutator phenotype pathway.
MMP-7 as a prognostic marker in colorectal cancer.
MMP7 Modulation by Short- and Long-term Radiotherapy in Patients with Rectal Cancer.
Modifying Effects of Dietary Factors on (-)-Epigallocatechin-3-gallate-induced Pro-matrix Metalloproteinase-7 Production in HT-29 Human Colorectal Cancer Cells.
Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo.
Modulation of matrix metalloproteinase-7 (matrilysin) secretion in coculture of human colon carcinoma cells with fibroblasts from orthotopic and ectopic organs.
New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression.
Nobiletin, a citrus flavonoid, down-regulates matrix metalloproteinase-7 (matrilysin) expression in HT-29 human colorectal cancer cells.
Novel octapeptide-DTX prodrugs targeting MMP-7 as effective agents for the treatment of colorectal cancer with lower systemic toxicity.
Observation of microvessels and invasion in early colorectal neoplasms on narrow band imaging: combination with CD34 and matrix metalloproteinase-7 expression.
Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas.
Overexpression of MMP-13 gene in colorectal cancer with liver metastasis.
Overexpression of poly(ADP-ribose) polymerase-1 (PARP-1) in the early stage of colorectal carcinogenesis.
Overexpression of Reg4, alone or combined with MMP-7 overexpression, is predictive of poor prognosis in colorectal cancer.
Overexpression of the thymosin beta-4 gene is associated with increased invasion of SW480 colon carcinoma cells and the distant metastasis of human colorectal carcinoma.
Peritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer.
Prediction of distant metastasis by using reverse transcriptase-polymerase chain reaction for epithelial and variant CD44 mRNA in the peripheral blood of patients with colorectal cancer.
Prognostic significance of matrix metalloproteinase 7 immunohistochemical expression in colorectal cancer: a meta-analysis.
Prognostic significance of MMP-7 expression in colorectal cancer: A meta-analysis.
Prognostic significance of the TNM system criteria, levels of serum insulin-like growth factors and their transport proteins, VEGF and MMP-7 in colorectal cancer.
Prosurvival long noncoding RNA PINCR regulates a subset of p53 targets in human colorectal cancer cells by binding to Matrin 3.
Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.
Relationship between matrix metalloproteinase-7 and pit pattern in early stage colorectal cancer.
Relationship of serum MMP-7 levels for colorectal cancer: a meta-analysis.
Retraction Note to: Relationship of serum MMP-7 levels for colorectal cancer: a meta-analysis.
Role of matrix metalloproteinases (MMPs) in colorectal cancer.
Rosiglitazone and retinoic acid inhibit proliferation and induce apoptosis in the HCT-15 human colorectal cancer cell line.
Serum IGF-I, IGFBP-3, and matrix metalloproteinase-7 levels and acquired chemo-resistance in advanced colorectal cancer.
Serum levels of TIMP-1 and MMP-7 as potential biomarkers in patients with metastatic colorectal cancer.
Serum matrilysin correlates with poor survival independently of KRAS and BRAF status in refractory advanced colorectal cancer patients treated with irinotecan plus cetuximab.
Serum matrilysin levels predict outcome in curatively resected colorectal cancer patients.
Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients.
Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas.
Single-pair fluorescence resonance energy transfer analysis of mRNA transcripts for highly sensitive gene expression profiling in near real time.
Stiff substrates increase YAP-signaling-mediated matrix metalloproteinase-7 expression.
Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.
Systematic assessment of protein phenotypes characterizing high-grade tumour budding in mismatch repair-proficient colorectal cancer.
The Contribution of MMP-7 Genotypes to Colorectal Cancer Susceptibility in Taiwan.
The expression of mmp-7 messenger-RNA in primary and metastatic human colorectal adenocarcinoma.
TNM staging for GIT cancers is correlated with the level of MMPs and TGF-?1.
[beta-Catenin induces invasive growth by activating matrix metalloproteinases in colorectal carcinoma]
[Effects of tamoxifen on apoptosis and matrix metalloproteinase-7 expression in estrogen receptor beta-positive colorectal cancer cell line HT-29]
[Expression of LOX in Colorectal Cancer Tissues and Its Relationship with Progress and Prognosis].
[Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal neoplasm]
[Function of MMP-7 in colorectal cancer]
[Genetic diagnosis of colorectal cancer]
[Prognostic significance of the molecular markers in human gastrointestinal cancer]
[The significance of beta-catenin and matrix metalloproteinase-7 expression in colorectal adenoma and carcinoma]
Coronary Artery Disease
Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients.
Analysis of MMP-7 and TIMP-2 gene polymorphisms in coronary artery disease and myocardial infarction: A Turkish case-control study.
Changes in plasma levels of MMP-9, MMP-7 and their inhibitors in patients with coronary artery disease.
Increased plasma concentration of matrix metalloproteinase-7 in patients with coronary artery disease.
Role of matrix metalloproteinases in coronary artery disease.
[Changes in proinflammatory cytokine and destructive metalloproteinase levels during formation of unstable atherosclerotic plaque]
[Inflammatory-destructive biomarkers of atherosclerotic plaques instability. Study of arterial wall and blood].
Cough
Elevated matrilysin levels in bronchoalveolar lavage fluid do not distinguish idiopathic pulmonary fibrosis from other interstitial lung diseases.
COVID-19
Immunofibrotic drivers of impaired lung function in postacute sequelae of SARS-CoV-2 infection.
Crohn Disease
Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers.
Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?
Expressions of Matrix Metalloproteinases (MMP-2, MMP-7, and MMP-9) and Their Inhibitors (TIMP-1, TIMP-2) in Inflammatory Bowel Diseases.
Cryptogenic Organizing Pneumonia
Is metalloproteinase-7 specific for idiopathic pulmonary fibrosis?
Cystic Fibrosis
Matrilysin expression and function in airway epithelium.
Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis.
Matrix Metalloproteinases-7 and Kidney Fibrosis.
Regulation of matrilysin expression in airway epithelial cells by Pseudomonas aeruginosa flagellin.
Cystitis
Molecular Basis of Acute Cystitis Reveals Susceptibility Genes and Immunotherapeutic Targets.
Cysts
Analyses of matrix metalloproteinases and their inhibitors in cyst fluid of serous ovarian tumors.
Induction of matrix metalloprotease-7 is common in mucinous ovarian tumors including early stage disease.
Matrilysin (MMP-7) Inhibition of BMP-7 Induced Renal Tubular Branching Morphogenesis Suggests a Role in the Pathogenesis of Human Renal Dysplasia.
Demyelinating Diseases
Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barré syndrome.
Dermatomyositis
Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies.
Surfactant protein D is associated with 3-month mortality of anti-MDA5 antibody-interstitial lung disease.
Diabetes Complications
Serum MMP-7 is increased in diabetic renal disease and diabetic diastolic dysfunction.
Diabetes Mellitus
Changes in Activity of Matrix Metalloproteinases and Serum Concentrations of Proinsulin and C-Peptide Depending on the Compensation Stage of Type 2 Diabetes Mellitus.
Diabetes Associated Markers After Bariatric Surgery: Fetuin-A, but Not Matrix Metalloproteinase-7, Is Reduced.
Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes.
Matrix metalloproteinase -7, -8, -9 and -13 in gingival tissue of patients with type 1 diabetes and periodontitis.
Matrix metalloproteinase-7 in periodontitis with type 2 diabetes mellitus.
The impact of type 2 diabetes and atorvastatin treatment on serum levels of MMP-7 and MMP-8.
Diabetes Mellitus, Type 1
Matrix metalloproteinase -7, -8, -9 and -13 in gingival tissue of patients with type 1 diabetes and periodontitis.
Urinary excretion of RAS, BMP, and WNT pathway components in diabetic kidney disease.
Diabetes Mellitus, Type 2
Advanced glycation end products decrease mesangial cell MMP-7: a role in matrix accumulation in diabetic nephropathy?
Changes in Activity of Matrix Metalloproteinases and Serum Concentrations of Proinsulin and C-Peptide Depending on the Compensation Stage of Type 2 Diabetes Mellitus.
Diabetes Associated Markers After Bariatric Surgery: Fetuin-A, but Not Matrix Metalloproteinase-7, Is Reduced.
Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes.
Matrix metalloproteinase-7 in periodontitis with type 2 diabetes mellitus.
The impact of type 2 diabetes and atorvastatin treatment on serum levels of MMP-7 and MMP-8.
Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetes.
Diabetic Retinopathy
Diabetes-induced peroxynitrite impairs the balance of pro-nerve growth factor and nerve growth factor, and causes neurovascular injury.
Digestive System Neoplasms
Current evidence on associations between the MMP-7 (-181A>G) polymorphism and digestive system cancer risk.
Distal Myopathies
Autosomal-dominant distal myopathy associated with a recurrent missense mutation in the gene encoding the nuclear matrix protein, matrin 3.
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy.
Heterogeneity of Matrin 3 in the developing and aging murine central nervous system.
Matrin 3 in neuromuscular disease: physiology and pathophysiology.
Mutant MATR3 mouse model to explain multisystem proteinopathy.
Mutation analysis of MATR3 in Australian familial amyotrophic lateral sclerosis.
Subcellular Localization of Matrin 3 Containing Mutations Associated with ALS and Distal Myopathy.
Transgenic mice overexpressing the ALS-linked protein Matrin 3 develop a profound muscle phenotype.
Down Syndrome
Manifold decreased protein levels of matrin 3, reduced motor protein HMP and hlark in fetal Down's syndrome brain.
Duodenal Ulcer
Elevated Serum Matrix Metalloproteinase-3 and -7 in H. pylori-Related Gastric Cancer Can Be Biomarkers Correlating with a Poor Survival.
Dyspnea
Elevated MMP-7 levels in patients with systemic sclerosis: correlation with pulmonary involvement.
Matrix metalloproteinase 7 in diagnosis and differentiation of pulmonary arterial hypertension.
Serum Matrix Metalloproteinase-7, Respiratory Symptoms, and Mortality in Community-dwelling Adults: The Multi-Ethnic Study of Atherosclerosis.
Embolism
Association between expression of MMP-7 and MMP-9 and pelvic lymph node and para-aortic lymph node metastasis in early cervical cancer.
Encephalitis
Cleavage of neuronal synaptosomal-associated protein of 25 kDa by exogenous matrix metalloproteinase-7.
Matrix metalloproteinase-7 modulates synaptic vesicle recycling and induces atrophy of neuronal synapses.
Encephalomyelitis
Matrix metalloproteinase-7 facilitates immune access to the CNS in experimental autoimmune encephalomyelitis.
Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system.
Encephalomyelitis, Autoimmune, Experimental
Matrix metalloproteinase-7 facilitates immune access to the CNS in experimental autoimmune encephalomyelitis.
Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system.
Endocarditis
[The study of activity of matrix metalloproteinases abd reactants of inflammation in patients with endocarditis.]
Endometrial Hyperplasia
Matrix Metalloproteinases and Their Tissue Inhibitors in Blood Serum of Patients with Endometrial Cancer: Clinical and Morphological Correlations.
Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.
Endometrial Neoplasms
Development of in situ zymography to localize active matrix metalloproteinase-7 (matrilysin-1).
Enhanced production and activation of matrix metalloproteinase-7 (matrilysin) in human endometrial carcinomas.
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
Matrix metalloproteinase-7 (MMP-7) polymorphism is a risk factor for endometrial cancer susceptibility.
Matrix Metalloproteinases and Their Tissue Inhibitors in Blood Serum of Patients with Endometrial Cancer: Clinical and Morphological Correlations.
No Association between Matrix Metalloproteinase (MMP)-1, MMP-3, and MMP-7 SNPs and Endometrial Cancer Risk.
Selected immunohistochemical prognostic factors in endometrial cancer.
Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.
[Immunohistochemical markers expression in hysteroscopy and hysterectomy specimens from endometrial cancer patients: comparison]
[Matrix metalloproteinases and their tissue inhibitors in malignancies of the female genital tract]
[The utility of metalloproteinases (MMPs) and their inhibitors (TIMPs) in diagnostics of gynecological malignancies].
Endometriosis
Analysis of matrix metalloproteinase-7 expression in eutopic and ectopic endometrium samples from patients with different forms of endometriosis.
Associations between various possible promoter polymorphisms of MMPs genes and endometriosis risk: a meta-analysis.
Effect of Wnt/?-catenin signal pathway on of matrix metalloproteinase-7 and vascular endothelial growth factor gene expressions in endometriosis.
EGFR-mediated matrix metalloproteinase-7 up-regulation promotes epithelial-mesenchymal transition via ERK1-AP1 axis during ovarian endometriosis progression.
Endometriosis Leads to an Increased Trefoil Factor 3 Concentration in the Peritoneal Cavity but Does Not Alter Systemic Levels.
Extracellular matrix metalloproteinase inducer (EMMPRIN) expression in the baboon endometrium: menstrual cycle and endometriosis.
Polymorphisms in the promoter regions of the matrix metalloproteinases-7, -9 and the risk of endometriosis and adenomyosis in China.
Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice.
Esophageal Neoplasms
Clinicopathological significance of matrix metalloproteinase-7 protein expression in esophageal cancer: a meta-analysis.
Interrelation between expression of matrix metalloproteinase 7 and beta-catenin in esophageal cancer.
IPO5 promotes malignant progression of esophageal cancer through activating MMP7.
Malignant Potential of Gastrointestinal Cancers Assessed by Structural Equation Modeling.
Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers.
MMP-10, MMP-7, TIMP-1 and TIMP-2 mRNA expression in esophageal cancer.
Esophageal Squamous Cell Carcinoma
A Panel of Tumor-associated Autoantibodies for the Detection of Early-stage Breast Cancer.
Activin A enhances MMP-7 activity via the transcription factor AP-1 in an esophageal squamous cell carcinoma cell line.
Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma.
Association of matrix metalloproteinase-7 (-181A>G) polymorphism with risk of esophageal squamous cell carcinoma in Kashmir Valley.
Autoantibodies against MMP-7 as a novel diagnostic biomarker in esophageal squamous cell carcinoma.
Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma.
Correlation among 16 biological factors [p53, p21(waf1), MIB-1 (Ki-67), p16(INK4A), cyclin D1, E-cadherin, Bcl-2, TNF-?, NF-?B, TGF-?, MMP-7, COX-2, EGFR, HER2/neu, ER, and HIF-1?] and clinical outcomes following curative chemoradiation therapy in 10 patients with esophageal squamous cell carcinoma.
Difference in responsiveness of human esophageal squamous cell carcinoma lines to epidermal growth factor for MMP-7 expression.
Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma.
Interrelation between expression of matrix metalloproteinase 7 and beta-catenin in esophageal cancer.
The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma.
Extranodal Extension
The Matrix Metalloproteinase-7 Polymorphism Rs10895304 Is Associated with Increased Recurrence Risk in Patients with Clinically Localized Prostate Cancer.
Fatty Liver
Serum matrix metalloproteinase 7 (MMP7) is a biomarker of fibrosis in patients with non-alcoholic fatty liver disease.
Fibromatosis, Aggressive
Correlation between beta-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors.
Frontotemporal Dementia
Matrin 3 in neuromuscular disease: physiology and pathophysiology.
Frontotemporal Lobar Degeneration
Genetic analysis of matrin 3 gene in French amyotrophic lateral sclerosis patients and frontotemporal lobar degeneration with amyotrophic lateral sclerosis patients.
Gallbladder Neoplasms
Enhanced expression of trophinin promotes invasive and metastatic potential of human gallbladder cancer cells.
Gastritis
Elevated Serum Matrix Metalloproteinase-3 and -7 in H. pylori-Related Gastric Cancer Can Be Biomarkers Correlating with a Poor Survival.
Expression of Wnt3, ?-catenin and MMP-7 in gastric cancer and precancerous lesions and their correlations with Helicobacter pylori infection.
Helicobacter pylori upregulates matrilysin (MMP-7) in epithelial cells in vivo and in vitro in a Cag dependent manner.
Serum IL-10, MMP-7, MMP-9 Levels in Helicobacter pylori Infection and Correlation with Degree of Gastritis.
Gastrointestinal Neoplasms
Clinical impact of matrix metalloproteinase-7 mRNA expression in the invasive front and inner surface of tumor tissues in patients with colorectal cancer.
Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers.
Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers.
Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.
Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers.
Retinoic acids reduce matrilysin (matrix metalloproteinase 7) and inhibit tumor cell invasion in human colon cancer.
[Prognostic significance of the molecular markers in human gastrointestinal cancer]
Gastrointestinal Stromal Tumors
The diagnostic importance of matrix metalloproteinase-7 and nestin in gastrointestinal stromal tumors.
Gingivitis
Immunohistochemical analysis of the gingiva with periodontitis of type I plasminogen deficiency compared to gingiva with gingivitis and periodontitis and healthy gingiva.
Study of the participation of MMP-7, EMMPRIN and cyclophilin A in the pathogenesis of periodontal disease.
Glioblastoma
ADAM12 is selectively overexpressed in human glioblastomas and is associated with glioblastoma cell proliferation and shedding of heparin-binding epidermal growth factor.
Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
Heterogeneous regional expression patterns of matrix metalloproteinases in human malignant gliomas.
MMP-7 (matrilysin) expression in human brain tumors.
[Increased expression of gelatinases A and B, matrilysin and TIMP-1 genes in human malignant gliomas ]
Glioma
Association between expression of HOTAIR and invasiveness of gliomas, and its predictive value.
Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
Expressions of matrilysin and stromelysin in human glioma cells.
Expressions of matrix metalloproteinase-7 and matrix metalloproteinase-14 associated with the activation of extracellular signal-regulated kinase1/2 in human brain gliomas of different pathological grades.
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
MMP-7 (matrilysin) expression in human brain tumors.
MT1-MMP and MMP-7 in invasion and metastasis of human cancers.
[Increased expression of gelatinases A and B, matrilysin and TIMP-1 genes in human malignant gliomas ]
Glomerulonephritis
Molecular characterization of a low-molecular-mass matrix metalloproteinase secreted by glomerular mesangial cells as PUMP-1.
Glomerulonephritis, IGA
Serum Matrix Metalloproteinase-7 Level is Associated with Fibrosis and Renal Survival in Patients with IgA Nephropathy.
Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
Glomerulosclerosis, Focal Segmental
Matrix metalloproteinase-7 as a surrogate marker predicts renal Wnt/?-catenin activity in CKD.
Guillain-Barre Syndrome
Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barré syndrome.
Head and Neck Neoplasms
Matrix metalloproteinase-7 and -13 expression associate to cisplatin resistance in head and neck cancer cell lines.
[Prediction of Post-operative Lymph Node Metastasis with a Molecular Biological Test in Head and Neck Cancer].
Heart Arrest
Serum matrix metalloproteinases in patients resuscitated from cardiac arrest. The association with therapeutic hypothermia.
Heart Failure
Matrix metalloproteinase 7 in diagnosis and differentiation of pulmonary arterial hypertension.
Heart Neoplasms
The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma.
Hepatitis C
Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C.
Hepatitis C, Chronic
Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C.
Hepatitis, Chronic
Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C.
Hidradenitis
Matrix metalloproteinase matrilysin is constitutively expressed in adult human exocrine epithelium.
HIV Infections
Effects of norepinephrine, HIV type 1 infection, and leukocyte interactions with endothelial cells on the expression of matrix metalloproteinases.
Marked relationship between matrix metalloproteinase 7 and brain atrophy in HIV infection.
Matrix metalloproteinase levels in early HIV infection and relation to in vivo brain status.
MMP-7 promoter polymorphisms do not influence CD4+ recovery and changes in plasma viral load during antiretroviral therapy for HIV-1 infection.
Hyperlipidemias
Apolipoprotein A-IV is a novel substrate for matrix metalloproteinases.
Hypertension
Increased vascular and uteroplacental matrix metalloproteinase-1 and -7 levels and collagen type I deposition in hypertension in pregnancy: role of TNF-?.
Matrix metalloproteinase 7 in diagnosis and differentiation of pulmonary arterial hypertension.
Matrix metalloproteinase-7 and ADAM-12 (a disintegrin and metalloproteinase-12) define a signaling axis in agonist-induced hypertension and cardiac hypertrophy.
MMP-2 mediates angiotensin II-induced hypertension under the transcriptional control of MMP-7 and TACE.
The expression of MMP-7 in serum and aneurysm tissues of patients with abdominal aortic aneurysm associated with hypertension and the clinical efficacy of endovascular exclusion.
Hypertension, Pulmonary
Immunohistochemical study of endothelin-1 and matrix metalloproteinases in plexogenic pulmonary arteriopathy.
Matrix metalloproteinase 7 in diagnosis and differentiation of pulmonary arterial hypertension.
Idiopathic Interstitial Pneumonias
Interstitial Score and Concentrations of IL-4R?, PAR-2, and MMP-7 in Bronchoalveolar Lavage Fluid Could Be Useful Markers for Distinguishing Idiopathic Interstitial Pneumonias.
Is metalloproteinase-7 specific for idiopathic pulmonary fibrosis?
MMP-7 and fcDNA serum levels in early NSCLC and idiopathic interstitial pneumonia: preliminary study.
Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis From Other Idiopathic Interstitial Pneumonias.
Idiopathic Pulmonary Fibrosis
Allele Specific Transactivation of Matrix Metalloproteinase 7 by FOXA2 and Correlation with Plasma Levels in Idiopathic Pulmonary Fibrosis.
Blood biomarkers MMP-7 and SP-A: predictors of outcome in idiopathic pulmonary fibrosis.
Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis.
Current Concepts of Biliary Atresia and Matrix Metalloproteinase-7: A Review of Literature.
Elevated matrilysin levels in bronchoalveolar lavage fluid do not distinguish idiopathic pulmonary fibrosis from other interstitial lung diseases.
Is metalloproteinase-7 specific for idiopathic pulmonary fibrosis?
Levels of circulating MMP-7 degraded elastin are elevated in pulmonary disorders.
Matrix metalloproteinase-10: a novel biomarker for idiopathic pulmonary fibrosis.
MMP-7 is a predictive biomarker of disease progression in patients with idiopathic pulmonary fibrosis.
Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis From Other Idiopathic Interstitial Pneumonias.
Production and activation of matrix metalloproteinase 7 (matrilysin 1) in the lungs of patients with idiopathic pulmonary fibrosis.
Serial Measurements of Circulating KL-6, SP-D, MMP-7, CA19-9, CA-125, CCL18, and Periostin in Patients with Idiopathic Pulmonary Fibrosis Receiving Antifibrotic Therapy: An Exploratory Study.
Serum Biomarkers in Differential Diagnosis of Idiopathic Pulmonary Fibrosis and Connective Tissue Disease-Associated Interstitial Lung Disease.
Validation of the prognostic value of MMP-7 in idiopathic pulmonary fibrosis.
[Change of matrix metalloproteinase-1 and matrix metalloproteinase-7 in serum and bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and sarcoidosis].
Infections
A Cell Proliferation and Inflammatory Signature Is Induced by Lawsonia intracellularis Infection in Swine.
Bacterial exposure induces and activates matrilysin in mucosal epithelial cells.
cag Pathogenicity island-dependent upregulation of matrix metalloproteinase-7 in infected patients with Helicobacter pylori.
Elucidating the function and tolerance mechanism of gamma delta (? ?) T cells in a Helicobacter pylori infection model.
EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture.
Expression of Wnt3, ?-catenin and MMP-7 in gastric cancer and precancerous lesions and their correlations with Helicobacter pylori infection.
Helicobacter pylori upregulates matrilysin (MMP-7) in epithelial cells in vivo and in vitro in a Cag dependent manner.
Heparanase-Regulated Syndecan-1 Shedding Facilitates Herpes Simplex Virus 1 Egress.
Human neural stem cell-derived neuron/astrocyte co-cultures respond to La Crosse virus infection with proinflammatory cytokines and chemokines.
Human T-cell leukemia virus type 1 Tax transactivates the matrix metalloproteinase 7 gene via JunD/AP-1 signaling.
Individual matrix metalloproteinases control distinct transcriptional responses in airway epithelial cells infected with Pseudomonas aeruginosa.
Juvenile, but Not Adult, Mice Display Increased Myeloid Recruitment and Extracellular Matrix Remodeling during Respiratory Syncytial Virus Infection.
Matrilysin (matrix metalloproteinase 7) in parturition, premature rupture of membranes, and intrauterine infection.
Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of children with Japanese encephalitis virus infection.
Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis.
MMP-7 promoter polymorphisms do not influence CD4+ recovery and changes in plasma viral load during antiretroviral therapy for HIV-1 infection.
Newcastle disease virus mediated apoptosis and migration inhibition of human oral cancer cells: A probable role of ?-catenin and matrix metalloproteinase-7.
Nuclear matrix protein Matrin 3 is a regulator of ZAP-mediated retroviral restriction.
Regulation of matrilysin expression in airway epithelial cells by Pseudomonas aeruginosa flagellin.
Role of airway epithelial injury in murine orthotopic tracheal allograft rejection.
Role of matrix metalloproteinase-7 in the modulation of a Chlamydia trachomatis infection.
Serum IL-10, MMP-7, MMP-9 Levels in Helicobacter pylori Infection and Correlation with Degree of Gastritis.
The detection of Helicobacter pylori cag pathogenicity islands (PAIs) and expression of matrix metalloproteinase-7 (MMP-7) in gastric epithelial dysplasia and intramucosal cancer.
The role of matrix metalloproteinase-7 in redefining the gastric microenvironment in response to Helicobacter pylori.
[Expressions of MMP-7 and TIMP-1 in Chronic Stomach Disease Patients with Different Syndromes of Chinese Medicine].
Infertility, Male
Overexpression of the matrix metalloproteinase matrilysin results in premature mammary gland differentiation and male infertility.
Inflammatory Bowel Diseases
Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?
Expressions of Matrix Metalloproteinases (MMP-2, MMP-7, and MMP-9) and Their Inhibitors (TIMP-1, TIMP-2) in Inflammatory Bowel Diseases.
The Role of Matrix Metalloproteinases in Intestinal Epithelial Wound Healing During Normal and Inflammatory States.
Insulin Resistance
Do different bariatric surgical procedures influence plasma levels of matrix metalloproteinase-2, -7, and -9 among patients with type 2 diabetes mellitus?
Insulinoma
Molecular cloning of matrin 3. A 125-kilodalton protein of the nuclear matrix contains an extensive acidic domain.
Intervertebral Disc Degeneration
Human disc degeneration is associated with increased MMP 7 expression.
Intervertebral Disc Displacement
Experimental chemonucleolysis with recombinant human matrix metalloproteinase 7 in human herniated discs and dogs.
Experimental studies on the effects of recombinant human matrix metalloproteinases on herniated disc tissues--how to facilitate the natural resorption process of herniated discs.
Human disc degeneration is associated with increased MMP 7 expression.
Translational research of herniated discs: current status of diagnosis and treatment.
Up-regulated expression of matrilysin and neutrophil collagenase in human herniated discs.
Ischemic Stroke
Combined Effects of MMP-7, MMP-8 and MMP-26 on the Risk of Ischemic Stroke.
Discovery of New Risk Markers for Ischemic Stroke Using a Novel Targeted Proteomics Chip.
Kallmann Syndrome
Cigarette smoke modulates PC3 prostate cancer cell migration by altering adhesion molecules and the extracellular matrix.
Keratoacanthoma
Transformation-specific matrix metalloproteinases, MMP-7 and MMP-13, are present in epithelial cells of keratoacanthomas.
Kidney Diseases
The Many Faces of Matrix Metalloproteinase-7 in Kidney Diseases.
Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetes.
Kidney Failure, Chronic
ACE I/D and MMP-7 A-181G variants and the risk of end stage renal disease.
Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetes.
Kidney Neoplasms
Distance-dependent visual fluorescence immunoassay on CdTe quantum dot-impregnated paper through silver ion-exchange reaction.
Prognostic Role of Matrix Metalloproteinases 2, 7, 8, 9 and Their Type 1 Tissue Inhibitor in Blood Serum of Patients with Kidney Cancer.
Quantitative immunohistochemical analysis of matrilysin 1 (MMP-7) in various renal cell carcinoma subtypes.
Laminopathies
Laminopathies and lamin-associated signaling pathways.
Laryngeal Neoplasms
Matrix metalloproteinases (MMPs) and inhibitor of metalloproteinases (TIMP) mRNA and protein expression in laryngeal squamous cell carcinoma.
[Relationship of matrilysin with invasion, metastasis, and prognosis in laryngeal cancer]
[The expression of tumor related macrophages and matrix solution element in laryngeal squamous carcinoma tissue and the relationship with tumor microvascular density].
Laryngopharyngeal Reflux
Role of Matrix Metalloproteinases 7 in the Pathogenesis of Laryngopharyngeal Reflux: Decreased E-cadherin in Acid exposed Primary Human Pharyngeal Epithelial Cells.
Usefulness of matrix metalloproteinase-7 in saliva as a diagnostic biomarker for laryngopharyngeal reflux disease.
Leg Ulcer
Expression of matrix metalloproteinase (MMP)-7 and MMP-13 and loss of MMP-19 and p16 are associated with malignant progression in chronic wounds.
Leiomyoma
Increased expression of stromelysin 3 mRNA in leiomyomas (uterine fibroids) compared with myometrium.
Leukemia
Automated Extraction of DNA and RNA from a Single Formalin-Fixed Paraffin-Embedded Tissue Section for Analysis of Both Single-Nucleotide Polymorphisms and mRNA Expression.
Contribution of Matrix Metalloproteinase-7 Genotypes to the Risk of Non-solid Tumor, Childhood Leukemia.
Genomic profiling of thousands of candidate polymorphisms predicts risk of relapse in 778 Danish and German childhood acute lymphoblastic leukemia patients.
Identification of novel genes regulated by chorionic gonadotropin in baboon endometrium during the window of implantation.
[Resistance of leukemia cells to Fas/FasL-mediated apoptosis and strategies replying to antiapoptosis of leukemia cells--review]
Leukemia, Myeloid, Acute
Expression and clinical significance of serum MMP-7 and PTEN levels in patients with acute myeloid leukemia.
The prognostic value of matrix metalloproteinase-7 and matrix metalloproteinase-15 in acute myeloid leukemia.
Leukemia, T-Cell
Human T-cell leukemia virus type 1 Tax transactivates the matrix metalloproteinase 7 gene via JunD/AP-1 signaling.
Lichen Planus, Oral
COX-2, MMP-7 expression in oral lichen planus and oral squamous cell carcinoma.
Listeriosis
Matrix metalloproteinase expression in sheep with listerial meningoencephalitis.
Liver Cirrhosis
A novel nonsynonymous variant of matrix metalloproteinase-7 confers risk of liver cirrhosis.
Biomarkers for the diagnosis and post-Kasai portoenterostomy prognosis of biliary atresia: a systematic review and meta-analysis.
Current Concepts of Biliary Atresia and Matrix Metalloproteinase-7: A Review of Literature.
Evaluation of matrix metalloproteinases and their endogenous tissue inhibitors in biliary atresia-associated liver fibrosis.
Increased MMP-7 expression in biliary epithelium and serum underpins native liver fibrosis after successful portoenterostomy in biliary atresia.
Matrilysin (MMP-7) is a major matrix metalloproteinase upregulated in biliary atresia-associated liver fibrosis.
Matrix Metalloproteinases-7 and Kidney Fibrosis.
Predicting native liver injury and survival in biliary atresia.
Quantification of Serum Matrix Metallopeptide 7 Levels May Assist in the Diagnosis and Predict the Outcome for Patients with Biliary Atresia.
[Expressions of MDM2 and MMP-7 in normal liver, cirrhosis, hepatocellular carcinoma tissues]
Liver Diseases
Increased MMP-7 expression in biliary epithelium and serum underpins native liver fibrosis after successful portoenterostomy in biliary atresia.
Serum levels of TIMP-1 and MMP-7 as potential biomarkers in patients with metastatic colorectal cancer.
Serum matrix metalloproteinase 7 (MMP7) is a biomarker of fibrosis in patients with non-alcoholic fatty liver disease.
Serum Matrix Metalloproteinase 7 Is a Diagnostic Biomarker of Biliary Injury and Fibrosis in Pediatric Autoimmune Liver Disease.
Lung Diseases
Exploring the Role of Matrix Metalloproteinases as Biomarkers in Sporadic Lymphangioleiomyomatosis and Tuberous Sclerosis Complex. A Pilot Study.
Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.
Implications for matrix metalloproteinases as modulators of pediatric lung disease.
Levels of circulating MMP-7 degraded elastin are elevated in pulmonary disorders.
Matrix metalloproteinase-7 expression in fibrosing lung disease: restoring the balance.
Lung Diseases, Interstitial
Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis.
Cholesterol, lipoproteins and subclinical interstitial lung disease: the MESA study.
Elevated matrilysin levels in bronchoalveolar lavage fluid do not distinguish idiopathic pulmonary fibrosis from other interstitial lung diseases.
Extracellular matrix metalloproteinase inducer in interstitial pneumonias.
Matrix metalloproteinase 7 is a candidate biomarker in systemic sclerosis-associated interstitial lung disease.
Serum Biomarkers in Differential Diagnosis of Idiopathic Pulmonary Fibrosis and Connective Tissue Disease-Associated Interstitial Lung Disease.
Surfactant protein D is associated with 3-month mortality of anti-MDA5 antibody-interstitial lung disease.
Lung Injury
High attenuation areas on chest computed tomography in community-dwelling adults: the MESA study.
Induction of pulmonary matrilysin expression by combustion and ambient air particles.
Matrilysin (Matrix Metalloproteinase-7) regulates anti-inflammatory and antifibrotic pulmonary dendritic cells that express CD103 (alpha(E)beta(7)-integrin).
Matrilysin (MMP-7) catalytic activity regulates ?-catenin localization and signaling activation in lung epithelial cells.
MMP7 shedding of syndecan-1 facilitates re-epithelialization by affecting alpha(2)beta(1) integrin activation.
The biological activity of FasL in human and mouse lungs is determined by the structure of its stalk region.
Lung Neoplasms
Beyond Conventional: The New Horizon of Anti-Angiogenic microRNAs in Non-Small Cell Lung Cancer Therapy.
CCL25 promotes the migration and invasion of non-small cell lung cancer cells by regulating VEGF and MMPs in a CCR9-dependent manner.
Clinical significance of immunohistochemical expression of insulin-like growth factor-1 receptor and matrix metalloproteinase-7 in resected non-small cell lung cancer.
Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer.
Correlation Between MMP-7 and bFGF Expressions in Non-small Cell Lung Cancer Tissue and Clinicopathologic Features.
Detection of Matrilysin Activity Using Polypeptide Functionalized Reduced Graphene Oxide Field-Effect Transistor Sensor.
Effect of Osimertinib on the expression of serum mmp-7 and mmp-9 in patients with non-small cell lung cancer.
Elevated matrix metalloproteinase-7 expression promotes metastasis in human lung carcinoma.
Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study.
Expression of matrix metalloproteinases 3, 10 and 11 (stromelysins 1, 2 and 3) and matrix metalloproteinase 7 (matrilysin) by cancer cells in non-small cell lung neoplasms. Clinicopathologic studies.
Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer Relation to clinicopathological factors, beta-catenin and prognosis.
Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.
Expression of mRNA MMP-7 and mRNA TIMP-1 in non-small cell lung cancer.
Fibulin-3 promoter methylation alters the invasive behavior of non-small cell lung cancer cell lines via MMP-7 and MMP-2 regulation.
Fibulin-3 suppresses Wnt/?-catenin signaling and lung cancer invasion.
Fibulin-5 inhibits Wnt/?-catenin signaling in lung cancer.
Fibulin-5 suppresses lung cancer invasion by inhibiting matrix metalloproteinase-7 expression.
Levels of circulating MMP-7 degraded elastin are elevated in pulmonary disorders.
Matrilysin inhibits proliferation and modulates sensitivity of lung cancer cells to FasL-mediated apoptosis.
Matrilysin-1 mediates bronchiolization of alveoli, a potential premalignant change in lung cancer.
Matrix metalloproteinase-7 facilitates insulin-like growth factor bioavailability through its proteinase activity on insulin-like growth factor binding protein 3.
Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer.
Predictive value of MMP-7 expression for response to chemotherapy and survival in patients with non-small cell lung cancer.
Prognostic value of matrix metalloproteinase-7 expression in patients with non-small cell lung cancer.
Roles of osteopontin and matrix metalloproteinase-7 in occurrence, progression, and prognosis of nonsmall cell lung cancer.
The Contribution of MMP-7 Promoter Polymorphisms to Taiwan Lung Cancer Susceptibility.
[EFEMP1 Suppresses Growth and Invasion of Lung Cancer Cells ?by Downregulating Matrix Metalloproteinase-7 Expression].
[Expression of bone morphogenetic proteins, matrix metalloproteinases and inhibitors of matrix metalloproteinases in lung cancers and their prognostic significance]
[The expression level and clinical significance of MMP-7 protein?in peripheral blood in the patients with lung cancer].
Lupus Erythematosus, Systemic
Role of MMP-7 in the pathogenesis of systemic lupus erythematosus (SLE).
Lupus Nephritis
Association of Urinary Matrix Metalloproteinase 7 with Incident Renal Flare in Lupus Nephritis.
Lymphatic Metastasis
Association between expression of MMP-7 and MMP-9 and pelvic lymph node and para-aortic lymph node metastasis in early cervical cancer.
Association of matrilysin expression with progression and poor prognosis in human pancreatic adenocarcinoma.
Association of matrilysin mRNA expression with K-ras mutations and progression in pancreatic ductal adenocarcinomas.
CD44v6, MMP-7 and nuclear Cdx2 are significant biomarkers for prediction of lymph node metastasis in primary gastric cancer.
Clinical impact of matrix metalloproteinase-7 mRNA expression in the invasive front and inner surface of tumor tissues in patients with colorectal cancer.
Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer.
Clinical Significance of MMP-7 and PTEN Expression in Colorectal Cancer.
Clinical significance of mucin phenotype, beta-catenin and matrix metalloproteinase 7 in early undifferentiated gastric carcinoma.
Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers.
Correlation Between MMP-7 and bFGF Expressions in Non-small Cell Lung Cancer Tissue and Clinicopathologic Features.
Correlation of lymph node metastases and expression of matrix metalloproteinase-7 in patients with gastric cancer.
Correlation of polymorphism of IL-8 and MMP-7 with occurrence and lymph node metastasis of early stage cervical cancer.
Detection of regional lymph node metastases in colon cancer by using RT-PCR for matrix metalloproteinase 7, matrilysin.
Dickkopf-1 expression is associated with tumorigenity and lymphatic metastasis in human hilar cholangiocarcinoma.
Downregulation of matrix metalloprotease-9 and urokinase plasminogen activator by TX-1877 results in decreased tumor growth and metastasis on xenograft model of rectal cancer.
Expression and prognostic value of matrix metalloproteinase-7 in colorectal cancer.
Expression and significance of IGF-2, PCNA, MMP-7, and ?-actin in gastric carcinoma with Lauren classification.
Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-1 in human prostate.
Expression of Matrix Metalloproteinase-7 is an Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma.
Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases.
Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis.
Expression of tissue levels of matrix metalloproteinases and their inhibitors in breast cancer.
Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric adenocarcinoma.
Expressions of Matrix Metalloproteinase-7 and -9 and their Prognostic Significances in Rectal Cancer.
Immunohistochemical molecular markers as predictors of curability of endoscopically resected submucosal colorectal cancer.
Immunohistochemical study of vascular endothelial growth factor (VEGF) and matrilysin (MMP-7) in T1 adenocarcinoma of the colon and rectum to predict lymph node metastases or distant metastases.
Malignant Potential of Gastrointestinal Cancers Assessed by Structural Equation Modeling.
Matrilsin expression is a useful marker of submucosal invasion and lymph node metastasis in early stage signet ring cell carcinoma of the stomach.
Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer.
MMP-10, MMP-7, TIMP-1 and TIMP-2 mRNA expression in esophageal cancer.
MMP-7 A-181G Polymorphism in Breast Cancer Patients from Western Iran.
MMP-7 is upregulated by COX-2 and promotes proliferation and invasion of lung adenocarcinoma cells.
Prognostic significance of matrix metalloproteinase-7 (MMP-7) expression at the invasive front in gastric carcinoma.
Prognostic significance of matrix metalloproteinase-7 in gastric cancer survival: a meta-analysis.
Relationship between E-cadherin, matrix metalloproteinase-7 gene expression and clinicopathological features in gastric carcinoma.
Role of MMP-7 in the formation of peritoneal dissemination in gastric cancer.
Roles of osteopontin and matrix metalloproteinase-7 in occurrence, progression, and prognosis of nonsmall cell lung cancer.
Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients' prognosis in bladder cancer.
Suppression Of ?-catenin Nuclear Translocation By CGP57380 Decelerates Poor Progression And Potentiates Radiation-Induced Apoptosis in Nasopharyngeal Carcinoma.
The clinical value of Vav3 in peripheral blood for predicting lymphatic metastasis of gastric cancer.
[Correlation between expression of MMP-7 in gastric submucosal invasive carcinoma and lymph node micrometastasis]
[Expression and clinical significance of Ang-2 and MMP-7 in laryngeal carcinoma]
[Expression and clinical significance of matrilysin (MMP-7) in human rectal cancer]
[Expression of ETV5 and MMP-7 in Early Stage Cervical Squamous Cell Carcinoma and Its Role in Lymphatic Metastasis.]
[Prediction of Post-operative Lymph Node Metastasis with a Molecular Biological Test in Head and Neck Cancer].
[Prognostic significance of the molecular markers in human gastrointestinal cancer]
[Siliconchiptechnology-based MMP-7 analysis in urine : An option for preoperative identification of lymph node metastasis in bladder cancer.]
[The significance of beta-catenin and matrix metalloproteinase-7 expression in colorectal adenoma and carcinoma]
[The utility of metalloproteinases (MMPs) and their inhibitors (TIMPs) in diagnostics of gynecological malignancies].
Lymphoma
PCDH10 inhibits invasion of lymphoma cells by regulating ?-catenin.
Significant increase in the expression of matrix metalloproteinase 7 in primary CNS lymphoma.
Tungsten Oxide Nanoplates; the Novelty in Targeting Metalloproteinase-7 Gene in Both Cervix and Colon Cancer Cells.
[mRNA and Protein Expression of AXIN,?-Catenin, MMP7 and MMP9 and Their Relationship in Lymphoma Cells].
Lymphoma, B-Cell
Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases.
Tungsten Oxide Nanoplates; the Novelty in Targeting Metalloproteinase-7 Gene in Both Cervix and Colon Cancer Cells.
Lymphoma, T-Cell
Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways.
Macular Degeneration
Expression of matrix metalloproteinase-7 in choroidal neovascular membranes in age-related macular degeneration.
Role of matrix metalloproteinase-7 in angiogenesis associated with age-related macular degeneration.
matrilysin deficiency
Matrix metalloproteinase-7 and premalignant host responses in Helicobacter pylori-infected mice.
Matrix metalloproteinase-7 protects against acute kidney injury by priming renal tubules for survival and regeneration.
Medulloblastoma
Ciz1, Cip1 interacting zinc finger protein 1 binds the consensus DNA sequence ARYSR(0-2)YYAC.
Melanoma
Binding of alpha5 monoclonal antibody to cell surface alpha5beta1 integrin modulates MMP-2 and MMP-7 activity in B16F10 melanoma cells.
Expression of matrilysin (matrix metalloproteinase-7) in primary cutaneous and metastatic melanoma.
Melanocyte mediated paracrine induction of extracellular matrix degrading proteases in squamous cell carcinoma cells.
Meningoencephalitis
Matrix metalloproteinase expression in sheep with listerial meningoencephalitis.
Mesothelioma
Multiplex Soluble Biomarker Analysis from Pleural Effusion.
Mesothelioma, Malignant
MMP-7 is a highly specific negative marker for benign and malignant mesothelial cells in serous effusions.
Multiplex Soluble Biomarker Analysis from Pleural Effusion.
Mouth Neoplasms
Association of Matrix Metalloproteinase-7 Genotypes to the Risk of Oral Cancer in Taiwan.
High gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancer.
Newcastle disease virus mediated apoptosis and migration inhibition of human oral cancer cells: A probable role of ?-catenin and matrix metalloproteinase-7.
Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis.
Mucocutaneous Lymph Node Syndrome
Integrins ?4 and ?M, collagen1A1, and matrix metalloproteinase 7 are upregulated in acute Kawasaki disease vasculopathy.
Multiple Myeloma
A loss of host-derived MMP-7 promotes myeloma growth and osteolytic bone disease in vivo.
Multiple Sclerosis
Association of matrix metalloproteinase-7A-181G variants with the risk of multiple sclerosis.
Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions.
Functional Promoter Polymorphisms of MMP-2 C-735T and MMP-9 C-1562T and Their Synergism with MMP-7 A-181G in Multiple Sclerosis.
Matrix metalloproteinase activity stimulates N-cadherin shedding and the soluble N-cadherin ectodomain promotes classical microglial activation.
Matrix metalloproteinase-7 and matrix metalloproteinase-9 in pediatric multiple sclerosis.
Matrix metalloproteinase-7 facilitates immune access to the CNS in experimental autoimmune encephalomyelitis.
Matrix metalloproteinase-7, matrix metalloproteinase-9, and disease activity in pediatric multiple sclerosis.
The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis.
Muscle Cramp
Cationic antimicrobial peptides serve as activation signals for the Salmonella Typhimurium PhoPQ and PmrAB regulons in vitro and in vivo.
Muscular Atrophy
Transgenic mice overexpressing the ALS-linked protein Matrin 3 develop a profound muscle phenotype.
Muscular Diseases
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy.
Knockdown of genes involved in axonal transport enhances the toxicity of human neuromuscular disease-linked MATR3 mutations in Drosophila.
Obstetric risk in patients with myopathy due to MATR3 mutations.
Subcellular Localization of Matrin 3 Containing Mutations Associated with ALS and Distal Myopathy.
Myocardial Infarction
Analysis of MMP-7 and TIMP-2 gene polymorphisms in coronary artery disease and myocardial infarction: A Turkish case-control study.
In vivo matrix metalloproteinase-7 substrates identified in the left ventricle post-myocardial infarction using proteomics.
Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction.
Proteomic Analysis of the Left Ventricle Post-myocardial Infarction to Identify In Vivo Candidate Matrix Metalloproteinase Substrates.
Role of matrix metalloproteinases in coronary artery disease.
Serum tissue-degrading proteinases and incident cardiovascular disease events.
Myoma
Analysis of matrix metalloproteinase-7 expression in eutopic and ectopic endometrium samples from patients with different forms of endometriosis.
Myositis
Matrix metalloproteinases in inflammatory myopathies: enhanced immunoreactivity near atrophic myofibers.
Nasal Polyps
Involvement of the extracellular matrix proteins periostin and tenascin C in nasal polyp remodeling by regulating the expression of MMPs.
V?1? ??T Cells Are Correlated With Increasing Expression of Eosinophil Cationic Protein and Metalloproteinase-7 in Chronic Rhinosinusitis With Nasal Polyps Inducing the Formation of Edema.
[The protein expression difference of transforming growth factor beta1, matrix metalloproteinases 1,7,9 and tissue inhibitors of matrix metalloproteinases-1 between chronic rhinosinusitis, nasal polyps and normal mucosa tissues]
Nasopharyngeal Carcinoma
Regulation of matrix metalloproteinase-1 by Epstein-Barr virus proteins.
The long noncoding RNA FOXCUT promotes proliferation and migration by targeting FOXC1 in nasopharyngeal carcinoma.
Neoplasm Metastasis
A new formula for predicting liver metastasis in patients with colorectal cancer: immunohistochemical analysis of a large series of 439 surgically resected cases.
Aberrant Activation Of Hedgehog Signalling Promotes Cell Migration And Invasion Via Matrix Metalloproteinase-7 In Ovarian Cancer Cells.
Activating transcription factor 4 promotes esophageal squamous cell carcinoma invasion and metastasis in mice and is associated with poor prognosis in human patients.
Alterations of metastasis-related genes identified using an oligonucleotide microarray of genistein-treated HCC1395 breast cancer cells.
Amperometric Biosensor of Matrix Metalloproteinase-7 Enhanced by Pd-Functionalized Carbon Nanocomposites.
Association between expression of MMP-7 and MMP-9 and pelvic lymph node and para-aortic lymph node metastasis in early cervical cancer.
Association of 12 serum biochemical markers of angiogenesis, tumour invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluation.
Association of matrilysin expression with progression and poor prognosis in human pancreatic adenocarcinoma.
Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma.
Association of matrilysin mRNA expression with K-ras mutations and progression in pancreatic ductal adenocarcinomas.
Association of matrix metalloproteinase-7 (-181A>G) polymorphism with risk of esophageal squamous cell carcinoma in Kashmir Valley.
beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer.
Beta-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: relationships with carcinogenesis and metastasis.
Bio-informatics analysis of renal carcinoma gene matrix metalloproteinase-7.
By activating matrix metalloproteinase-7, shear stress promotes chondrosarcoma cell motility, invasion and lung colonization.
c-Myc transactivates GP73 and promotes metastasis of hepatocellular carcinoma cells through GP73-mediated MMP-7 trafficking in a mildly hypoxic microenvironment.
Cancer invasion regulates vascular complexity in a three-dimensional biomimetic model.
Catecholamine up-regulates MMP-7 expression by activating AP-1 and STAT3 in gastric cancer.
CAV1 promotes HCC cell progression and metastasis through Wnt/?-catenin pathway.
CD44v6, MMP-7 and nuclear Cdx2 are significant biomarkers for prediction of lymph node metastasis in primary gastric cancer.
Cholesterol sulfate alters substrate preference of matrix metalloproteinase-7 and promotes degradations of pericellular laminin-332 and fibronectin.
Cleavage of the Perlecan-Semaphorin 3A-Plexin A1-Neuropilin-1 (PSPN) Complex by Matrix Metalloproteinase 7/Matrilysin Triggers Prostate Cancer Cell Dyscohesion and Migration.
Clinical impact of matrix metalloproteinase-7 mRNA expression in the invasive front and inner surface of tumor tissues in patients with colorectal cancer.
Clinical relevance of the expression of mRNA of MMP-7, MMP-9, TIMP-1, TIMP-2 and CEA tissue samples from colorectal liver metastases.
Clinical significance of immunohistochemical expression of insulin-like growth factor-1 receptor and matrix metalloproteinase-7 in resected non-small cell lung cancer.
Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer.
Clinical Significance of MMP-7 and PTEN Expression in Colorectal Cancer.
Clinical significance of mucin phenotype, beta-catenin and matrix metalloproteinase 7 in early undifferentiated gastric carcinoma.
Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers.
Clinicopathologic and prognostic significance of MMP-7 (matrilysin) expression in human rectal cancer.
Clinicopathological significance of matrix metalloproteinase-7 protein expression in esophageal cancer: a meta-analysis.
Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
Coexpression of matrix metalloproteinase-7 (MMP-7) and epidermal growth factor (EGF) receptor in colorectal cancer: an EGF receptor tyrosine kinase inhibitor is effective against MMP-7-expressing cancer cells.
Colorectal carcinoma susceptibility and metastases are associated with matrix metalloproteinase-7 promoter polymorphisms.
Common MMP-7 polymorphisms and breast cancer susceptibility: a multistage study of association and functionality.
Concomitantly elevated serum matrix metalloproteinases 3 and 9 can predict survival of synchronous squamous cell carcinoma of the upper aero-digestive tract.
Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers.
Contribution of sialidase NEU1 to suppression of metastasis of human colon cancer cells through desialylation of integrin beta4.
Correlation Between MMP-7 and bFGF Expressions in Non-small Cell Lung Cancer Tissue and Clinicopathologic Features.
Correlation of lymph node metastases and expression of matrix metalloproteinase-7 in patients with gastric cancer.
Correlation of polymorphism of IL-8 and MMP-7 with occurrence and lymph node metastasis of early stage cervical cancer.
Detection of regional lymph node metastases in colon cancer by using RT-PCR for matrix metalloproteinase 7, matrilysin.
Development of in situ zymography to localize active matrix metalloproteinase-7 (matrilysin-1).
Diallyl trisulfide increases the effectiveness of TRAIL and inhibits prostate cancer growth in an orthotopic model: molecular mechanisms.
DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
Down-regulation of matrix metalloproteinase-7 inhibits metastasis of human anaplastic thyroid cancer cell line.
Downregulation of matrix metalloprotease-9 and urokinase plasminogen activator by TX-1877 results in decreased tumor growth and metastasis on xenograft model of rectal cancer.
Effect of Wnt/?-catenin signal pathway on of matrix metalloproteinase-7 and vascular endothelial growth factor gene expressions in endometriosis.
EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer.
Elevated matrix metalloproteinase 7 expression promotes the proliferation, motility and metastasis of tongue squamous cell carcinoma.
Elevated matrix metalloproteinase-7 expression promotes metastasis in human lung carcinoma.
Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomy.
Enhanced production and activation of matrix metalloproteinase-7 (matrilysin) in human endometrial carcinomas.
Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and ?-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
Expression and activity levels of matrix metalloproteinase-7 and in situ localization of caseinolytic activity in colorectal cancer.
Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis.
Expression and prognostic value of matrix metalloproteinase-7 in colorectal cancer.
Expression and significance of IGF-2, PCNA, MMP-7, and ?-actin in gastric carcinoma with Lauren classification.
Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinomas. Implications for vessel invasion and metastasis.
Expression of gelatinases A and B, stromelysin-3 and matrilysin genes in breast carcinomas: clinico-pathological correlations.
Expression of heparanase gene, CD44v6, MMP-7 and nm23 protein and their relationship with the invasion and metastasis of gastric carcinomas.
Expression of insulin-like growth factor-2, c-MET, matrix metalloproteinase-7 and MUC-1 in primary lesions and lymph node metastatic lesions of gastric cancer.
Expression of matrilysin (matrix metalloproteinase-7) in primary cutaneous and metastatic melanoma.
Expression of matrilysin in vascular endothelial cells adjacent to matrilysin-producing tumors.
Expression of matrix metalloproteinase 7, laminin and type IV collagen-associated liver metastasis in human colorectal cancer: immunohistochemical approach.
Expression of matrix metalloproteinase matrilysin (MMP-7) was induced by activated Ki-ras via AP-1 activation in SW1417 colon cancer cells.
Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-1 in human prostate.
Expression of matrix metalloproteinase-7 involving in growth, invasion, metastasis and angiogenesis of gastric cancer.
Expression of Matrix Metalloproteinase-7 is an Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma.
Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis.
Expression of matrix metalloproteinases 7 and 2 in human renal cell carcinoma.
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
Expression of matrix metalloproteinases in human transitional cell carcinoma of the urinary bladder.
Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases.
Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis.
Expression of MMP-7 and MT1-MMP in peritoneal dissemination of gastric cancer.
Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases.
Expression of tissue levels of matrix metalloproteinases and their inhibitors in breast cancer.
Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric adenocarcinoma.
Expressions of Matrix Metalloproteinase-7 and -9 and their Prognostic Significances in Rectal Cancer.
Expressions of TIMP-1, COX-2 and MMP-7 in Colon Polyp and Colon Cancer.
Fibulin-3 suppresses Wnt/?-catenin signaling and lung cancer invasion.
Fibulin-5 suppresses lung cancer invasion by inhibiting matrix metalloproteinase-7 expression.
First evidence that the anti-malarial drug Artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases.
High-mobility group box?1: a novel inducer of the epithelial-mesenchymal transition in colorectal carcinoma.
Immunohistochemical expression of MMP-7 protein and its serum level in colorectal cancer.
Immunohistochemical molecular markers as predictors of curability of endoscopically resected submucosal colorectal cancer.
Immunohistochemical study of vascular endothelial growth factor (VEGF) and matrilysin (MMP-7) in T1 adenocarcinoma of the colon and rectum to predict lymph node metastases or distant metastases.
In silico trials to design potent inhibitors against matrilysin (MMP-7).
In vitro method for diagnosing and monitoring renal cell carcinoma using matrix metalloprotease-7 as humoral biomarker.
Inhibition of peritoneal dissemination in human gastric cancer by MMP-7-specific antisense oligonucleotide.
Inhibitory effect of matrilysin antisense oligonucleotides on human colon cancer cell invasion in vitro.
Inhibitory effects of green tea catechins on the activity of human matrix metalloproteinase 7 (matrilysin).
Intrahepatic micrometastases around liver metastases from gastric cancer.
In vivo and in vitro inhibition of human gastric cancer progress by upregulating Kank1 gene.
Malignant Potential of Gastrointestinal Cancers Assessed by Structural Equation Modeling.
Matrilsin expression is a useful marker of submucosal invasion and lymph node metastasis in early stage signet ring cell carcinoma of the stomach.
Matrilysin (matrix metalloprotease-7) cleaves membrane-bound annexin II and enhances binding of tissue-type plasminogen activator to cancer cell surfaces.
Matrilysin (matrix metalloproteinase-7) expression in ulcerative colitis-related tumorigenesis.
Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas.
Matrilysin (MMP-7) induces homotypic adhesion of human colon cancer cells and enhances their metastatic potential in nude mouse model.
Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase.
Matrilysin as a target for chemotherapy for colon cancer: use of antisense oligonucleotides as antimetastatic agents.
Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation.
Matrilysin stimulates DNA synthesis of cultured vascular endothelial cells and induces angiogenesis in vivo.
Matrilysin-specific antisense oligonucleotide inhibits liver metastasis of human colon cancer cells in a nude mouse model.
Matrilysin/MMP-7 Cleavage of Perlecan/HSPG2 Complexed with Semaphorin 3A Supports FAK-Mediated Stromal Invasion by Prostate Cancer Cells.
Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers.
Matrix metalloproteinase-2 and -7 expression in colorectal cancer.
Matrix metalloproteinase-7 and matrix metalloproteinase-25 in oral tongue squamous cell carcinoma.
Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer.
Matrix metalloproteinase-7 as a marker of metastasis and predictor of poor survival in bladder cancer.
Matrix metalloproteinase-7 degrades all insulin-like growth factor binding proteins and facilitates insulin-like growth factor bioavailability.
Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases.
Matrix metalloproteinase-7 expression in gastric carcinoma.
Matrix metalloproteinase-7 facilitates insulin-like growth factor bioavailability through its proteinase activity on insulin-like growth factor binding protein 3.
Matrix metalloproteinase-7 induces homotypic tumor cell aggregation via proteolytic cleavage of the membrane-bound Kunitz-type inhibitor HAI-1.
Matrix metalloproteinase-7 may serve as a novel biomarker for cervical cancer.
Matrix metalloproteinase-7 mRNA and protein expression in gastric carcinoma: a meta-analysis.
Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment.
Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.
Matrix metalloproteinases may contribute compensationally to tumor invasion in T1 colorectal carcinomas.
Mesothelin binding to CA125/MUC16 promotes pancreatic cancer cell motility and invasion via MMP-7 activation.
Messenger RNA expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human hepatocellular carcinoma.
MMP-10, MMP-7, TIMP-1 and TIMP-2 mRNA expression in esophageal cancer.
MMP-7 A-181G Polymorphism in Breast Cancer Patients from Western Iran.
MMP-7 is upregulated by COX-2 and promotes proliferation and invasion of lung adenocarcinoma cells.
Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo.
Modulation of matrix metalloproteinase-7 (matrilysin) secretion in coculture of human colon carcinoma cells with fibroblasts from orthotopic and ectopic organs.
MT1-MMP and MMP-7 in invasion and metastasis of human cancers.
Multistep carcinogenesis of perihilar cholangiocarcinoma arising in the intrahepatic large bile ducts.
Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways.
Nobiletin, a citrus flavonoid, down-regulates matrix metalloproteinase-7 (matrilysin) expression in HT-29 human colorectal cancer cells.
Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis.
Overexpression of a disintegrin and metalloproteinase 21 is associated with motility, metastasis, and poor prognosis in hepatocellular carcinoma.
Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas.
Overexpression of Reg4, alone or combined with MMP-7 overexpression, is predictive of poor prognosis in colorectal cancer.
Pericellular activation of proMMP-7 (promatrilysin-1) through interaction with CD151.
Peritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer.
Plasma matrix metalloproteinase-7 as a metastatic marker and survival predictor in patients with renal cell carcinomas.
Plasma MMP-2 and MMP-7 levels are elevated first month after surgery and may promote growth of residual metastases.
Polymorphisms of matrix metalloproteinase-7 and -9 are associated with oral tongue squamous cell carcinoma.
Prediction of distant metastasis by using reverse transcriptase-polymerase chain reaction for epithelial and variant CD44 mRNA in the peripheral blood of patients with colorectal cancer.
Prognostic significance of matrix metalloproteinase-7 (MMP-7) expression at the invasive front in gastric carcinoma.
Prognostic significance of matrix metalloproteinase-7 in epithelial ovarian cancer and its relation to beta-catenin expression.
Prognostic significance of matrix metalloproteinase-7 in gastric cancer survival: a meta-analysis.
Prognostic significance of MMP-7 expression in colorectal cancer: A meta-analysis.
Regulation of osteopontin and related proteins in rat CC531 colorectal cancer cells.
Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma.
Relationship between E-cadherin, matrix metalloproteinase-7 gene expression and clinicopathological features in gastric carcinoma.
Retinoic acids reduce matrilysin (matrix metalloproteinase 7) and inhibit tumor cell invasion in human colon cancer.
Role of matrix metalloproteinases and their inhibitors in tumor invasion and metastasis.
Role of MMP-7 in the formation of peritoneal dissemination in gastric cancer.
Role of PTEN and MMP-7 expression in growth, invasion, metastasis and angiogenesis of gastric carcinoma.
Roles of matrix metalloproteinase-7 (MMP-7) in cancer.
Roles of osteopontin and matrix metalloproteinase-7 in occurrence, progression, and prognosis of nonsmall cell lung cancer.
Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients' prognosis in bladder cancer.
Serum levels of TIMP-1 and MMP-7 as potential biomarkers in patients with metastatic colorectal cancer.
Serum matrilysin levels predict outcome in curatively resected colorectal cancer patients.
Sex determining region Y-box 12 (SOX12) promotes gastric cancer metastasis by upregulating MMP7 and IGF1.
SIPA1 promotes invasion and migration in human oral squamous cell carcinoma by ITGB1 and MMP7.
Study of matrix metalloproteinases and their inhibitors in breast cancer.
Suppression Of ?-catenin Nuclear Translocation By CGP57380 Decelerates Poor Progression And Potentiates Radiation-Induced Apoptosis in Nasopharyngeal Carcinoma.
Suppression of matrilysin inhibits colon cancer cell invasion in vitro.
The Contribution of MMP-7 Genotypes to Colorectal Cancer Susceptibility in Taiwan.
The Contribution of MMP-7 Promoter Polymorphisms to Taiwan Lung Cancer Susceptibility.
The matrix metalloproteinase 7 (MMP7) links Hsp90 chaperone with acquired drug resistance and tumor metastasis.
The matrix metalloproteinase-7 and pro-enzyme of metalloproteinase-1 as a potential marker for patients with rectal cancer without distant metastasis.
The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma.
Tissue factor/activated factor VIIa induces matrix metalloproteinase-7 expression through activation of c-Fos via ERK1/2 and p38 MAPK signaling pathways in human colon cancer cell.
TNM staging for GIT cancers is correlated with the level of MMPs and TGF-?1.
Trefoil Factor 1 Suppresses Epithelial-mesenchymal Transition through Inhibition of TGF-beta Signaling in Gastric Cancer Cells.
Tumour matrilysin expression predicts metastatic potential of stage I (pT1) colon and rectal cancers.
Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett's oesophageal adenocarcinoma.
Urinary matrix metalloproteinase-7 level is associated with the presence of metastasis in bladder cancer.
Validation of the diagnostic and prognostic relevance of serum MMP-7 levels in renal cell cancer by using a novel automated fluorescent immunoassay method.
[beta-Catenin induces invasive growth by activating matrix metalloproteinases in colorectal carcinoma]
[Correlation between expression of MMP-7 in gastric submucosal invasive carcinoma and lymph node micrometastasis]
[Expression and clinical significance of Ang-2 and MMP-7 in laryngeal carcinoma]
[Expression and clinical significance of matrilysin (MMP-7) in human rectal cancer]
[Expression of ETV5 and MMP-7 in Early Stage Cervical Squamous Cell Carcinoma and Its Role in Lymphatic Metastasis.]
[Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal neoplasm]
[Expressions of FOXC1 and MMP-7 in molecular subtypes of breast cancer and their association with clinicopathological characteristics].
[Genetic diagnosis of colorectal cancer]
[Localization and expression of matrix metalloproteinase-7 in human prostate]
[Prediction of Post-operative Lymph Node Metastasis with a Molecular Biological Test in Head and Neck Cancer].
[Prognostic significance of the molecular markers in human gastrointestinal cancer]
[Relationship of matrilysin with invasion, metastasis, and prognosis in laryngeal cancer]
[Siliconchiptechnology-based MMP-7 analysis in urine : An option for preoperative identification of lymph node metastasis in bladder cancer.]
[The expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in transplanted tumor of salivary adenoid cystic carcinoma cell lines]
[The significance of beta-catenin and matrix metalloproteinase-7 expression in colorectal adenoma and carcinoma]
[The utility of metalloproteinases (MMPs) and their inhibitors (TIMPs) in diagnostics of gynecological malignancies].
Neoplasm Micrometastasis
Intrahepatic micrometastases around liver metastases from gastric cancer.
Prediction of peritoneal micrometastasis by peritoneal lavaged cytology and reverse transcriptase-polymerase chain reaction for matrix metalloproteinase-7 mRNA.
[Correlation between expression of MMP-7 in gastric submucosal invasive carcinoma and lymph node micrometastasis]
Neoplasm, Residual
Prognostic significance of matrix metalloproteinase-7 in epithelial ovarian cancer and its relation to beta-catenin expression.
Neoplasms
14-3-3 Proteins Modulate the ETS Transcription Factor ETV1 in Prostate Cancer.
?-Catenin-independent noncanonical Wnt pathway might be induced in gastric cancers.
A loss of host-derived MMP-7 promotes myeloma growth and osteolytic bone disease in vivo.
A new formula for predicting liver metastasis in patients with colorectal cancer: immunohistochemical analysis of a large series of 439 surgically resected cases.
A novel orthotopic mouse model of head and neck cancer and lymph node metastasis.
A rat monoclonal antibody that recognizes pro- and active MMP-7 indicates polarized expression in vivo.
A subset of high-grade pulmonary neuroendocrine carcinomas shows up-regulation of matrix metalloproteinase-7 associated with nuclear beta-catenin immunoreactivity, independent of EGFR and HER-2 gene amplification or expression.
A/G polymorphism of matrix metalloproteinase 7 gene promoter region and cancer risk: A meta-analysis.
A/G Polymorphism of the MMP-7 Gene Promoter Region in Colorectal Cancer.
Aberrant Activation Of Hedgehog Signalling Promotes Cell Migration And Invasion Via Matrix Metalloproteinase-7 In Ovarian Cancer Cells.
Activation of adventitial fibroblasts in the early stage of the aortic transplant vasculopathy in rat.
Active matrix metalloproteinase-7 is associated with invasion in buccal squamous cell carcinoma.
ADAM12 is selectively overexpressed in human glioblastomas and is associated with glioblastoma cell proliferation and shedding of heparin-binding epidermal growth factor.
Amperometric Biosensor of Matrix Metalloproteinase-7 Enhanced by Pd-Functionalized Carbon Nanocomposites.
Andrographolide as a Therapeutic Agent Against Breast and Ovarian Cancers.
Application of MMP-7 and MMP-10 in assisting the diagnosis of malignant pleural effusion.
Assessing matrix metalloproteinase expression and activity in hepatocellular carcinomas.
Association between expression of MMP-7 and MMP-9 and pelvic lymph node and para-aortic lymph node metastasis in early cervical cancer.
Association between the functional polymorphism in the matrix metalloproteinase-7 promoter and susceptibility to adult astrocytoma.
Association of E1AF mRNA expression with tumor progression and matrilysin in human rectal cancer.
Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
Association of matrilysin expression with progression and poor prognosis in human pancreatic adenocarcinoma.
Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma.
Association of matrilysin mRNA expression with K-ras mutations and progression in pancreatic ductal adenocarcinomas.
Association of matrix metalloproteinase-7 (-181A>G) polymorphism with risk of esophageal squamous cell carcinoma in Kashmir Valley.
Association of Matrix Metalloproteinase-7 Genotypes with the Risk of Bladder Cancer.
Association of matrix metalloproteinases 1, 7, and 9 gene polymorphisms with genetic susceptibility to colorectal carcinoma in a Han Chinese population.
Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer.
beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer.
Beta-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: relationships with carcinogenesis and metastasis.
Binding of active matrilysin to cell surface cholesterol sulfate is essential for its membrane-associated proteolytic action and induction of homotypic cell adhesion.
Bio-informatics analysis of renal carcinoma gene matrix metalloproteinase-7.
Biochemical changes during growth and regression of pregnancy-dependent mammary tumors of GR/A mice.
Biochemical characterization and zinc binding group (ZBGs) inhibition studies on the catalytic domain of MMP7 (cdMMP7).
Biological and molecular characterization of a new human ampullary cancer cell line.
Breast Heterogeneity: Obstacles to Developing Universal Biomarkers of Breast Cancer Initiation and Progression.
Butein blocks tumor necrosis factor alpha-induced interleukin 8 and matrix metalloproteinase 7 production by inhibiting p38 kinase and osteopontin mediated signaling events in HT-29 cells.
Cancer cell death induced by the intracellular self-assembly of an enzyme-responsive supramolecular gelator.
Cancer chemopreventive effects of lycopene: suppression of MMP-7 expression and cell invasion in human colon cancer cells.
Cancer invasion regulates vascular complexity in a three-dimensional biomimetic model.
Carcinoma of the parotid gland: developing prognostic indices.
CCL25 promotes the migration and invasion of non-small cell lung cancer cells by regulating VEGF and MMPs in a CCR9-dependent manner.
CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling.
Cellular sources of MMP-7, MMP-13 and MMP-28 in ulcerative colitis.
Characterization of matrix metalloproteinase-26, a novel metalloproteinase widely expressed in cancer cells of epithelial origin.
Charge-Triggered Membrane Insertion of Matrix Metalloproteinase-7, Supporter of Innate Immunity and Tumors.
Cholesterol sulfate alters substrate preference of matrix metalloproteinase-7 and promotes degradations of pericellular laminin-332 and fibronectin.
Chronic exposure to exogenous matrilysin induces chemoresistance and enhances Bcl-2 expression in A549 lung adenocarcinoma cells.
Chronic stress promotes gastric cancer progression and metastasis: an essential role for ADRB2.
Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
Circulating Plasma Biomarkers of Survival in Antifibrotic-Treated Patients With Idiopathic Pulmonary Fibrosis.
Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease.
Clarification of the active gelatinolytic sites in human ovarian neoplasms using in situ zymography.
Cleavage of CD95 by matrix metalloproteinase-7 induces apoptosis resistance in tumour cells.
Cleavage of E-Cadherin by Matrix Metalloproteinase-7 Promotes Cellular Proliferation in Nontransformed Cell Lines via Activation of RhoA.
Cleavage of the Perlecan-Semaphorin 3A-Plexin A1-Neuropilin-1 (PSPN) Complex by Matrix Metalloproteinase 7/Matrilysin Triggers Prostate Cancer Cell Dyscohesion and Migration.
CLEC3A, MMP7, and LCN2 as novel markers for predicting recurrence in resected G1 and G2 pancreatic neuroendocrine tumors.
Clinical impact of matrix metalloproteinase-7 mRNA expression in the invasive front and inner surface of tumor tissues in patients with colorectal cancer.
Clinical significance of immunohistochemical expression of insulin-like growth factor-1 receptor and matrix metalloproteinase-7 in resected non-small cell lung cancer.
Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer.
Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma.
Clinical Significance of Matrix Metalloproteinases in Blood Plasma of Patients with Gastric Cancer.
Clinical Significance of MMP-7 and PTEN Expression in Colorectal Cancer.
Clinical significance of serum MMP-2 and MMP-7 in patients with ovarian cancer.
Clinical utility of circulating matrix metalloproteinase-7 (MMP-7), CC chemokine ligand 18 (CCL18) and CC chemokine ligand 11 (CCL11) as markers for diagnosis of epithelial ovarian cancer.
Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers.
Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer.
Clinicopathologic and prognostic significance of MMP-7 (matrilysin) expression in human rectal cancer.
Clinicopathological assessment and quantitative estimation of the matrix metalloproteinases MMP-2 and MMP-7 and the inhibitors TIMP-1 and TIMP-2 in colorectal carcinoma tissue samples.
Clinicopathological significance of matrix metalloproteinase-7 protein expression in esophageal cancer: a meta-analysis.
Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
Cobalt chloride-induced hypoxia modulates the invasive potential and matrix metalloproteinases of primary and metastatic breast cancer cells.
Coexpression of matrilysin and laminin-5 gamma2 chain may contribute to tumor cell migration in colorectal carcinomas.
Coexpression of matrix metalloproteinase-7 (MMP-7) and epidermal growth factor (EGF) receptor in colorectal cancer: an EGF receptor tyrosine kinase inhibitor is effective against MMP-7-expressing cancer cells.
Coexpression of Matrix Metalloproteinase-7 and Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Biomarker in Gastric Cancer.
Common MMP-7 polymorphisms and breast cancer susceptibility: a multistage study of association and functionality.
Comparative enzyme immunoassay of matrix metalloproteinases-2, -7, -9 and their tissue inhibitor-2 in tumors and plasma of patients with gastric cancer.
Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival.
Comprehensive Omics Analysis of a Novel Small-Molecule Inhibitor of Chemoresistant Oncogenic Signatures in Colorectal Cancer Cell with Antitumor Effects.
Concomitant consumption of lycopene and fish oil inhibits tumor growth and progression in a mouse xenograft model of colon cancer.
Considering the critical interface between tumor cells and stromal cells in the search for targets for anticancer therapy.
Construction of a sensitive protease sensor with DNA-peptide conjugates for single-molecule detection of multiple matrix metalloproteinases.
Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers.
Contribution of Matrix Metalloproteinase-7 Genotypes to the Risk of Non-solid Tumor, Childhood Leukemia.
Contribution of sialidase NEU1 to suppression of metastasis of human colon cancer cells through desialylation of integrin beta4.
Correlation among 16 biological factors [p53, p21(waf1), MIB-1 (Ki-67), p16(INK4A), cyclin D1, E-cadherin, Bcl-2, TNF-?, NF-?B, TGF-?, MMP-7, COX-2, EGFR, HER2/neu, ER, and HIF-1?] and clinical outcomes following curative chemoradiation therapy in 10 patients with esophageal squamous cell carcinoma.
Correlation between beta-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors.
Correlation between the immunohistochemical expressions of MMP-1, MMP-7 and VEGF and prognostic factors in colorectal adenocarcinoma.
Correlation of lymph node metastases and expression of matrix metalloproteinase-7 in patients with gastric cancer.
Correlation of polymorphism of IL-8 and MMP-7 with occurrence and lymph node metastasis of early stage cervical cancer.
Correlations of Moesin expression with the pathological stage, nerve infiltration, tumor location and pain severity in patients with pancreatic cancer.
Current evidence on associations between the MMP-7 (-181A>G) polymorphism and digestive system cancer risk.
CYR61 downregulation correlates with tumor progression by promoting MMP-7 expression in human gastric carcinoma.
Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer.
Decreased synthesis of matrix metalloproteinase-7 and adhesion to the extracellular matrix proteins of human colon cancer cells treated with troglitazone.
Degradation of entactin by matrix metalloproteinases. Susceptibility to matrilysin and identification of cleavage sites.
Degradation of fibronectin fibrils by matrilysin and characterization of the degradation products.
Depletion of cell surface CD44 in nonmelanoma skin tumours is associated with increased expression of matrix metalloproteinase 7.
Design, Synthesis and Biological Evaluation of 3,9-diazatetraasteranes as Novel Matrilysin Inhibitors.
Designing 129Xe NMR biosensors for matrix metalloproteinase detection.
Detection of Matrilysin Activity Using Polypeptide Functionalized Reduced Graphene Oxide Field-Effect Transistor Sensor.
Determination of matrilysin activity in gastrointestinal neoplasia.
Development of a Non-Hydroxamate Dual Matrix Metalloproteinase (MMP)-7/-13 Inhibitor.
Dickkopf-1 expression is associated with tumorigenity and lymphatic metastasis in human hilar cholangiocarcinoma.
Differential expression of c-jun and c-fos mRNAs in squamous cell carcinoma of the head and neck: associations with uPA, gelatinase B, and matrilysin mRNAs.
Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms.
Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
Differential Protein Expression Profiles in Glaucomatous Trabecular Meshwork: An Evaluation Study on a Small Primary Open Angle Glaucoma Population.
Differential regulation of MMP-9 and TIMP-2 expression in malignant melanoma developed in metallothionein/RET transgenic mice.
Differing effects of endogenous and synthetic inhibitors of metalloproteinases on intestinal tumorigenesis.
Discovery of New Risk Markers for Ischemic Stroke Using a Novel Targeted Proteomics Chip.
Docosahexaenoic acid induces proteasome-dependent degradation of beta-catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2.
Down-regulation of matrix metalloproteinase-7 inhibits metastasis of human anaplastic thyroid cancer cell line.
Downregulation of matrix metalloprotease-9 and urokinase plasminogen activator by TX-1877 results in decreased tumor growth and metastasis on xenograft model of rectal cancer.
Downregulation of SFRP5 expression and its inverse correlation with those of MMP-7 and MT1-MMP in gastric cancer.
Dynamic molecular changes associated with epithelial-mesenchymal transition and subsequent mesenchymal-epithelial transition in the early phase of metastatic tumor formation.
E-cadherin, beta-catenin adhesion complex and relation to matrilysin expression in pT3 rectosigmoid cancers.
E1A-F is overexpressed early in human colorectal neoplasia and associated with cyclooxygenase-2 and matrix metalloproteinase-7.
Effect of hGC-MSCs from human gastric cancer tissue on cell proliferation, invasion and epithelial-mesenchymal transition in tumor tissue of gastric cancer tumor-bearing mice.
Effect of preoperative radiotherapy on matrilysin gene expression in rectal cancer.
Effect of Repeated Freezing and Thawing on Biomarker Stability in Plasma and Serum Samples.
Effect of sulindac sulfide on metallohydrolases in the human colon cancer cell line HT-29.
Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers on lymphangiogenesis of gastric cancer in a nude mouse model.
Effects of chlorella on activities of protein tyrosine phosphatases, matrix metalloproteinases, caspases, cytokine release, B and T cell proliferations, and phorbol ester receptor binding.
Effects of silencing S100A8 and S100A9 with small interfering RNA on the migration of CNE1 nasopharyngeal carcinoma cells.
EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer.
Electrochemical detection of matrix metalloproteinase-7 using an immunoassay on a methylene blue/2D MoS2/graphene oxide electrode.
Elevated matrix metalloproteinase 7 expression promotes the proliferation, motility and metastasis of tongue squamous cell carcinoma.
Elevated matrix metalloproteinase-7 expression promotes metastasis in human lung carcinoma.
Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes.
Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomy.
Enamel matrix derivative induces the expression of tissue inhibitor of matrix metalloproteinase-3 in human gingival fibroblasts via extracellular signal-regulated kinase.
Encapsulation of individual living cells with enzyme responsive polymer nanoshell.
Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions.
Endometriosis Leads to an Increased Trefoil Factor 3 Concentration in the Peritoneal Cavity but Does Not Alter Systemic Levels.
Endothelium specific matrilysin (MMP-7) expression in human cancers.
Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?
Enhanced secretion and activation of matrilysin during malignant conversion of human colorectal epithelium and its relationship with invasive potential of colon cancer cells.
Enteric bacterial protein AvrA promotes colonic tumorigenesis and activates colonic beta-catenin signaling pathway.
Enzyme-Triggered Morphological Transition of Peptide Nanostructures for Tumor-Targeted Drug Delivery and Enhanced Cancer Therapy.
Ethanolic Extract of Traditional Chinese Medicine (TCM) Gamboge Inhibits Colon Cancer
ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells.
Examining the role of Paneth cells in the small intestine by lineage ablation in transgenic mice.
Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis.
Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas.
Expression and significance of IGF-2, PCNA, MMP-7, and ?-actin in gastric carcinoma with Lauren classification.
Expression of ets-related transcriptional factor E1AF is associated with tumor progression and over-expression of matrilysin in human gastric cancer.
Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study.
Expression of insulin-like growth factor-2, c-MET, matrix metalloproteinase-7 and MUC-1 in primary lesions and lymph node metastatic lesions of gastric cancer.
Expression of matrilysin (matrix metalloproteinase-7) in primary cutaneous and metastatic melanoma.
Expression of matrilysin in vascular endothelial cells adjacent to matrilysin-producing tumors.
Expression of matrilysin mRNA in colorectal adenomas and its induction by truncated fibronectin.
Expression of matrix metalloproteinase (MMP)-7 and MMP-13 and loss of MMP-19 and p16 are associated with malignant progression in chronic wounds.
Expression of matrix metalloproteinase 7 (matrilysin) in human osteoarthritic cartilage.
Expression of matrix metalloproteinase matrilysin (MMP-7) was induced by activated Ki-ras via AP-1 activation in SW1417 colon cancer cells.
Expression of matrix metalloproteinase-7 correlates with the invasion of T1 colorectal carcinoma.
Expression of matrix metalloproteinase-7 involving in growth, invasion, metastasis and angiogenesis of gastric cancer.
Expression of Matrix Metalloproteinase-7 is an Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma.
Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis.
Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature.
Expression of matrix metalloproteinases 2 and 7 in tumor cells correlates with the World Health Organization classification subtype and clinical stage of thymic epithelial tumors.
Expression of matrix metalloproteinases 2, 7 and 9 in patients with colorectal cancer.
Expression of matrix metalloproteinases 3, 10 and 11 (stromelysins 1, 2 and 3) and matrix metalloproteinase 7 (matrilysin) by cancer cells in non-small cell lung neoplasms. Clinicopathologic studies.
Expression of matrix metalloproteinases 7 and 2 in human renal cell carcinoma.
Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer Relation to clinicopathological factors, beta-catenin and prognosis.
Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck.
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.
Expression of matrix metalloproteinases in benign and malignant follicular thyroid lesions.
Expression of matrix metalloproteinases in human transitional cell carcinoma of the urinary bladder.
Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases.
Expression of metalloproteinase genes in human prostate cancer.
Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis.
Expression of MMP-7 and MT1-MMP in peritoneal dissemination of gastric cancer.
Expression of MMP-7(PUMP-1) mRNA in human colorectal cancers.
Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.
Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response.
Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas.
Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases.
Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice.
Expression of tissue levels of matrix metalloproteinases and their inhibitors in breast cancer.
Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric adenocarcinoma.
Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas.
Expression of Wnt target genes in solid pseudopapillary tumor of the pancreas: a pilot study.
Expression of Wnt3, ?-catenin and MMP-7 in gastric cancer and precancerous lesions and their correlations with Helicobacter pylori infection.
Expressions of Matrix Metalloproteinase-7 and -9 and their Prognostic Significances in Rectal Cancer.
Expressions of Matrix Metalloproteinases 2, 7, and 9 in Carcinogenesis of Pancreatic Ductal Adenocarcinoma.
Expressions of TIMP-1, COX-2 and MMP-7 in Colon Polyp and Colon Cancer.
FGF-1/-3/FGFR4 signaling in cancer-associated fibroblasts promotes tumor progression in colon cancer through Erk and MMP-7.
Fibulin-3 suppresses Wnt/?-catenin signaling and lung cancer invasion.
Fibulin-5 inhibits Wnt/?-catenin signaling in lung cancer.
Fibulin-5 suppresses lung cancer invasion by inhibiting matrix metalloproteinase-7 expression.
Functional expression of the chemokine receptor XCR1 on oral epithelial cells.
Genetic Alterations in Gastric Cancer Associated with Helicobacter pylori Infection.
Genetic polymorphisms in matrix metalloproteinases -1 and -7 and susceptibility to gastric cancer: an association study and meta-analysis.
Ginkgo biloba L. leaf extract offers multiple mechanisms in bridling N-methylnitrosourea - mediated experimental colorectal cancer.
HER2-dependent MMP-7 expression is mediated by activated STAT3.
Heterogeneous regional expression patterns of matrix metalloproteinases in human malignant gliomas.
High levels of serum VEGF and TIMP-1 are correlated with colon cancer liver metastasis and intrahepatic recurrence after liver resection.
High-mobility group box?1: a novel inducer of the epithelial-mesenchymal transition in colorectal carcinoma.
HRCT and histopathological evaluation of fibrosis and tissue destruction in IPF associated with pulmonary emphysema.
Human leukocyte elastase counteracts matrix metalloproteinase-7 induced apoptosis resistance of tumor cells.
Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells.
Identification of gene expression profiles correlated to tumor progression in a preclinical model of colon carcinogenesis.
IL-18 immunoadjuvanted xenogeneic canine MMP-7 DNA vaccine overcomes immune tolerance and supresses the growth of murine mammary tumor.
Immunohistochemical Comparison of Malignancy Between Radial Invasion and Mucosal Extension in Hilar Cholangiocarcinoma.
Immunohistochemical expression of matrix metalloproteinases in squamous cell carcinoma of the tongue and lower lip.
Immunohistochemical expression of MMP-7 protein and its serum level in colorectal cancer.
Immunohistochemical molecular markers as predictors of curability of endoscopically resected submucosal colorectal cancer.
Immunohistochemical study of vascular endothelial growth factor (VEGF) and matrilysin (MMP-7) in T1 adenocarcinoma of the colon and rectum to predict lymph node metastases or distant metastases.
In silico trials to design potent inhibitors against matrilysin (MMP-7).
In vitro method for diagnosing and monitoring renal cell carcinoma using matrix metalloprotease-7 as humoral biomarker.
Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas.
Increased expression of matrix metalloproteinase-7 in invasive early gastric cancer.
Increased metabolites of 5-lipoxygenase from hypoxic ovarian cancer cells promote tumor-associated macrophage infiltration.
Increased production of matrix metalloproteinase-7 (MMP-7) by asbestos exposure enhances tissue migration of human regulatory T-like cells.
Independent histological risk factors for lymph node metastasis of superficial esophageal squamous cell carcinoma; implication of claudin-5 immunohistochemistry for expanding the indications of endoscopic resection.
Induction of matrix metalloprotease-7 is common in mucinous ovarian tumors including early stage disease.
Induction of tumour cell apoptosis by matrix metalloproteinase inhibitors: new tricks from a (not so) old drug.
Inflammation-related factors predicting prognosis of gastric cancer.
Influence of "Flexible" versus "Rigid" Nanoparticles on the Stability of Matrix Metalloproteinase-7.
Inhibition of peritoneal dissemination in human gastric cancer by MMP-7-specific antisense oligonucleotide.
Inhibitory effect of matrilysin antisense oligonucleotides on human colon cancer cell invasion in vitro.
Inhibitory effect of soluble EP2 receptor on ovarian tumor growth in nude mice and utility of TMPRSS4 as a combinatorial molecular target.
Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via down-regulation of PI3K/Akt signaling pathway.
Inhibitory effects of green tea catechins on the activity of human matrix metalloproteinase 7 (matrilysin).
Insulin-like growth factor binding protein-5 is a target of matrix metalloproteinase-7: implications for epithelial-mesenchymal signaling.
Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.
Integrin- and cadherin-mediated induction of the matrix metalloprotease matrilysin in cocultures of malignant oral squamous cell carcinoma cells and dermal fibroblasts.
Interaction between Tumor-Associated Dendritic Cells and Colon Cancer Cells Contributes to Tumor Progression via CXCL1.
Interleukin-12 deficiency is permissive for angiogenesis in UV radiation-induced skin tumors.
Interleukin-1beta secreted from monocytic cells induces the expression of matrilysin in the prostatic cell line LNCaP.
Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
Interrelation between expression of matrix metalloproteinase 7 and beta-catenin in esophageal cancer.
Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin.
Intraductal papillary mucinous neoplasms of the pancreas: an analysis of protein expression and clinical features.
Intrahepatic micrometastases around liver metastases from gastric cancer.
Inverse relationship between matrilysin expression and proliferative activity of cells in advanced gastric carcinoma.
Investigations for a multi-marker RT-PCR to improve sensitivity of disseminated tumor cell detection.
Involvement of matrix metalloproteinase-7 in invasion-metastasis through induction of cell dissociation in pancreatic cancer.
Involvement of specific matrix metalloproteinases during tumor necrosis factor/IFNgamma-based cancer therapy in mice.
In vivo and in vitro inhibition of human gastric cancer progress by upregulating Kank1 gene.
IPO5 promotes malignant progression of esophageal cancer through activating MMP7.
Knockdown of MMP-7 inhibits cell proliferation and enhances sensitivity to 5-fluorouracil and X-ray irradiation in colon cancer cells.
Magnolol suppresses the proliferation and invasion of cholangiocarcinoma cells via inhibiting the NF-?B signaling pathway.
Mangiferin exerts antitumor activity in breast cancer cells by regulating matrix metalloproteinases, epithelial to mesenchymal transition, and ?-catenin signaling pathway.
Mangiferin: a natural miracle bioactive compound against lifestyle related disorders.
Mapping of the metalloproteinase gene matrilysin (MMP7) to human chromosome 11q21-->q22.
Matrilsin expression is a useful marker of submucosal invasion and lymph node metastasis in early stage signet ring cell carcinoma of the stomach.
Matrilysin (matrix metalloprotease-7) cleaves membrane-bound annexin II and enhances binding of tissue-type plasminogen activator to cancer cell surfaces.
Matrilysin (matrix metalloproteinase-7) expression in ulcerative colitis-related tumorigenesis.
Matrilysin (matrix metalloproteinase-7) selects for apoptosis-resistant mammary cells in vivo.
Matrilysin (matrix metalloproteinase-7): a new promising drug target in cancer and inflammation?
Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas.
Matrilysin (MMP-7) cleaves C-type lectin domain family 3 member A (CLEC3A) on tumor cell surface and modulates its cell adhesion activity.
Matrilysin (MMP-7) degrades VE-cadherin and accelerates accumulation of beta-catenin in the nucleus of human umbilical vein endothelial cells.
Matrilysin (MMP-7) induces homotypic adhesion of human colon cancer cells and enhances their metastatic potential in nude mouse model.
Matrilysin (MMP-7) is a novel broadly expressed tumor antigen recognized by antigen-specific T cells.
Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase.
Matrilysin (PUMP) correlates with dermal invasion during appendageal development and cutaneous neoplasia.
Matrilysin expression in human prostate carcinoma.
Matrilysin gene expression in sporadic and familial colorectal adenomas.
Matrilysin in early stage intestinal tumorigenesis.
Matrilysin inhibits proliferation and modulates sensitivity of lung cancer cells to FasL-mediated apoptosis.
Matrilysin is associated with progression of colorectal tumor.
Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation.
Matrilysin stimulates DNA synthesis of cultured vascular endothelial cells and induces angiogenesis in vivo.
Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis.
Matrilysin-1 mediates bronchiolization of alveoli, a potential premalignant change in lung cancer.
Matrilysin-specific antisense oligonucleotide inhibits liver metastasis of human colon cancer cells in a nude mouse model.
Matrilysin/matrix metalloproteinase-7(MMP7) cleavage of perlecan/HSPG2 creates a molecular switch to alter prostate cancer cell behavior.
Matrilysin: a rapidly expanding role in the etiopathogenesis of systemic malignancies.
Matrix Metalloprotease-7 Mediates Nucleolar Assembly and Intra-nucleolar Cleaving p53 in Gefitinib-Resistant Cancer Stem Cells.
Matrix metalloproteinase (MMP)-7 in Barrett's esophagus and esophageal adenocarcinoma: expression, metabolism, and functional significance.
Matrix metalloproteinase (MMP)-7 in salivary gland cancer.
Matrix metalloproteinase 7 and perlecan in oral epithelial dysplasia and carcinoma in situ: an aid for histopathologic recognition of their cell proliferation centers.
Matrix metalloproteinase 7 expression in ampullary carcinoma.
Matrix metalloproteinase 7 is required for tumor formation, but dispensable for invasion and fibrosis in SMAD4-deficient intestinal adenocarcinomas.
Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers.
Matrix metalloproteinase matrilysin is constitutively expressed in adult human exocrine epithelium.
Matrix Metalloproteinase Responsive, Proximity-activated Polymeric Nanoparticles for siRNA Delivery.
Matrix metalloproteinase-2 and -7 expression in colorectal cancer.
Matrix metalloproteinase-7 (MMP-7) polymorphism is a risk factor for endometrial cancer susceptibility.
Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma.
Matrix metalloproteinase-7 and matrix metalloproteinase-25 in oral tongue squamous cell carcinoma.
Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer.
Matrix metalloproteinase-7 degrades all insulin-like growth factor binding proteins and facilitates insulin-like growth factor bioavailability.
Matrix metalloproteinase-7 expression and biologic aggressiveness of cholangiocellular carcinoma.
Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases.
Matrix metalloproteinase-7 expression in gastric carcinoma.
Matrix metalloproteinase-7 facilitates insulin-like growth factor bioavailability through its proteinase activity on insulin-like growth factor binding protein 3.
Matrix metalloproteinase-7 increases resistance to Fas-mediated apoptosis and is a poor prognostic factor of patients with colorectal carcinoma.
Matrix metalloproteinase-7 induces homotypic tumor cell aggregation via proteolytic cleavage of the membrane-bound Kunitz-type inhibitor HAI-1.
Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas.
Matrix metalloproteinase-7 mRNA and protein expression in gastric carcinoma: a meta-analysis.
Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity.
Matrix metalloproteinase-9 contributes to intestinal tumourigenesis in the adenomatous polyposis coli multiple intestinal neoplasia mouse.
Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment.
Matrix metalloproteinase-9 interplays with the IGFBP2-IGFII complex to promote cell growth and motility in astrocytomas.
Matrix metalloproteinase7 -181A/G polymorphism is associated with increased cancer risk among high-quality studies: Evidence from a meta-analysis.
Matrix metalloproteinases (MMPs) in targeted drug delivery: Synthesis of a Potent and Highly Selective Inhibitor against Matrix metalloproteinases-7.
Matrix metalloproteinases 2, 7, and 9 in tumors and sera of patients with breast cancer.
Matrix metalloproteinases 7 and 9 and their types 1 and 4 tissue inhibitors in tumors and plasma of patients with colorectal cancer.
Matrix Metalloproteinases and Their Tissue Inhibitors in Blood Serum of Patients with Endometrial Cancer: Clinical and Morphological Correlations.
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.
Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis.
Matrix metalloproteinases in blood vessel development in human fetal skin and in cutaneous tumors.
Matrix metalloproteinases involvement in pathologic conditions.
Matrix metalloproteinases may contribute compensationally to tumor invasion in T1 colorectal carcinomas.
Matrix metalloproteinases-7, -8, -9 and TIMP-1 in the follow-up of diisocyanate-induced asthma.
Matrix-degrading metalloproteinases in tumor progression.
Matrix-metalloproteinases in Hodgkin lymphoma.
Measurement of indicator genes using global complementary DNA (cDNA) amplification, by polyadenylic acid reverse transcriptase polymerase chain reaction (poly A RT-PCR): A feasibility study using paired samples from tissue and ductal juice in patients undergoing pancreatoduodenectomy.
Mechanisms of the Epithelial-Mesenchymal Transition and Tumor Microenvironment in Helicobacter pylori-Induced Gastric Cancer.
Medulloblastoma displays distinct regional matrix metalloprotease expression.
Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways.
Messenger RNA expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human hepatocellular carcinoma.
Metalloelastase (MMP-12) expression by tumour cells in squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome.
Metalloproteinase-1, metalloproteinase-7, and p53 immunoexpression and their correlation with clinicopathological prognostic factors in colorectal adenocarcinoma.
Methotrexate gamma-hydroxamate derivatives as potential dual target antitumor drugs.
Microarray Analysis of Gene Expression at the Tumor Front of Colon Cancer.
Microenvironmental markers are correlated with lymph node metastasis in invasive submucosal colorectal cancer.
Mixed lineage kinase-3/JNK1 axis promotes migration of human gastric cancer cells following gastrin stimulation.
MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues.
MMP-10, MMP-7, TIMP-1 and TIMP-2 mRNA expression in esophageal cancer.
MMP-7 (-181A>G) promoter polymorphisms and risk for cervical cancer.
MMP-7 (matrilysin) accelerated growth of human umbilical vein endothelial cells.
MMP-7 (matrilysin) expression in human brain tumors.
MMP-7 and SGCE as distinctive molecular factors in sporadic colorectal cancers from the mutator phenotype pathway.
MMP-7 as a prognostic marker in colorectal cancer.
MMP-7 derived peptides with MHC class-I binding motifs from canine mammary tumor tissue elicit strong antigen-specific T-cell responses in BALB/c mice.
MMP-7 expression may influence the rate of distant recurrences and disease-specific survival in HPV-positive oropharyngeal squamous cell carcinoma.
MMP-7 is upregulated by COX-2 and promotes proliferation and invasion of lung adenocarcinoma cells.
MMP-7 overexpression is an independent prognostic marker in gastric cancer.
MMP-7 Serum and Tissue Levels Are Associated with Poor Survival in Platinum-Treated Bladder Cancer Patients.
MMP7 Modulation by Short- and Long-term Radiotherapy in Patients with Rectal Cancer.
Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo.
Modulation of matrix metalloproteinase-7 (matrilysin) secretion in coculture of human colon carcinoma cells with fibroblasts from orthotopic and ectopic organs.
Molecular characterization of a low-molecular-mass matrix metalloproteinase secreted by glomerular mesangial cells as PUMP-1.
Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas.
MT1-MMP and MMP-7 in invasion and metastasis of human cancers.
Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction.
N-cadherin haploinsufficiency increases survival in a mouse model of pancreatic cancer.
Nanoassembled Peptide Biosensors for Rapid Detection of Matrilysin Cancer Biomarker.
Nobiletin, a citrus flavonoid, down-regulates matrix metalloproteinase-7 (matrilysin) expression in HT-29 human colorectal cancer cells.
Nuclear beta-catenin expression is closely related to ulcerative growth of colorectal carcinoma.
Oncogenic beta-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer.
Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP).
Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis.
Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer.
Overexpression of matrix metalloproteinase-7 and -9 in NSCLC tumor and stromal cells: Correlation with a favorable clinical outcome.
Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas.
Overexpression of MMP-13 gene in colorectal cancer with liver metastasis.
Overexpression of poly(ADP-ribose) polymerase-1 (PARP-1) in the early stage of colorectal carcinogenesis.
Oxidative stress mediates air pollution particle-induced acute lung injury and molecular pathology.
Paracrine factor and cell-cell contact-mediated induction of protease and c-ets gene expression in malignant keratinocyte/dermal fibroblast cocultures.
Pericellular activation of proMMP-7 (promatrilysin-1) through interaction with CD151.
Phosphatase of regenerating liver-3 promotes migration and invasion by upregulating matrix metalloproteinases-7 in human colorectal cancer cells.
Photodynamic molecular beacon as an activatable photosensitizer based on protease-controlled singlet oxygen quenching and activation.
Plasma levels of MMP-7 and TIMP-1 in laboratory diagnostics and differentiation of selected histological types of epithelial ovarian cancers.
Plasma MMP-2 and MMP-7 levels are elevated first month after surgery and may promote growth of residual metastases.
Polyamine-dependent expression of the matrix metalloproteinase matrilysin in a human colon cancer-derived cell line.
Polymorphisms in MMP-1, MMP-2, MMP-7, MMP-13 and MT2A do not contribute to breast, lung and colon cancer risk in polish population.
Polymorphisms of matrix metalloproteinase-7 and -9 are associated with oral tongue squamous cell carcinoma.
Polyozellin blocks tumor necrosis factor ?-induced interleukin 8 and matrix metalloproteinase 7 production in the human intestinal epithelial cell line HT-29.
Polyphenol Extract from Evening Primrose (Oenothera paradoxa) Inhibits Invasion Properties of Human Malignant Pleural Mesothelioma Cells.
Prediction of distant metastasis by using reverse transcriptase-polymerase chain reaction for epithelial and variant CD44 mRNA in the peripheral blood of patients with colorectal cancer.
Prediction of peritoneal micrometastasis by peritoneal lavaged cytology and reverse transcriptase-polymerase chain reaction for matrix metalloproteinase-7 mRNA.
Predictive value of MMP-7 expression for response to chemotherapy and survival in patients with non-small cell lung cancer.
Preoperative levels of matrix metalloproteinase-7 and -9 and tissue inhibitor of matrix metalloproteinase-1 relation to pathologic parameters in bladder carcinoma patients.
Production of metalloproteinase-7 (matrilysin) by human myeloma cells and its potential involvement in metalloproteinase-2 activation.
Production of recombinant human matrix metalloproteinase 7 (Matrilysin) with potential role in tumor invasion by refolding from Escherichia coli inclusion bodies and development of sandwich ELISA of MMP-7.
Prognostic impact of ER? and MMP7 expression on overall survival in colon cancer.
Prognostic Role of Matrix Metalloproteinases 2, 7, 8, 9 and Their Type 1 Tissue Inhibitor in Blood Serum of Patients with Kidney Cancer.
Prognostic role of tumor-associated proteases in colorectal cancer.
Prognostic significance of matrix metalloproteinase 7 immunohistochemical expression in colorectal cancer: a meta-analysis.
Prognostic significance of matrix metalloproteinase-7 (MMP-7) expression at the invasive front in gastric carcinoma.
Prognostic significance of matrix metalloproteinase-7 in epithelial ovarian cancer and its relation to beta-catenin expression.
Prognostic significance of MMP-7 expression in colorectal cancer: A meta-analysis.
Prognostic significance of the TNM system criteria, levels of serum insulin-like growth factors and their transport proteins, VEGF and MMP-7 in colorectal cancer.
Prognostic value of matrix metalloproteinases in oral squamous cell carcinoma.
Protease-activated receptor-1 antagonist F 16618 reduces arterial restenosis by down-regulation of tumor necrosis factor ? and matrix metalloproteinase 7 expression, migration, and proliferation of vascular smooth muscle cells.
Proteomic profiling for detection of early-stage heart failure in the community.
Pump-1 cDNA codes for a protein with characteristics similar to those of classical collagenase family members.
Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.
Quantitative immunohistochemical analysis of matrilysin 1 (MMP-7) in various renal cell carcinoma subtypes.
Rapid detection of matrix metalloproteinase-7 and carcinoembryonic antigen mRNA expression in intraoperative pleural lavage samples using the reverse transcriptase loop-mediated isothermal amplification method.
Regulation of matrix metalloproteinases: an overview.
Regulation of osteopontin and related proteins in rat CC531 colorectal cancer cells.
Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma.
Relation of matrilysin messenger RNA expression with invasive activity in human gastric cancer.
Relationship between E-cadherin, matrix metalloproteinase-7 gene expression and clinicopathological features in gastric carcinoma.
Relationship between matrix metalloproteinase-7 and pit pattern in early stage colorectal cancer.
Relationship between morphological features and kinetic patterns of enhancement of the dynamic breast magnetic resonance imaging and tumor expression of metalloproteases and their inhibitors in invasive breast cancer.
Relationship between the expression of VEGF signal components and matrix metalloproteinases in ovarian tumors.
Release of membrane-associated mucins from ocular surface epithelia.
Retinoic acids reduce matrilysin (matrix metalloproteinase 7) and inhibit tumor cell invasion in human colon cancer.
Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis.
Role of matrix metalloproteinases and their inhibitors in tumor invasion and metastasis.
Role of MMP-7 in the formation of peritoneal dissemination in gastric cancer.
Role of PTEN and MMP-7 expression in growth, invasion, metastasis and angiogenesis of gastric carcinoma.
Role of the Metalloproteinase-7 (181A>G) Polymorphism in Gastric Cancer Susceptibility: A Case Control Study in Kashmir Valley.
Roles of matrix metalloproteinase-7 (MMP-7) in cancer.
SCC-S2 Facilitates Tumor Proliferation and Invasion via Activating Wnt Signaling and Depressing Hippo Signaling in Colorectal Cancer Cells and Predicts Poor Prognosis of Patients.
Selected Matrix Metalloproteinases (MMP-2, MMP-7) and Their Inhibitor (TIMP-2) in Adult and Pediatric Cancer.
Selective cleavage of human IgG by the matrix metalloproteinases, matrilysin and stromelysin.
Sequential dynamics of inflammatory cytokine, angiogenesis inducing factor and matrix degrading enzymes during spontaneous resorption of the herniated disc.
Serial Measurements of Circulating KL-6, SP-D, MMP-7, CA19-9, CA-125, CCL18, and Periostin in Patients with Idiopathic Pulmonary Fibrosis Receiving Antifibrotic Therapy: An Exploratory Study.
Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2.
Serum levels of TIMP-1 and MMP-7 as potential biomarkers in patients with metastatic colorectal cancer.
Serum markers of intrahepatic cholangiocarcinoma.
Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients.
Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer.
Shed Syndecan-1 is involved in chemotherapy resistance via the EGFR pathway in colorectal cancer.
Silencing of estrogen receptor ? promotes the invasion and migration of osteosarcoma cells through activating Wnt signaling pathway.
Sodium-Glucose Co-Transporter 2 Inhibitors and Insights from Biomarker Measurement in Heart Failure Patients.
Stimulation of MMP-7 (matrilysin) by Helicobacter pylori in human gastric epithelial cells: role in epithelial cell migration.
Structure and expression of the human gene for the matrix metalloproteinase matrilysin.
Study of matrix metalloproteinases and their inhibitors in breast cancer.
Suppression of matrilysin inhibits colon cancer cell invasion in vitro.
Synergistic cooperation between the AP-1 and LEF-1 transcription factors in activation of the matrilysin promoter by the src oncogene: implications in cellular invasion.
Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.
Systemic Th17-like cytokine pattern in gangrenous appendicitis but not in phlegmonous appendicitis.
Targeting matrilysin and its impact on tumor growth in vivo: the potential implications in breast cancer therapy.
The behavior of MMP-2, MMP-7, MMP-9 and their inhibitors TIMP-1, TIMP-2 in adenoma-colorectal cancer sequence.
The clinical value of Vav3 in peripheral blood for predicting lymphatic metastasis of gastric cancer.
The combinational therapy of trastuzumab and cetuximab inhibits tumor growth in a patient-derived tumor xenograft model of gastric cancer.
The Contribution of MMP-7 Genotypes to Colorectal Cancer Susceptibility in Taiwan.
The Contribution of MMP-7 Promoter Polymorphisms to Taiwan Lung Cancer Susceptibility.
The detection of Helicobacter pylori cag pathogenicity islands (PAIs) and expression of matrix metalloproteinase-7 (MMP-7) in gastric epithelial dysplasia and intramucosal cancer.
The diagnostic importance of matrix metalloproteinase-7 and nestin in gastrointestinal stromal tumors.
The expression of matrix metalloproteinase matrilysin indicates the degree of inflammation in ulcerative colitis.
The expression of mmp-7 messenger-RNA in primary and metastatic human colorectal adenocarcinoma.
The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis.
The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma.
The influence of matrix metalloproteinase-7 on early mammary tumorigenesis in the multiple intestinal neoplasia mouse.
The intrinsic mitochondrial membrane potential of colonic carcinoma cells is linked to the probability of tumor progression.
The matrix metalloprotease pump-1 (MMP-7, Matrilysin): A candidate marker/target for ovarian cancer detection and treatment.
The matrix metalloproteinase 7 (MMP7) links Hsp90 chaperone with acquired drug resistance and tumor metastasis.
The matrix metalloproteinase inhibitor RS-130830 attenuates brain injury in experimental pneumococcal meningitis.
The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis.
The matrix metalloproteinase-7 and pro-enzyme of metalloproteinase-1 as a potential marker for patients with rectal cancer without distant metastasis.
The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors.
The multifunctional role of the immunohistochemical expression of MMP-7 in invasive breast cancer.
The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors.
The VEGF angiogenic switch of fibroblasts is regulated by MMP-7 from cancer cells.
Therapy of Advanced Squamous Cell Carcinoma of the Skin.
Tissue factor/activated factor VIIa induces matrix metalloproteinase-7 expression through activation of c-Fos via ERK1/2 and p38 MAPK signaling pathways in human colon cancer cell.
TNM staging for GIT cancers is correlated with the level of MMPs and TGF-?1.
Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas.
Transformation-specific matrix metalloproteinases, MMP-7 and MMP-13, are present in epithelial cells of keratoacanthomas.
Transforming growth factor-beta1 modulates tumor-stromal cell interactions of prostate cancer through insulin-like growth factor-I.
Trefoil Factor 1 Suppresses Epithelial-mesenchymal Transition through Inhibition of TGF-beta Signaling in Gastric Cancer Cells.
Tricolor imaging of MMPs to investigate the promoting roles of inflammation on invasion and migration of tumor cells.
Tumor associated proteases -- prognostic markers of colorectal cancer.
Tumor suppressive function of Matrin 3 in the basal-like breast cancer.
Tumour matrilysin expression predicts metastatic potential of stage I (pT1) colon and rectal cancers.
Tuneable peptide cross-linked nanogels for enzyme-triggered protein delivery.
Tuning Liposome Membrane Permeability by Competitive Peptide Dimerization and Partitioning-Folding Interactions Regulated by Proteolytic Activity.
Type IV collagen ?1-chain noncollagenous domain blocks MMP-2 activation both in-vitro and in-vivo.
Update meta-analysis on MMP-7 -181A>G polymorphism and cancer risk: evidence from 25 studies.
Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett's oesophageal adenocarcinoma.
Vaccine Against Gastrin, Polyclonal Antibody Stimulator, Decreases Pancreatic Cancer Metastases.
Validation of the diagnostic and prognostic relevance of serum MMP-7 levels in renal cell cancer by using a novel automated fluorescent immunoassay method.
[beta-Catenin induces invasive growth by activating matrix metalloproteinases in colorectal carcinoma]
[Clinical prospects of tumor-associated proteases and their tissue inhibitors investigation in oncologic patient].
[Correlation between expression of MMP-7 in gastric submucosal invasive carcinoma and lymph node micrometastasis]
[Diversity of invasiveness and matrix metalloproteinases expression profile of human gastric carcinoma xenografted in different tissue environments]
[Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers on angiogenesis of gastric cancer in a nude mouse model]
[Expression and clinical significance of matrilysin (MMP-7) in human rectal cancer]
[Expression of ETV5 and MMP-7 in Early Stage Cervical Squamous Cell Carcinoma and Its Role in Lymphatic Metastasis.]
[Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal neoplasm]
[Genetic diagnosis of colorectal cancer]
[Increased expression of gelatinases A and B, matrilysin and TIMP-1 genes in human malignant gliomas ]
[Inflammatory-destructive biomarkers of atherosclerotic plaques instability. Study of arterial wall and blood].
[Localization and expression of matrix metalloproteinase-7 in human prostate]
[Matrilysin-1 and cancer pathology]
[Matrix metalloproteinases and their tissue inhibitors in malignancies of the female genital tract]
[Prognostic significance of the molecular markers in human gastrointestinal cancer]
[Relationship of matrilysin with invasion, metastasis, and prognosis in laryngeal cancer]
[The expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in transplanted tumor of salivary adenoid cystic carcinoma cell lines]
[The expression of tumor related macrophages and matrix solution element in laryngeal squamous carcinoma tissue and the relationship with tumor microvascular density].
[The significance of beta-catenin and matrix metalloproteinase-7 expression in colorectal adenoma and carcinoma]
[VALUE OF METALPROTEINASES OF BLOOD IN PATHOGENESIS OF EPITELIAL SKIN TUMORS AND THE POSSIBILITY OF THEIR SURGICAL CORRECTION].
Neoplasms, Squamous Cell
Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
Neoplastic Cells, Circulating
Cleavage of the Perlecan-Semaphorin 3A-Plexin A1-Neuropilin-1 (PSPN) Complex by Matrix Metalloproteinase 7/Matrilysin Triggers Prostate Cancer Cell Dyscohesion and Migration.
Nephritis, Hereditary
Dysregulation of renal MMP-3 and MMP-7 in canine X-linked Alport syndrome.
Neuritis
Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barré syndrome.
Neuritis, Autoimmune, Experimental
Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barré syndrome.
Neuroblastoma
Amyloid-? with isomerized Asp7 cytotoxicity is coupled to protein phosphorylation.
Neuroendocrine Tumors
A subset of high-grade pulmonary neuroendocrine carcinomas shows up-regulation of matrix metalloproteinase-7 associated with nuclear beta-catenin immunoreactivity, independent of EGFR and HER-2 gene amplification or expression.
Neuromuscular Diseases
Matrin 3 in neuromuscular disease: physiology and pathophysiology.
Newcastle Disease
Newcastle disease virus mediated apoptosis and migration inhibition of human oral cancer cells: A probable role of ?-catenin and matrix metalloproteinase-7.
Non-alcoholic Fatty Liver Disease
Serum biomarkers of fibrosis and extracellular matrix remodeling in patients with nonalcoholic fatty liver disease: association with liver histology.
Serum matrix metalloproteinase 7 (MMP7) is a biomarker of fibrosis in patients with non-alcoholic fatty liver disease.
Obesity
Influence of significant weight loss on serum matrix metalloproteinase (MMP)-7 levels.
Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation.
Role of MMP-1 (-519A/G, -1607 1G/2G), MMP-3 (Lys45Glu), MMP-7 (-181A/G), and MMP-12 (-82A/G) Variants and Plasma MMP Levels on Obesity-Related Phenotypes and Microvascular Reactivity in a Tunisian Population.
Obstetric Labor, Premature
Matrilysin (matrix metalloproteinase 7) in parturition, premature rupture of membranes, and intrauterine infection.
Oligodendroglioma
Correlations of polymorphisms in matrix metalloproteinase-1, -2, and -7 promoters to susceptibility to malignant gliomas.
Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
Opisthorchiasis
Plasma hydroxyproline, MMP-7 and collagen I as novel predictive risk markers of hepatobiliary disease-associated cholangiocarcinoma.
Osteoarthritis
A Mixture Containing Fermented Achyranthes japonica Nakai Ameliorates Osteoarthritis in Knee Joints of Monoiodoacetate-Injected Rats.
Expression and correlation of matrix metalloproteinase-7 and interleukin-15 in human osteoarthritis.
Expression of ADAM15 in rheumatoid synovium: up-regulation by vascular endothelial growth factor and possible implications for angiogenesis.
Expression of matrix metalloproteinase 7 (matrilysin) in human osteoarthritic cartilage.
Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis.
Osteoarthritis, Knee
[Influence of Bushen Huoxue decoction on beta-catenin, MMP-7 of synoviocytes in rats with knee osteoarthritis].
Osteolysis
MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL.
Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis.
Osteoporosis
Estrogen-deficient osteoporosis enhances the recruitment and activity of osteoclasts by breast cancer cells.
Inhibition of osteoclast differentiation and matrix metalloproteinase production by CD4+CD25+ T cells in mice.
Osteosarcoma
Effects of SOST Gene Silencing on Proliferation, Apoptosis, Invasion, and Migration of Human Osteosarcoma Cells Through the Wnt/?-Catenin Signaling Pathway.
Irisin reverses the IL-6 induced epithelial-mesenchymal transition in osteosarcoma cell migration and invasion through the STAT3/Snail signaling pathway.
Osteosarcoma oncogene expression detected by in situ hybridization.
Ovarian Diseases
Clinical significance of serum MMP-2 and MMP-7 in patients with ovarian cancer.
Ovarian Neoplasms
Aberrant Activation Of Hedgehog Signalling Promotes Cell Migration And Invasion Via Matrix Metalloproteinase-7 In Ovarian Cancer Cells.
Andrographolide as a Therapeutic Agent Against Breast and Ovarian Cancers.
Clinical significance of serum MMP-2 and MMP-7 in patients with ovarian cancer.
Inhibition of matrilysin expression by antisense or RNA interference decreases lysophosphatidic acid-induced epithelial ovarian cancer invasion.
Leptin Induces Matrix Metalloproteinase 7 Expression To Promote Ovarian Cancer Cell Invasion By Activating ERK And JNK Pathways.
Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase.
Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion.
Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways.
Plasma endothelial protein C receptor influences innate immune response in ovarian cancer by decreasing the population of natural killer and TH17 helper cells.
Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China.
Potential role of HE4 in multimodal screening for epithelial ovarian cancer.
Serial Patterns of Ovarian Cancer Biomarkers in a Prediagnosis Longitudinal Dataset.
The matrix metalloprotease pump-1 (MMP-7, Matrilysin): A candidate marker/target for ovarian cancer detection and treatment.
Validation of a Biomarker Panel and Longitudinal Biomarker Performance for Early Detection of Ovarian Cancer.
[The utility of metalloproteinases (MMPs) and their inhibitors (TIMPs) in diagnostics of gynecological malignancies].
Paget Disease, Extramammary
Matrilysin-1 (MMP-7) and MMP-19 are expressed by Paget's cells in extramammary Paget's disease.
Pancreatic Neoplasms
Association of matrilysin mRNA expression with K-ras mutations and progression in pancreatic ductal adenocarcinomas.
Beta-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: relationships with carcinogenesis and metastasis.
Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival.
Evaluation of matrix metalloproteinase 7 in plasma and pancreatic juice as a biomarker for pancreatic cancer.
Identification of genes showing differential expression in antisense K-ras-transduced pancreatic cancer cells with suppressed tumorigenicity.
Involvement of matrix metalloproteinase-7 in invasion-metastasis through induction of cell dissociation in pancreatic cancer.
Involvement of MMP-7 in invasion of pancreatic cancer cells through activation of the EGFR mediated MEK-ERK signal transduction pathway.
Matrix metalloproteinase 7 expression in ampullary carcinoma.
Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas.
Mesothelin binding to CA125/MUC16 promotes pancreatic cancer cell motility and invasion via MMP-7 activation.
Nuclear Localizing Peptide-Conjugated, Redox-Sensitive Polymersomes for Delivering Curcumin and Doxorubicin to Pancreatic Cancer Microtumors.
Prognostic impact of a compartment-specific angiogenic marker profile in patients with pancreatic cancer.
REG4 contributes to the invasiveness of pancreatic cancer by upregulating MMP-7 and MMP-9.
STAT3 knockdown reduces pancreatic cancer cell invasiveness and matrix metalloproteinase-7 expression in nude mice.
The potential molecular mechanism of overexpression of uPA, IL-8, MMP-7 and MMP-9 induced by TRAIL in pancreatic cancer cell.
Triterpenes from Poria cocos suppress growth and invasiveness of pancreatic cancer cells through the downregulation of MMP-7.
[Erratum] Triterpenes from Poria cocos suppress growth and invasiveness of pancreatic cancer cells through the downregulation of MMP-7.
Pancreatitis
Association of Matrix Metalloproteinases -7, -8 and -9 and TIMP -1 with Disease Severity in Acute Pancreatitis. A Cohort Study.
Role of IL-6 in the resolution of pancreatitis in obese mice.
Pancreatitis, Chronic
Association of matrix metalloproteinase-7 (-181A/G) promoter polymorphism in chronic pancreatitis.
Evaluation of matrix metalloproteinase 7 in plasma and pancreatic juice as a biomarker for pancreatic cancer.
Papilloma
MMP-7 expression may influence the rate of distant recurrences and disease-specific survival in HPV-positive oropharyngeal squamous cell carcinoma.
Paralysis
Transgenic mice overexpressing the ALS-linked protein Matrin 3 develop a profound muscle phenotype.
Paresis
Transgenic mice overexpressing the ALS-linked protein Matrin 3 develop a profound muscle phenotype.
Peptic Ulcer
cag Pathogenicity island-dependent upregulation of matrix metalloproteinase-7 in infected patients with Helicobacter pylori.
Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers.
Peri-Implantitis
Levels and molecular forms of MMP-7 (matrilysin-1) and MMP-8 (collagenase-2) in diseased human peri-implant sulcular fluid.
Periapical Periodontitis
MMP-7 and TIMP-1, New Targets in Predicting Poor Wound Healing in Apical Periodontitis.
Periodontal Diseases
Gingival crevicular fluid matrix metalloproteinase (MMP)-7, extracellular MMP inducer, and tissue inhibitor of MMP-1 levels in periodontal disease.
Study of the participation of MMP-7, EMMPRIN and cyclophilin A in the pathogenesis of periodontal disease.
[The relationship between chronic periodontitis and the instability of carotid atherosclerotic plaque by serum level of MMP-9, MCP-1 and MMP-7].
Periodontal Pocket
Matrilysin (matrix metalloproteinase-7) expression in human junctional epithelium.
Periodontitis
Immunohistochemical analysis of the gingiva with periodontitis of type I plasminogen deficiency compared to gingiva with gingivitis and periodontitis and healthy gingiva.
Matrix metalloproteinase-7 in periodontitis with type 2 diabetes mellitus.
Mucin 4 and matrix metalloproteinase 7 as novel salivary biomarkers for periodontitis.
Study of the participation of MMP-7, EMMPRIN and cyclophilin A in the pathogenesis of periodontal disease.
[The relationship between chronic periodontitis and the instability of carotid atherosclerotic plaque by serum level of MMP-9, MCP-1 and MMP-7].
Pleural Effusion
Application of MMP-7 and MMP-10 in assisting the diagnosis of malignant pleural effusion.
Multiplex Soluble Biomarker Analysis from Pleural Effusion.
Pleural Effusion, Malignant
Application of MMP-7 and MMP-10 in assisting the diagnosis of malignant pleural effusion.
Pneumoconiosis
Associations of MMP-7 and OPN gene polymorphisms with risk of coal workers' pneumoconiosis in a Chinese population: a case-control study.
Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: a case-control study.
Pneumonia
Is metalloproteinase-7 specific for idiopathic pulmonary fibrosis?
Oxidative stress mediates air pollution particle-induced acute lung injury and molecular pathology.
Role of matrix metalloproteinase-7 in the modulation of a Chlamydia trachomatis infection.
Pneumonia, Bacterial
Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis.
Polyarteritis Nodosa
Role of matrix metalloproteinases, proinflammatory cytokines, and oxidative stress-derived molecules in hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy.
Polycystic Kidney Diseases
Matrilysin (MMP-7) expression in renal tubular damage: association with Wnt4.
Polymyositis
Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies.
Matrix metalloproteinases in inflammatory myopathies: enhanced immunoreactivity near atrophic myofibers.
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Matrix metalloproteinase upregulation in chronic inflammatory demyelinating polyneuropathy and nonsystemic vasculitic neuropathy.
Pre-Eclampsia
Collagenase-I, stromelysin-I, and matrilysin are expressed within the placenta during multiple stages of human pregnancy.
Increased vascular and uteroplacental matrix metalloproteinase-1 and -7 levels and collagen type I deposition in hypertension in pregnancy: role of TNF-?.
Matrix metalloproteinase multiplex screening identifies increased MMP-2 urine concentrations in women predicted to develop preeclampsia.
Matrix metalloproteinase-2 C-735T and its interaction with matrix metalloproteinase-7 A-181G polymorphism are associated with the risk of preeclampsia: influence on total antioxidant capacity and blood pressure.
Matrix metalloproteinase-7 A-181G and its interaction with matrix metalloproteinase-9 C-1562T polymorphism in preeclamptic patients: association with malondialdehyde level and severe preeclampsia.
The prediction of early preeclampsia: Results from a longitudinal proteomics study.
The prediction of late-onset preeclampsia: Results from a longitudinal proteomics study.
Pregnancy, Ectopic
Progesterone exposure prevents matrix metalloproteinase-3 (MMP-3) stimulation by interleukin-1alpha in human endometrial stromal cells.
Prostatic Neoplasms
A loss of host-derived MMP-7 promotes myeloma growth and osteolytic bone disease in vivo.
Aberrant expression of fibroblast growth factor receptor-1 in prostate epithelial cells allows induction of promatrilysin expression by fibroblast growth factors.
Association of zinc level and polymorphism in MMP-7 gene with prostate cancer in Polish population.
Considering the critical interface between tumor cells and stromal cells in the search for targets for anticancer therapy.
E1AF expression is associated with extra-prostatic growth and matrix metalloproteinase-7 expression in prostate cancer.
EGF induces the expression of matrilysin in the human prostate adenocarcinoma cell line, LNCaP.
Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomy.
ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells.
Expression and functional role of CCR9 in prostate cancer cell migration and invasion.
Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice.
Fibroblast growth factor-1 induced promatrilysin expression through the activation of extracellular-regulated kinases and STAT3.
IL-7/IL-7 receptor axis stimulates prostate cancer cell invasion and migration via AKT/NF-?B pathway.
Matrilysin expression in the involuting rat ventral prostate.
Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion.
Matrix metalloproteinase 7, soluble Fas and Fas ligand serum levels for predicting docetaxel resistance and survival in castration-resistant prostate cancer.
Molecular basis for the involvement of thymidine phosphorylase in cancer invasion.
Overexpression of SOX18 promotes prostate cancer progression via the regulation of TCF1, c-Myc, cyclin D1 and MMP-7.
Pharmacological inhibition of FGF receptor signaling inhibits LNCaP prostate tumor growth, promatrilysin, and PSA expression.
Production of recombinant human matrix metalloproteinase 7 (Matrilysin) with potential role in tumor invasion by refolding from Escherichia coli inclusion bodies and development of sandwich ELISA of MMP-7.
Promatrilysin expression is induced by fibroblast growth factors in the prostatic carcinoma cell line LNCaP but not in normal primary prostate epithelial cells.
The Matrix Metalloproteinase-7 Polymorphism Rs10895304 Is Associated with Increased Recurrence Risk in Patients with Clinically Localized Prostate Cancer.
The prognostic value of serum MMP-7 levels in prostate cancer patients who received docetaxel, abiraterone, or enzalutamide therapy.
Up-regulation of TRPM-2, MMP-7 and ID-1 during sex hormone-induced prostate carcinogenesis in the Noble rat.
[Localization and expression of matrix metalloproteinase-7 in human prostate]
[Protein kinase D3 is involved in negative regulation of MMP-7 in prostate cancer cells.]
Prostatitis
Matrix metalloproteinases in the pathogenesis of estradiol-induced nonbacterial prostatitis in the lateral prostate lobe of the Wistar rat.
Proteinuria
The Many Faces of Matrix Metalloproteinase-7 in Kidney Diseases.
Tubular injury triggers podocyte dysfunction by ?-catenin-driven release of MMP-7.
Psoriasis
Matrix metalloproteinase-7 could be a predictor for acute inflammation in psoriatic patients.
Metalloelastase (MMP-12) and 92-kDa gelatinase (MMP-9) as well as their inhibitors, TIMP-1 and -3, are expressed in psoriatic lesions.
Pterygium
Active matrilysin (MMP-7) in human pterygia: potential role in angiogenesis.
Pulmonary Arterial Hypertension
Matrix metalloproteinase 7 in diagnosis and differentiation of pulmonary arterial hypertension.
Pulmonary Disease, Chronic Obstructive
Is MMP-7 Gene Polymorphism a Possible Risk Factor for Chronic Obstructive Pulmonary Disease in Turkish Patients.
MMP-3 (-1171 5A/6A; Lys45Glu) variants affect serum levels of matrix metalloproteinase (MMP)-3 and correlate with severity of COPD: A study of MMP-3, MMP-7 and MMP-12 in a Tunisian population.
Plasma sE-cadherin and the plasma sE-cadherin/sVE-cadherin ratio are potential biomarkers for chronic obstructive pulmonary disease.
Sputum biomarkers in IPF: Evidence for raised gene expression and protein level of IGFBP-2, IL-8 and MMP-7.
Pulmonary Edema
Osteopontin Exacerbates Pulmonary Damage in Influenza-Induced Lung Injury.
Pulmonary Fibrosis
Antifibrotic effects of a novel pirfenidone derivative in vitro and in vivo.
Associations of MMP-7 and OPN gene polymorphisms with risk of coal workers' pneumoconiosis in a Chinese population: a case-control study.
Current Concepts of Biliary Atresia and Matrix Metalloproteinase-7: A Review of Literature.
Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans.
Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium.
Matrix Metalloproteinases-7 and Kidney Fibrosis.
Overexpression of matrix metalloproteinase-7 in pulmonary fibrosis.
Time course of matrix metalloproteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis.
Q Fever
Involvement of matrix metalloproteinases in chronic Q fever.
Rectal Neoplasms
Association of E1AF mRNA expression with tumor progression and matrilysin in human rectal cancer.
Clinicopathologic and prognostic significance of MMP-7 (matrilysin) expression in human rectal cancer.
Effect of preoperative radiotherapy on matrilysin gene expression in rectal cancer.
Expressions of Matrix Metalloproteinase-7 and -9 and their Prognostic Significances in Rectal Cancer.
The matrix metalloproteinase-7 and pro-enzyme of metalloproteinase-1 as a potential marker for patients with rectal cancer without distant metastasis.
Tumour matrilysin expression predicts metastatic potential of stage I (pT1) colon and rectal cancers.
[Expression and clinical significance of matrilysin (MMP-7) in human rectal cancer]
Renal Insufficiency, Chronic
Matrix metalloproteinase-7 as a surrogate marker predicts renal Wnt/?-catenin activity in CKD.
MMP-7 as a potential marker of cardiovascular complications in patients with chronic kidney disease (CKD).
The Many Faces of Matrix Metalloproteinase-7 in Kidney Diseases.
Reperfusion Injury
Matrix metalloproteinase-7 protects against acute kidney injury by priming renal tubules for survival and regeneration.
Reproductive Tract Infections
Role of matrix metalloproteinase-7 in the modulation of a Chlamydia trachomatis infection.
Respiratory Insufficiency
Implications for matrix metalloproteinases as modulators of pediatric lung disease.
Retinoblastoma
[Analysis of angiogenesis associated factors of retinoblastoma cell line and tumor tissues]
Rheumatoid Nodule
MMP expression in rheumatoid inflammation: the rs11568818 polymorphism is associated with MMP-7 expression at an extra-articular site.
Salivary Gland Neoplasms
Matrix metalloproteinase (MMP)-7 in salivary gland cancer.
Sarcoidosis
Elevated matrilysin levels in bronchoalveolar lavage fluid do not distinguish idiopathic pulmonary fibrosis from other interstitial lung diseases.
Matrix metalloproteinases and their tissue inhibitors in the lesions of cardiac and pulmonary sarcoidosis: an immunohistochemical study.
Plasma matrix metalloproteinase 7, CC-chemokine ligand 18, and periostin as markers for pulmonary sarcoidosis.
Serum metalloproteinases 1 and 7 in the diagnosis of idiopathic pulmonary fibrosis and other interstitial pneumonias.
[Change of matrix metalloproteinase-1 and matrix metalloproteinase-7 in serum and bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and sarcoidosis].
Sarcoidosis, Pulmonary
Plasma matrix metalloproteinase 7, CC-chemokine ligand 18, and periostin as markers for pulmonary sarcoidosis.
Sarcoma
Effusion cytodiagnosis of carcinosarcoma derived from the female genital tract: immunohistochemical features of MMP-7 and Ki-67 and immunofluorescence double staining analyses of eight cases.
Osteosarcoma oncogene expression detected by in situ hybridization.
Scleroderma, Localized
Immunohistochemical Similarities between Lichen Sclerosus et Atrophicus and Morphea: A Case Study.
Scleroderma, Systemic
Elevated MMP-7 levels in patients with systemic sclerosis: correlation with pulmonary involvement.
Seizures
Matrix metalloproteinase-7 regulates cleavage of pro-nerve growth factor and is neuroprotective following kainic acid-induced seizures.
Silicosis
Effects of tetrandrine combined with acetylcysteine on exercise tolerance, pulmonary function and serum TNF-?1 and MMP-7 in silicosis patients.
Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: a case-control study.
Sinusitis
Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: expression in chronic sinusitis vs nasal polyposis.
Skin Diseases
Matrix metalloproteinase-7 could be a predictor for acute inflammation in psoriatic patients.
Skin Neoplasms
Autoantibodies against p53, MMP-7, and Hsp70 as Potential Biomarkers for Detection of Nonmelanoma Skin Cancers.
[VALUE OF METALPROTEINASES OF BLOOD IN PATHOGENESIS OF EPITELIAL SKIN TUMORS AND THE POSSIBILITY OF THEIR SURGICAL CORRECTION].
Squamous Cell Carcinoma of Head and Neck
A novel orthotopic mouse model of head and neck cancer and lymph node metastasis.
Active matrix metalloproteinase-7 is associated with invasion in buccal squamous cell carcinoma.
Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
COX-2, MMP-7 expression in oral lichen planus and oral squamous cell carcinoma.
Differential expression of c-jun and c-fos mRNAs in squamous cell carcinoma of the head and neck: associations with uPA, gelatinase B, and matrilysin mRNAs.
Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis.
High gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancer.
Integrin- and cadherin-mediated induction of the matrix metalloprotease matrilysin in cocultures of malignant oral squamous cell carcinoma cells and dermal fibroblasts.
Matrix metalloproteinase-7 and matrix metalloproteinase-25 in oral tongue squamous cell carcinoma.
Matrix metalloproteinases (MMPs) and inhibitor of metalloproteinases (TIMP) mRNA and protein expression in laryngeal squamous cell carcinoma.
MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues.
MMP-7 expression may influence the rate of distant recurrences and disease-specific survival in HPV-positive oropharyngeal squamous cell carcinoma.
MT1-MMP and MMP-7 in invasion and metastasis of human cancers.
Polymorphisms of matrix metalloproteinase-7 and -9 are associated with oral tongue squamous cell carcinoma.
Prognostic value of matrix metalloproteinases in oral squamous cell carcinoma.
Regulation of programmed-death ligand in the human head and neck squamous cell carcinoma microenvironment is mediated through matrix metalloproteinase-mediated proteolytic cleavage.
The role of matrix metalloproteinases in squamous cell carcinomas of the head and neck.
Stomach Diseases
[Expressions of MMP-7 and TIMP-1 in Chronic Stomach Disease Patients with Different Syndromes of Chinese Medicine].
Stomach Neoplasms
?-Catenin-independent noncanonical Wnt pathway might be induced in gastric cancers.
Apoptosis-promoting and migration-suppressing effect of alantolactone on gastric cancer cell lines BGC-823 and SGC-7901 via regulating p38MAPK and NF-?B pathways.
Association of extracellular cleavage of E-cadherin mediated by MMP-7 with HGF-induced in vitro invasion in human stomach cancer cells.
ASSOCIATION OF MMP-7 -181A>G POLYMORPHISM WITH COLORECTAL CANCER AND GASTRIC CANCER SUSCEPTIBILITY: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Catecholamine up-regulates MMP-7 expression by activating AP-1 and STAT3 in gastric cancer.
CD44v6, MMP-7 and nuclear Cdx2 are significant biomarkers for prediction of lymph node metastasis in primary gastric cancer.
Clinical Significance of Matrix Metalloproteinases in Blood Plasma of Patients with Gastric Cancer.
Coexpression of Matrix Metalloproteinase-7 and Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Biomarker in Gastric Cancer.
Comparative enzyme immunoassay of matrix metalloproteinases-2, -7, -9 and their tissue inhibitor-2 in tumors and plasma of patients with gastric cancer.
Correlation of lymph node metastases and expression of matrix metalloproteinase-7 in patients with gastric cancer.
Downregulation of SFRP5 expression and its inverse correlation with those of MMP-7 and MT1-MMP in gastric cancer.
Effect of hGC-MSCs from human gastric cancer tissue on cell proliferation, invasion and epithelial-mesenchymal transition in tumor tissue of gastric cancer tumor-bearing mice.
Elevated Serum Matrix Metalloproteinase-3 and -7 in H. pylori-Related Gastric Cancer Can Be Biomarkers Correlating with a Poor Survival.
Expression and significance of IGF-2, PCNA, MMP-7, and ?-actin in gastric carcinoma with Lauren classification.
Expression of ets-related transcriptional factor E1AF is associated with tumor progression and over-expression of matrilysin in human gastric cancer.
Expression of insulin-like growth factor-2, c-MET, matrix metalloproteinase-7 and MUC-1 in primary lesions and lymph node metastatic lesions of gastric cancer.
Expression of matrix metalloproteinase-7 involving in growth, invasion, metastasis and angiogenesis of gastric cancer.
Expression of MMP-7 and MT1-MMP in peritoneal dissemination of gastric cancer.
Expression of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancer.
Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric adenocarcinoma.
Expression of Wnt3, ?-catenin and MMP-7 in gastric cancer and precancerous lesions and their correlations with Helicobacter pylori infection.
Helicobacter pylori potentiates epithelial:mesenchymal transition in gastric cancer: links to soluble HB-EGF, gastrin and matrix metalloproteinase-7.
Helicobacter pylori strain-selective induction of matrix metalloproteinase-7 in vitro and within gastric mucosa.
Helicobacter pylori upregulates matrilysin (MMP-7) in epithelial cells in vivo and in vitro in a Cag dependent manner.
Increased expression of matrix metalloproteinase-7 in invasive early gastric cancer.
Inhibition of peritoneal dissemination in human gastric cancer by MMP-7-specific antisense oligonucleotide.
In vivo and in vitro inhibition of human gastric cancer progress by upregulating Kank1 gene.
Isocitrate dehydrogenase 2 inhibits gastric cancer cell invasion via matrix metalloproteinase 7.
Matrix metalloproteinase gene expressions might be oxidative stress targets in gastric cancer cell lines.
Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers.
Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer.
Meta-analysis of Associations Between four Polymorphisms in the Matrix Metalloproteinases Gene and Gastric Cancer Risk.
MMP-7 overexpression is an independent prognostic marker in gastric cancer.
Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas.
p120 and Kaiso regulate Helicobacter pylori-induced expression of matrix metalloproteinase-7.
Polymorphisms of matrix metalloproteinase-7 and chymase are associated with susceptibility to and progression of gastric cancer in Japan.
Prediction of peritoneal recurrence by the mRNA level of CEA and MMP-7 in peritoneal lavage of gastric cancer patients.
Prognostic significance of matrix metalloproteinase-7 in gastric cancer survival: a meta-analysis.
PTEN Gene Induces Cell Invasion and Migration via Regulating AKT/GSK-3?/?-Catenin Signaling Pathway in Human Gastric Cancer.
Relation of matrilysin messenger RNA expression with invasive activity in human gastric cancer.
Role of MMP-7 in the formation of peritoneal dissemination in gastric cancer.
Role of the Metalloproteinase-7 (181A>G) Polymorphism in Gastric Cancer Susceptibility: A Case Control Study in Kashmir Valley.
Secreted Protein Acidic and Rich in Cysteine (SPARC) Suppresses Angiogenesis by Down-Regulating the Expression of VEGF and MMP-7 in Gastric Cancer.
Stimulation of MMP-7 (matrilysin) by Helicobacter pylori in human gastric epithelial cells: role in epithelial cell migration.
The clinical value of Vav3 in peripheral blood for predicting lymphatic metastasis of gastric cancer.
The detection of Helicobacter pylori cag pathogenicity islands (PAIs) and expression of matrix metalloproteinase-7 (MMP-7) in gastric epithelial dysplasia and intramucosal cancer.
The influence of transforming growth factor-?, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer.
[Effects of FRZB on growth and metastasis of gastric cancer cell line SGC-7901]
Stomach Ulcer
Genetic variants in matrix metalloproteinase genes are associated with development of gastric ulcer in H. Pylori infection.
Stroke
Matrix metalloproteinase and cytokine profiles in monocytes over the course of stroke.
Optical Interference-Free Surface-Enhanced Raman Scattering CO-Nanotags for Logical Multiplex Detection of Vascular Disease-Related Biomarkers.
Serum tissue-degrading proteinases and incident cardiovascular disease events.
Subarachnoid Hemorrhage
High Serum Level of Matrix Metalloproteinase-7 Is Associated With Increased Risk of Spontaneous Subarachnoid Hemorrhage.
Thrombosis
Expression changes and roles of matrix metalloproteinases in a rat model of traumatic deep vein thrombosis.
Thymoma
Expression of matrix metalloproteinases 2 and 7 in tumor cells correlates with the World Health Organization classification subtype and clinical stage of thymic epithelial tumors.
Matrin 3 co-immunoprecipitates with the heat shock proteins glucose-regulated protein 78 (GRP78), GRP75 and glutathione S-transferase ? isoform 2 (GST?2) in thymoma cells.
Thyroid Cancer, Papillary
Inverse relationships between the expression of MMP-7 and MMP-11 and predictors of poor prognosis of papillary thyroid carcinoma.
Thyroid Carcinoma, Anaplastic
Down-regulation of matrix metalloproteinase-7 inhibits metastasis of human anaplastic thyroid cancer cell line.
Thyroid Neoplasms
Down-regulation of matrix metalloproteinase-7 inhibits metastasis of human anaplastic thyroid cancer cell line.
Tonsillitis
The role of matrix metalloproteinases in recurrent tonsillitis.
Trichiasis
Conjunctival gene expression profiling using pathway focused arrays reveals increased matrix metalloproteinase-7 (matrilysin) transcription in trachomatous trichiasis.
Tuberculosis
1alpha,25-dihydroxyvitamin D inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection.
Effect of 1, 25 dihydroxyvitamin D(3) on matrix metalloproteinases MMP-7, MMP-9 and the inhibitor TIMP-1 in pulmonary tuberculosis.
Mycobacterium tuberculosis, but not vaccine BCG, specifically upregulates matrix metalloproteinase-1.
Plasma levels of C-reactive protein, matrix metalloproteinase-7 and lipopolysaccharide-binding protein distinguish active pulmonary or extrapulmonary tuberculosis from uninfected controls in children.
Tuberculosis, Multidrug-Resistant
Matrix metalloproteinase-1 is regulated in tuberculosis by a p38 MAPK-dependent, p-aminosalicylic acid-sensitive signaling cascade.
Tuberculosis, Pulmonary
Effect of 1, 25 dihydroxyvitamin D(3) on matrix metalloproteinases MMP-7, MMP-9 and the inhibitor TIMP-1 in pulmonary tuberculosis.
Uremia
Matrix metalloproteinase-7 in platelet-activated macrophages accounts for cardiac remodeling in uremic mice.
Ureteral Obstruction
Matrilysin (MMP-7) expression in renal tubular damage: association with Wnt4.
Urinary Bladder Neoplasms
A multiplexed, particle-based flow cytometric assay identified plasma matrix metalloproteinase-7 to be associated with cancer-related death among patients with bladder cancer.
Association of Matrix Metalloproteinase-7 Genotypes with the Risk of Bladder Cancer.
Matrix metalloproteinase-7 as a marker of metastasis and predictor of poor survival in bladder cancer.
MMP-7 Serum and Tissue Levels Are Associated with Poor Survival in Platinum-Treated Bladder Cancer Patients.
Molecular basis for the involvement of thymidine phosphorylase in cancer invasion.
Positive Correlation between Matrix Metalloproteinases and Epithelial-to-Mesenchymal Transition and its Association with Clinical Outcome in Bladder Cancer Patients.
Preoperative levels of matrix metalloproteinase-7 and -9 and tissue inhibitor of matrix metalloproteinase-1 relation to pathologic parameters in bladder carcinoma patients.
Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer.
The association between matrix metalloproteinase-7 genetic variant and bladder cancer risk in a Chinese Han population.
Urinary matrix metalloproteinase-7 level is associated with the presence of metastasis in bladder cancer.
Validation of Circulating MMP-7 Level as an Independent Prognostic Marker of Poor Survival in Urinary Bladder Cancer.
[Siliconchiptechnology-based MMP-7 analysis in urine : An option for preoperative identification of lymph node metastasis in bladder cancer.]
Uterine Cervical Neoplasms
Association between expression of MMP-7 and MMP-9 and pelvic lymph node and para-aortic lymph node metastasis in early cervical cancer.
Correlation of polymorphism of IL-8 and MMP-7 with occurrence and lymph node metastasis of early stage cervical cancer.
Endothelium specific matrilysin (MMP-7) expression in human cancers.
Matrix metalloproteinase-7 may serve as a novel biomarker for cervical cancer.
MMP-7 (-181A>G) promoter polymorphisms and risk for cervical cancer.
[Expression of ETV5 and MMP-7 in Early Stage Cervical Squamous Cell Carcinoma and Its Role in Lymphatic Metastasis.]
Vaccinia
The vaccinia virus G1L putative metalloproteinase is essential for viral replication in vivo.
Varicose Ulcer
Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds.
Varicose Veins
Pathogenesis of primary varicose veins.
Vascular Diseases
Optical Interference-Free Surface-Enhanced Raman Scattering CO-Nanotags for Logical Multiplex Detection of Vascular Disease-Related Biomarkers.
Vascular System Injuries
Protease-activated receptor-1 antagonist F 16618 reduces arterial restenosis by down-regulation of tumor necrosis factor ? and matrix metalloproteinase 7 expression, migration, and proliferation of vascular smooth muscle cells.